This week’s DeviceTalks Weekly is a bit of a retrospective on Medtronic’s Symplicity Spiral Renal Denervation System. It obviously ends on a happy note, and we’ll catch up with Jason Weidman, SVP and president of Medtronic’s Coronary and Renal Denervation business in an interview conducted in January. Thank you to AcuityMD for sponsoring this podcast. www.acuityMD.com. Weidman talked with Co-Host Tom Salemi last month to recap a bit of a history of the program including the dramatic – and successful – conclustion at the FDA. We also draw from an earlier interview Weidman gave to our MedtronicTalks Podcast in 2021. Together, these clips and interviews reflect the time and dedication that ambitious medtech programs require. In the current interview, Weidman also give a glimpse of renal denervation’s future. Other resources Medtech Talk Podcast - https://medtechmvp.com/media/medtech-talk-podcast/Mark-Gelfand-Howard-Levin-Discuss-Coridea-Ardian-and-How-They-re-Innovating-Medtech-Innovation 2021 MedtronicTalks Podcast with Jason Weidman - https://www.devicetalks.com/weidman-talks-us-through-the-long-road-to-ge Co-Host Chris Newmarker, executive editor of MassDevice, also discusses his new article – 10 Surgical Robotic Companies that You Need to Know. https://www.massdevice.com/10-surgical-robotics-companies-you-need-to-know-2024/ Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast player.

We’ll open this week’s episode with Paul Grand, CEO of the MedTech Innovator. Grand issued a last call for medical device entrepreneurs to apply to be part of this year’s program. Lots of good stuff come with it. Listen to the episode and apply at MedTechInnovator.org. Then Co-Hosts Tom Salemi and Chris Newmarker interview successful startup CEO Bill Gruber about his new book, The Leadership Blueprint. Gruber shares some experiences and lessons, but entrepreneurs are encouraged to buy the book on Amazon. Finally, Tom Salemi interviews Ahmet Tezel, Company Group Chairman and Global Head of J&J MedTech Innovation and R&D about his path into medtech and what the future holds for Johnson & Johnson and the medical device industry. Thank you to the sponsor of this episode – Tecan. Here’s a message - Tecan brings all the healthcare OEM pieces together with fully integrated solutions across the entire MedTech and life sciences spectrum from idea to implementation. Partner with us to revolutionize the way you develop medical technology with the Emphysys approach and turn your visionary ideas into a tangible reality in a matter of months, not years. www.emphysys.com/ Thank you for listening to the DeviceTalks Podcast Network. Subscribe now to the DeviceTalks Podcast Network.

This episode of AI Meets Life Sci emphasizes the prognostic and point-of-care decision-making power of AI in oncology while addressing real-world implementation issues from regulation and liability to clinician trust and adoption, through conversations with leaders at GE HealthCare and Catalyze Healthcare. In the first segment, Ben Newton, General Manager of Oncology at GE HealthCare describes likely future advances in multimodal computing, which could parse diverse datasets from pathology, imaging, genomics and other domains to predict likely outcomes in given treatment scenarios. Newton also emphasized AI's ability to help overwhelmed physicians by alleviating workflow bottlenecks and assisting with point-of-care decision making. Despite the promise, he underscored that such advances rely on incorporating clinicians’ valuable perspective when developing these AI systems and partnerships with other industry stakeholders, such as cloud partners like AWS and academic centers or hospitals, to access data and create foundation models. In the second segment, Haley Schwartz, CEO at Catalyze Healthcare, highlights the potential of using AI for screening applications as an initial stepping stone to build trust and adoption. She also notes that potential headwinds for hospital adoption of AI are questions related to legal liability and reimbursement impacts. In addition, Schwartz emphasizes the importance of physician involvement, especially during the early stages of AI integration into healthcare. Join us for the next episode of AI Meets Life Sci, featuring a keynote interview with Helen Merianos, Head of Sanofi’s R&D Portfolio Strategy. Thank you to our contributors, some of whom include Catalyze Healthcare and SmartTRAK Business Intelligence, for providing invaluable support. www.catalyzehealthcare.com www.smarttrak.com Tune in and subscribe to AI Meets Life Sci on all major podcast channels and follow youtube.com/@DeviceTalks or AI Meets Life Sci YouTube Podcast to ensure you never miss an episode. WATCH, LISTEN, and READ. Thank you for supporting AI Meets Life Sci! Read Now: Watch Now: youtu.be/XtGbJ-2Jyro

In this podcast we’ll talk with two CEOs scaling tall Medtech mountains. First, co-hosts Chris Newsmarker and Tom Salemi chat with Jan De Backer, CEO of Fluidda, developer of a novel new diagnostic tool for respiratory health. De Backer explains how his company is trying to bypass hospitals and build a new commercial path to patients. Then, Salemi talks with Scott Nelson, CEO of FastWave Medical, an innovative new company developing a new intravascular lithotripsy device. How does the start-up intend to compete with market leader Shockwave Medical? Thank you for listening to this episode of the DeviceTalks Weekly Podcast Don’t miss a future episode. Subscribe to the DeviceTalks Podcast Network.

This episode of Boston Scientific Talks features Boston Scientific's entrance into advanced endoluminal surgery and obesity management, spearheaded by its acquisition of Apollo Endosurgery in November 2022. Chief Medical Officer, Endoscopy Brian Dunkin, MD and SVP and President, Endoscopy Mike Jones explore the strategic value of this acquisition and the integration of Apollo's technology, which is poised to potentially revolutionize endoscopic procedures. The discussion centers on the potential of Apollo's technology in broadening Boston Scientific's endoluminal surgery capabilities. Jones highlights the addition of the overstitch device, which enhances the company's ability to perform endoscopic suturing and endoluminal sleeve gastroplasty, addressing obesity through minimally invasive means. Additionally, Dr. Dunkin provides a clinical perspective on how these technologies represent a paradigm shift in surgery, moving towards scarless, pain-free operations. They also explore the role of GLP-1 medications in the medical device market, underlining how pharmaceuticals complement devices in obesity treatment. The episode gives a comprehensive view of Boston Scientific's strategy in integrating Apollo's technology into its portfolio, the challenges of training and adoption, and the optimism for future innovations in minimally invasive procedures. Thank you to Freudenberg Medical for sponsoring this episode. Please visit Freudenberg Medical’s dedicated webpage at https://www.freudenbergmedical.com/en/single-use-scopes/ to learn more about their specific expertise in this area and to access Freudenberg Medical’s trend paper on the topic. Thank you for listening to the Boston Scientific Podcast. Subscribe to this podcast on every major podcast platform, https://linktr.ee/DeviceTalks

In this special episode of AbbottTalks, recorded live from DeviceTalks West in October 2023, we celebrate a pivotal moment in medical innovation: the 20th anniversary of Abbott's MitraClip™, a revolutionary device introduced in 2003. In the episode, the inventor of the MitraClip, Frederick St. Goar, MD, Interventional Cardiologist, El Camino Health, and Abbott's Santosh Prabhu, PhD, Divisional VP, Global Product Development, discuss the journey of the MitraClip, reflecting on its inception, evolution, and lasting impact on cardiac care over the past two decades. Dr. Goar provides insights into the early challenges and motivations behind inventing the MitraClip, emphasizing its role in transforming minimally invasive cardiac procedures. He reflects on the initial concept, design iterations, and clinical experiences with the device. Dr. Prabhu discusses the continuous enhancements made to the MitraClip since its inception, focusing on improved safety, efficacy, and usability. He highlights the MitraClip's role in reducing hospitalizations and improving patient outcomes, as evidenced by the five-year results from the landmark COAPT™ trial. The episode pays tribute to the legacy of the MitraClip, acknowledging its significant contribution to medical technology and patient care and emphasizing the importance of interdisciplinary collaboration and patient-centric approaches in medical innovation. Thank you to Zeus for sponsoring this episode of AbbottTalks. For more information about Zeus go to www.ZeusInc.com. Thanks for listening to this episode of the AbbottTalks podcast. Please subscribe to the DeviceTalks Podcast Network. COAPT Trial Release -https://abbott.mediaroom.com/2023-03-05-Late-Breaking-Data-from-Landmark-COAPT-TM-Trial-Show-Long-Term-Benefits-of-Abbotts-MitraClip-TM-Device MitraClip History - https://www.abbott.com/corpnewsroom/products-and-innovation/the-mitraclip-story.html#:~:text=MitraClip's%20story%20starts%20in%20California,The%20idea%20was%20unheard%20of.

In the latest episode of MedtechWOMEN Talks, Vivian Golfin, MD, Senior Associate at Intuitive Ventures, shares her expertise on the role of venture capitalists in the medical device product development cycle from the perspective of "The Venture Capitalist." In the episode, Dr. Golfin discusses the significance of early engagement with venture capital firms for startups and how Intuitive Ventures acts as a strategic partner rather than just a financier. She emphasizes the detailed due diligence process, focusing on understanding the risks and potential of medical device startups. Key topics include the importance of milestones like first-in-human trials, early pilot results, and the necessity of feedback in the development process. Dr. Golfin also addresses the evolving role of AI and ML in medical devices and the importance of data diversity. Her insights highlight the need for proactive communication, networking, and leveraging AI for health equity. Thank you to our sponsors Aptyx, Catalyze Healthcare, Confluent Medical Technologies, and Cretex Medical for providing vital support. https://aptyx.com/ https://catalyzehealthcare.com/ https://confluentmedical.com/ https://www.cretex.com/ Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. Thank you for supporting MedtechWOMEN Talks!

In the first episode of 2024, co-hosts Tom Salemi and Chris Newmarker bring Jonathan Norris, managing director of HSBC Innovation Banking, into the booth to review the medtech portion of the HSBC Venture Healthcare Report. Last year wasn’t medtech’s strongest, but Jon Norris gives entrepreneurs actionable advice and reason for hope. You can find the entire report on the Linked. Check the feed of Norris and Salemi for a link to the report. Or go here https://www.linkedin.com/feed/update/urn:li:activity:7148682579204800512/ Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network to receive future episodes of our many great shows.

In the inaugural episode of Ortho Innovation Talks: Zimmer Biomet, Rachel Ellingson, SVP and Chief Strategy Officer at Zimmer Biomet, shares insights into the company's growth strategy, emphasizing that growth can be achieved not only through addition - like innovation and acquisition - but also through subtraction, such as exiting lower growth, non-core businesses. In the episode, Ellingson discusses the decision to spin off Zimmer Biomet's spine and dental businesses and the significant undertaking required to create a new public company, which required integrating and then disintegrating business segments, building corporate infrastructure, and establishing a dedicated leadership team for the new entity - a major initiative involving over 500 people and a dedicated separation management office. Lastly, Ellingson discusses what's next in Zimmer Biomet's growth strategy, citing a balance between internal innovation and M&A and noting that the company plans to launch over 40 new products in the next 36 months, focusing on markets with at least 4% growth. Thank you to our season one sponsors, AcuityMD and Millstone Medical! Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. WATCH and LISTEN below, thank you for supporting Ortho Innovation Talks!

In our final DeviceTalks Weekly of the year, the news team assembles to highlight MassDevice’s Top Medtech Trends of 2023. Let us know if you think we missed something, but we think we recorded all the hits. Thank you for being part of DeviceTalks! We look forward to sharing YOUR stories in 2024. Happy New Year and Go Medtech! Thank you for listening to the DeviceTalks Weekly Podcast. Please subscribe to the DeviceTalks Podcast Network.

This episode of AI Meets Life Sci explores the potential for data-driven innovation in healthcare, through conversations with leaders at Microsoft and 1910 Genetics. In the first segment, Elena Bonfiglioli, Global Business Leader for Healthcare, Pharma and Life Sciences at Microsoft, discusses the significance of computation, an essential element of AI investments, in enhancing R&D productivity in healthcare. She emphasizes the need for new approaches to drug development, including shorter clinical trial timelines and the shift toward more efficient R&D. Bonfiglioli also highlights the importance of multimodal data in research and development. In addition, speaks to the integral role of computational methods in drug development, emphasizing how they augment our disease understanding and clinical trial design. In the second segment, Jen Nwankwo, PhD, Founder & CEO of 1910 Genetics - a Y Combinator and Sam Altman-backed startup, shares the innovation strategies around drug discovery. She details their problem-first approach, leading to an integrated, modality-agnostic drug discovery tech stack. Dr. Nwankwo highlights the use of Azure Quantum Elements in accelerating molecular simulations, positioning 1910 Genetics uniquely in designing both small and large molecules. Their global approach to accessible drug discovery through strategic partnerships is emphasized. Join us for the next episode of AI Meets Life Sci, featuring an exclusive interview with Ben Newton, Chief Digital Officer and GM of Oncology at GE Healthcare. Thank you to our contributors, some of whom include Catalyze Healthcare and SmartTRAK Business Intelligence, for providing invaluable support. Tune in and subscribe to AI Meets Life Sci on all major podcast channels and follow youtube.com/@DeviceTalks or AI Meets Life Sci YouTube Podcast to ensure you never miss an episode. WATCH, LISTEN, and READ. Thank you for supporting AI Meets Life Sci! Read Now: www.drugdiscoverytrends.com/microsoft-1910-genetics-data-hidden-gems

In this episode, we’ll talk with Medtech Industry Veteran Bill Hunter about the state of Medtech. The CEO of Canary Health, a leader in medical device sensor technology and data collection, draws lessons from his long career in the industry, sharing his victories and a moment he had previously considered a defeat. Be sure to follow Bill Hunter on LinkedIn. Then, CEO Blake Richards introduces us to Elucid, which developed a software as a service company that can help physicians to better determine the severity of vascular disease. How did Elucid raise over $100 million and venture capital, and what new policies will bolster its bottom line. Thanks for listening to the DeviceTalks Weekly Podcast. Please subscribe to the DeviceTalks Podcast Network.

In the second episode of MedtechWOMEN Talks, our guest Kathryn Rieger, PhD, Sr. Director, Human Factors & User Research at Intuitive, shares her insights on the medical device product development cycle from the perspective of "The Engineer." Drawing from her unique background in military tech and auto tech and her extensive experience in medtech, Dr. Rieger shares insights into how engineers influence the essential stages of the medical device product development cycle. In the episode, Dr. Rieger emphasizes the rigorous nature of verification and validation processes in medtech, underlining the importance of document control and thorough testing to ensure device safety and functionality. She also highlights the role of clinical studies in pre-market validation, underlining the significance of balancing safety considerations with regulatory compliance. Additionally, Dr. Rieger discusses the growing role of AI and machine learning in optimizing development processes while prioritizing user needs and safety. TL;DR - Key takeaways: 1. Integrating user experience and safety is crucial in medical device development. 2. A multidisciplinary approach to medtech product development is key. 3. Effective collaboration and communication are critical to successful product launches. Thank you to our sponsors Aptyx, Catalyze Healthcare, Confluent Medical Technologies, and Cretex Medical for providing vital support. aptyx.com catalyzehealthcare.com confluentmedical.com cretex.com Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. Thank you for supporting MedtechWOMEN Talks!

In this episode we’ll talk with Sean Gilligan, chief operating officer at AVS (Amplitude Vascular Systems), about that company’s big play in intravascular lithotripsy, the approached pioneered by vascular leader Shockwave Medical. Gilligan gives some detail on the company’s new approach and shares some insights from his own career as well. We also visit with Steve Levine, Sr. Director, Virtual Human Modeling, and Afrah Shafquat, Senior Data Scientist, both of Dassault Systemes, which sponsored this episode. The pair shared insights on what medical device companies can expect to see from a new set of guidelines being issued for digital simulations in Medtech regarding in silico clinical trials. For more information go to https://www.3ds.com/industries/life-sciences-healthcare/medical-device. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss an episode.

In this episode of Boston Scientific Talks, Paudie O'Connor, SVP of Global Supply Chain, reflects on how Boston Scientific is overcoming initial supply chain challenges by establishing a new operational efficiency and sustainability standard. Additionally, O'Connor highlights Boston Scientific's strategic shift towards more sustainable practices, including a significant reduction in carbon footprint by transitioning from air to ocean freight, reducing carbon footprint by 96%, and aiming for a 90% ocean freight rate by 2026. This shift necessitates infrastructural investments, such as building sterilization facilities closer to manufacturing sites, enabling direct market shipping, and significantly cutting down on ethylene oxide consumption. The discussion also covers innovations in packaging, with a move towards digital instructions and tailored packaging for different markets. This approach aligns with environmental goals while catering to diverse regulatory requirements. Lastly, O'Connor speaks to the role of supplier partnerships in achieving these ambitious targets, underlining Boston Scientific's commitment to not only navigating but also redefining the supply chain norms in the medical device industry. Listen to this episode of the DeviceTalks Weekly Podcast to hear more about Paudie O'Connor's career and work at Boston Scientific. https://www.devicetalks.com/what-boston-scientifics-evolving-supply-chain-strategy-means-for-partners-productivity-and-ma/  Thank you to Xometry for sponsoring this episode. Visit www.xometry.com to learn more about Xometry and get an instant quote or injection molding quote today.  Thank you for listening to the Boston Scientific Podcast. Subscribe to this podcast on every major podcast platform.

In this episode of StrykerTalks, neurovascular president Jim Marucci discusses the company's latest advancements in neurovascular technology and how that, and its expanding global footprint, are shaping the future of its neurovascular division. Marucci details the company's recent strategic acquisition of Cerus Endovascular, which has increased Stryker's capabilities in treating wide-neck bifurcated aneurysms. Furthering Stryker's goal to simplify procedures, reduce costs, and improve patient outcomes. The conversation also touches on developing new products like the Target Tetra detachable coil for smaller aneurysms and the potential of emerging technologies like AI, AR, and VR in neurovascular procedures. Marucci anticipates these technologies will play a crucial role in advancing the field and improving access to care globally. Tune in for a comprehensive overview of Stryker's current strategies, product innovations, and future directions in the neurovascular sector, underlining its commitment to enhancing stroke care and neurovascular treatments worldwide. Thank you to Zeus for sponsoring this episode. To learn more about how Zeus works with medical device companies, visit www.zeusinc.com. Thank you for listening to the StrykerTalks Podcast. Subscribe to this podcast on every major podcast platform.

In the first episode of the newest series from the DeviceTalks Podcast Network, our guest Kirsten Carroll, CEO of Kandu Health shares her insights on the medical device product development cycle from the perspective of "The Product Director." With more than a decade and a half in product management for Boston Scientific and Stryker Neurovascular, Kirsten discusses the roles of product management, design verification, and design validation in ensuring a successful product launch. She also highlights the significance of generating clinical evidence and tailoring it to different stakeholders. Kirsten's key message is the value of effective communication and collaboration in developing and launching medical devices. TL;DR Key take-aways: 1. Collaboration between different teams is crucial in the medical device product development cycle. 2. User needs should be clearly defined and translated into specifications for design verification. 3. Design validation involves testing the product with the intended users to ensure it meets their expectations. 4. Clinical evidence generation should align with the specific needs of different stakeholders. 5. Effective communication and collaboration are essential for successful product development and launch. Thank you to our sponsors Aptyx, Catalyze Healthcare, Confluent, and Cretex Medical for providing vital support. Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. Thank you for supporting MedtechWOMEN Talks.

In this episode, we’ll hear from Fred Khosravi, CEO of Imperative Care, a medical device company that is taking an unusually holistic approach to helping people who have suffered strokes. Host Tom Salemi interviewed the successful medical device CEO at DeviceTalks West. Before that we’ll talk with Delphine Zurkiya, senior partner at McKinsey & Co., about a new report that lays out a blueprint for medical device companies to improve efficiencies in R&D and customer outreach. But first we’ll highlight our newest member of the DeviceTalks Podcast family – AI Meets Life Sci – with co-hosts Kayleen Brown and Brian Buntz! Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast application.

Welcome to AI Meets Life Sci, the newest video podcast from DeviceTalks and Drug Discovery & Development. Co-hosted by Kayleen Brown, managing editor at DeviceTalks, and Brian Buntz, pharma and biotech editor, the series offers a comprehensive look into the intersection of AI and life sciences from two unique perspectives. In the first segment, Paul Friedman, MD, Chair of the Department of Cardiovascular Medicine at Mayo Clinic, and Dave McMullin, Chief Business Officer of Anumana, discuss the groundbreaking collaboration between Mayo Clinic and Anumana in applying AI to enhance cardiovascular diagnostics, particularly through ECGs. They explore how AI can detect cardiac conditions early, with a focus on the EAGLE study's findings on AI-enhanced ECGs, and discuss Anumana's role in transforming these AI innovations into accessible medical devices. In the second segment, Jeff Elton, PhD, CEO of ConcertAI, speaks to the transformative role of AI in clinical trials. He sheds light on AI's capabilities in improving patient selection for clinical trials and streamlining processes within life sciences. Dr. Elton emphasizes the broader implications of AI, from enhancing patient care to accelerating the development of new treatments, and discusses the ethical considerations of AI integration in healthcare.These interviews provide insights into the evolving roles of AI in various sectors like medtech, pharma, and biotech, showcasing its potential in transforming healthcare and research methodologies. But that's not all! Join us for the next episode of AI Meets Life Sci, which features an interview with the Global Business Leader for Health and Life Sciences at Microsoft. Catch the full episode on major podcast platforms and YouTube to dive deeper into the exciting convergence of AI and healthcare. Thank you to our contributors, some of who include Catalyze Healthcare and SmartTRAK Business Intelligence, for providing vital support. To learn more about our contributors, visit: www.catalyzehealthcare.com and www.smarttrak.com. Thank you for watching and listening to AI Meets Life Sci.

In this week’s episode we’ll speak with Rocco De Bernardis, Global President of OTTAVA, Johnson & Johnson MedTech. This week, J&J MedTech announced it was filing an IDE to begin clinical trials on its surgical robotics system, Ottava, in 2024. But what does this mean? What does Ottava look like? Why does J&J MedTech think it has what it takes to win over surgeons? And what does the future look like for the company’s surgical robotics platform? Co-hosts Tom Salemi and Chris Newmarker also chat with Karthik Bolisetty, senior associate at VC firm Gilde Healthcare, about the impact GLP-1 drugs could have on medical device start-ups. How does Gilde see the weight loss drugs impacting its portfolio and future investments? Finally, Gregg Tobin, CEO of Aptyx, our episode sponsor, talks about how the company’s new name better reflects its capabilities. Go to Aptyx.com for more information. Thanks for listening to the DeviceTalks Weekly podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast application.

In this episode of Boston Scientific Talks, Boston Scientific's electrophysiology leaders, Ken Stein, MD, SVP, Global Chief Medical Officer and Nick Spadea-Anello, Global President of Electrophysiology, offer a deep dive into the transformative potential of the FARAPULSE Pulsed Field Ablation System. They discuss the strategic development and clinical advantages of this innovative technology, emphasizing its ability to target cardiac tissue while minimizing the risk of collateral damage to vital structures like the esophagus. The duo also explores the synergistic potential of combining PFA with devices like the WATCHMAN for stroke prevention, painting a picture of a more streamlined, patient-centric approach to cardiac care. With a keen eye on the future, they discuss the vision for expanding PFA's applications, including its role in treating a broader spectrum of arrhythmias and its adaptability to various procedural settings. Tune in to learn more about Boston Scientific's forward-thinking approach to cardiac ablation. Thank you to Dassault Systèmes for sponsoring this episode. To learn how Dassault Systèmes enables innovation in medtech, visit www.medtecheco.com/lifecycle. Thank you for listening to the Boston Scientific Podcast. Subscribe to this podcast on every major podcast platform.

In this special episode of IntuitiveTalks, recorded live from DeviceTalks West, Dave Rosa, President of Intuitive, shares the experience of the company's pioneering role in surgical robotics. Rosa reflects on the initial skepticism faced by the company and the subsequent validation of their work as the industry has grown to embrace robotic assistance in surgery. He also discusses the balance between innovation and the practicalities of scaling a business, emphasizing the importance of reliability and supply chain management in healthcare technology. Rosa also addresses the future of surgical robotics, hinting at a shift towards more compact and specialized devices that could transform patient care. He highlights the economic benefits of robotic surgery, particularly its potential to reduce the overall costs of healthcare while improving surgical outcomes. A must for all medtech stakeholders, this episode offers a thoughtful perspective on leading a company at the forefront of medical technology. Rosa's conversation is a blend of personal experience and professional insights, providing valuable lessons on growth, adaptation, and the continuous effort to improve surgical care. Thanks to maxon Group for sponsoring this episode. Visit https://www.maxongroup.us/maxon/view/content/medical to learn more about how maxon Group works with medical device companies. Thank you for listening to the IntuitiveTalks Podcast. Subscribe to this podcast on every major podcast platform.

In this special episode of AbbottTalks, recorded live from DeviceTalks West, Julie Tyler, president of Abbott's Vascular business, discusses the company's strategic evolution and commitment to comprehensive patient care, including a new technology, the Esprit BTK, intended to be released next year. Additionally, Tyler provides an insider's perspective on Abbott's integration of Cardiovascular Systems Inc., revealing how this move enhances Abbott's portfolio and positions the company at the forefront of vascular health. Tyler's vision extends beyond current interventions, aiming to leverage data and predictive modeling to improve patient outcomes and potentially reduce the need for later-stage interventions. With a patient-centric approach, Tyler also discusses the challenges and successes in diversifying clinical trial demographics and expanding global reach. This episode is a must-listen for those interested in how strategic acquisitions and a holistic health model can redefine patient care. Thank you to Resonetics for sponsoring this episode. To learn more about how Resonetics works with medical device companies, visit https://resonetics.com/. Thank you for listening to the AbbottTalks Podcast. Subscribe to this podcast on every major podcast platform.

In this week’s episode, Quigen CEO Thierry Bernard gives us a look inside the diagnostics leader both today and a few years ago when it was responded to the world’s dire need for diagnostics. Bernard takes us back to the early days of the pandemic, including his perspective on how different countries responded to the crisis. We’ll also hear his vision for the future of diagnostics including how Qiagen will make testing even simpler. At the start of the show, Host Tom Salemi and Chris Newmarker, executive editor of life sciences, talk with Senior Editor Danielle Kirsh about the recently released Women in Medtech issue of Medical Design and Outsourcing magazine. Kirsh shares data she’s collected on how many women hold senior positions in the medical device industry. We’re seeing some progress, but not enough. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast player.

We recorded this episode on stage at the conclusion of DeviceTalks West. Our semi-esteemed panel included Co-Hosts Tom Salemi and Chris Newmarker as well as Sean Whooley of the Fast Five Podcast, Kayleen Brown of DeviceTalks, and Joe Mullings of The Mullings Group. We hit upon the highlights of DeviceTalks West. We hope you were there to enjoy the show yourself! Thanks to everyone who made #DTWest2023 such a huge success! Go Medtech!

Join us at DeviceTalks West on Oct. 18-19 at the Santa Clara Convention Center! In this episode, Tom Salemi invites all DeviceTalkers to our biggest West Coast meeting yet! Listen for the discount code (Oh heck, it’s DTW25). We’ll also run a replay of our interview with Dave Rosa, now president of Intuitive, who will be our opening keynote interview on Oct. 19. Register now at West.DeviceTalks.com! GO MEDTECH!

A college introduction to biomechanics set Nitin Salunke on an expected path into the medical device industry. But once his course was set Salunke helped manage innovative product launches at several large medical device companies including WL Gore, Cordis and Covidien/Medtronic. But Salunke always had his eyes on leading a start-up. In this discussion you’ll learn how he used each opportunity to help achieve that dream. Today, he leads Supira Medical, a white-hot startup developing a new type of pVAD. Salunke will also be a speaker at the upcoming DeviceTalks West meeting. Thanks for listening to this episode of DeviceTalks Weekly. Subscribe to the DeviceTalks Podcast Network on any major podcast channel.

In this episode of Boston Scientific Talks, Sandra Nagale, PhD, Director of Digital Health Platforms and Products, breaks down the transformative role of AI within the medical device industry. Motivated to drive impactful changes, Nagale emphasizes Boston Scientific's unwavering dedication to pioneering breakthrough medical solutions and enhancing patient and physician experiences through AI and emphasizes how products like BeatLogic and LUX-Dx ICM are redefining healthcare by providing actionable, real-time insights. Navigating the complexities of melding AI with healthcare, Nagale accentuates the necessity for solutions rooted in evidence that genuinely amplifies value. She highlights the urgency to streamline patient experiences, mitigate healthcare worker challenges, and elevate the patient journey. As Boston Scientific spearheads these advancements, Nagale envisions a future where medical devices seamlessly integrate into holistic patient care – from early detection to treatment. Dive into this episode to uncover how Boston Scientific is steering the medtech industry into an AI-augmented future. Thank you to S3 Connected Health for sponsoring this episode of Boston Scientific Talks. For more information about S3 Connected Health, go to s3connectedhealth.com. Thank you for listening to the Boston Scientific Podcast. Subscribe to this podcast on every major podcast platform.

This week’s episode is dedicated entirely to the 10 Finalists of MedTech Innovator’s Pitch Competitions. The final winners will be selected by the audience on Oct. 10 at the upcoming AdvaMed annual meeting. The finalists for MedTech Innovator’s grand prize of $350,000 are listed below. Click on the link to watch their 1-minute pitch video. Dr. Tom McClellan - Fingy3D - https://www.youtube.com/watch?v=KCoj_ZALf3c Amanda French - IFPx - https://www.youtube.com/watch?v=8B3j2weOkNo Jay Shah/Vivek Ganesh - Neurava - https://www.youtube.com/watch?v=lyUB9WCLeww Dr. Alex Woods - Newrotex - https://www.youtube.com/watch?v=MEhP_Ack32c Alex Ballatori/Shane Shahrestani - StrokeDx - https://www.youtube.com/watch?v=tdkl5QyDfD8 The companies listed below are vying for MedTech Innovator’s Execution Award. The winner will receive $25,000. Click on the link to watch their 1-minute pitch video. Harlee Sorkin - InterShunt Technologies - https://www.youtube.com/watch?v=QPi5FSRSjUQ Michael Ebner - Hypervision Surgical - https://www.youtube.com/watch?v=oTz-AXfwJgw Lori Arakaki - Opticyte - https://www.youtube.com/watch?v=AECmlLpv0hE Joanna Nathan - Prana Thoracic - https://www.youtube.com/watch?v=myjUp3Gg4mQ Dushyanth Surakanti - Sparta Biomedical - https://www.youtube.com/watch?v=wvS9PwpkT_c DeviceTalks’s Tom Salemi and Kayleen Brown visited with the founders and CEOs of each of the 10 companies. We’ll run through those interviews with Paul Grand, CEO of the MedTech Innovator program. Thanks for listening to the DeviceTalks Weekly Podcast Subscribe to the DeviceTalks Podcast Network on any major podcast application.

In the newest episode of AbbottTalks, Ryan Lakin, Divisional Vice President of Digital Solutions, Medical Devices at Abbott, delves deep into the transformative role of digital health solutions in the medical device landscape and emphasizes Abbott's commitment to not just treating the sick but also empowering individuals to maintain optimal health. Lakin shares insights into how Abbott's innovative technologies, like the FreeStyle Libre 2 glucose monitoring system and Lingo, are reshaping patient care by offering real-time data and insights. This proactive approach allows patients to understand their body's reactions to various stimuli, leading to more informed health decisions. Lakin also touches on the challenges of integrating digital tools into healthcare, highlighting the need for evidence-based solutions that genuinely add value. He underscores the importance of simplifying patient pathways, reducing healthcare worker burdens, and enhancing overall patient experiences. As Abbott continues to pioneer in this realm, Lakin speaks to a future where medical devices play a more holistic role in patient care, from prevention to intervention. Listen today to hear more on how Abbott is shaping the future of digital health. Thank you to GlobalMed-MDI for sponsoring this episode. To learn more about how GlobalMed-MDI works with medical device companies, visit www.moldeddevices.com. Thank you for listening to the AbbottTalks Podcast.

Osteoarthritis isn’t a typical target for startups but Moximed isn’t developing a typical device. In this episode, CEO Anton Clifford will walk us through the biomedical process that led to the decision to build a shock absorber that can stabilized an injured knee. The route been long, winding and has led the team over some bumpy roads but Moximed is poised to deliver on its long-time promise. At the start,co-hosts Tom Salemi and Chris Newmarker chat with Associate Editor Sean Whooley about Boston Scientific’s recent analyst day, with a tight focus on why Boston Scientific sees opportunity in China when other medical devices are withdrawing. Notes for this episode https://www.massdevice.com/boston-scientific-targets-next-level/ https://www.medicaldesignandoutsourcing.com/china-exposure-medtronic-intuitive-henry-schein-align-envista-dentsply-sirona/ https://www.massdevice.com/zimvie-reports-difficult-macroenvironment-q4-miss/ https://www.massdevice.com/category/massdevice-podcast/ Thanks for listening to the DeviceTalks Weekly Podcast Subscribe to the DeviceTalks Podcast Network on any major podcast player.

In this episode of IntuitiveTalks, Tony Jarc, Sr. Director of Digital & Machine Learning at Intuitive, walks us through the evolving landscape of surgical robotics, highlighting the transformative potential of AI and machine learning in enhancing surgical procedures, providing real-time guidance to ensure the best possible patient outcomes. Jarc also introduces Case Insights enabled by the My Intuitive hub, a digital tool designed to offer surgeons valuable post-operative feedback. But the platform's potential goes beyond the data. Jarc also underscores the significance of collaborating with surgeons from the early stages of product development to ensure its useability and effectiveness. As surgical robotics continue to advance, Jarc's insights provide a glimpse into how technology and human expertise can work in tandem for improved surgical procedures. Listen now to learn more about how Intuitive is not just embracing the intersection of AI and surgical robotics but using it to guide future opportunities. Thank you to TECAN, for sponsoring this episode of IntuitiveTalks. Visit tecan.com/paramit-design-to-manufacturing to hear from TECAN’s leadership team in an expert video series and to download TECAN’s Product Requirements Checklist to help you prepare for your product development. Thank you for listening to the IntuitiveTalks Podcast. Subscribe to this podcast on every major podcast platform.

This week we’ll visit with Daniel Hawkins, CEO of Avail Medsystems. Hawkins is a prolific and successful medtech entrepreneur who was an early employee at Intuitive and co-foudner of Shockwave Medical. Hawkins talks about both experiences, but DeviceTalks listeners should listen carefully for his insights on how ASCs are changing medtech and how OEMs are using Avail’s telepresence system to compensate. DeviceTalks Editorial Director Tom Salemi and Managing Editor Kayleen Brown share their takeways from the MedtechVISION conference in Menlo Park. The conference raised many themes that we’ll be exploring at DeviceTalks West on October 18-19 at the Santa Clara Convention Center. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on many major podcast player.

In this week’s episode, medical device pro Kurt Haggstrom details what led him to join high-flying neural implant company Synchron, which is one of the companies in a supposed race to create a direct link to the brain. Haggstrom will be sharing even more details at DeviceTalks West on Oct. 18-19 at the Santa Clara Convention Center. But today’s episode will give a sample of why he sees Synchron changing the world as it works to unlock “the natural highways of the brain.” We’ll also talk about the value of good engineering and marketing in medical devices. Find out more about Synchron here. https://synchron.com/ Executive editor Chris Newmarker joins us to discuss this week’s news that Philips reached a partial settlement in its class-action suit over sleep apnea machine recall. This isn’t the end of the story. To read all about the recall go here. https://www.massdevice.com/how-philips-significant-respiratory-devices-recall-unfolded/ Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast application.

This isn’t Bertin Nahum’s first surgical robotics rodeo. The CEO of Quantum Surgical previously co-founded, led and ultimately sold surgical robotics pioneer Medtech S.A. to Zimmer Biomet. Now, he’s leading several members of that founding team as Quantum Surgical develops a next generation of surgical robot to enable easier removal of cancerous tumors. Nahum brings great insight and perspective to the topic of surgical robotics, which is why he’ll sit on a panel of surgical robotic company CEOs and provider represents to discuss what surgical robotic systems of the future may look like. Register at DeviceTalks.com. Joining co-hosts Chris Newmarker and Tom Salemi is Danielle Kirsh, senior editor of MassDevice, to review a few of the highpoints of the current Medical Design and Outsourcing issue of the Big 100. We’ll talk about headcounts, R&D spends and CEO salaries. You can find the issue of the Big 100 here. https://www.medicaldesignandoutsourcing.com/september-2023-medtech-big-100-largest-device-companies/ Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast application.

In this episode of StrykerTalks, Andrés Rosales, VP and General Manager Endoscopy, delves into Stryker's groundbreaking 1788 visualization platform and and its potential to revolutionize surgical procedures. The 1788 visualization platform, Stryker's 26th generation camera, enables surgeons to see more so they can do more by visualizing tissue perfusion and illuminating cancer cells, ultimately improving patient outcomes. Rosales also discusses the newly 510(k) cleared SPY-PHI for lymphatic mapping within breast cancer, offering surgeons a more efficient and patient-friendly alternative to traditional radioactive markers. The innovation continues as Rosales hints at the future of Stryker's technology, emphasizing the role of data collection and algorithm development in improving surgical procedures. Tune in to discover how Stryker is setting new standards in surgical visualization and how Stryker is collaborating with customers to create meaningful tools that improve the patient experience. Thank you to GlobalMed-MDI for sponsoring this episode. To learn more about how GlobalMed-MDI works with medical device companies, visit www.moldeddevices.com. Thank you for listening to the StrykerTalks Podcast. Subscribe to this podcast on every major podcast platform

In this week’s podcast, we’ll visit with John McCutcheon, president and CEO of EBR Systems, which is developing a miniature pacemaker that is powered by ultrasound and located in the left ventricle of the heart. McCutcheon shares his plans for the start-up but more on the point of this week he recalls his experience as CEO of Emphasys Medical, an interventional pulmonology start-up that received a shocking negative recommendation from an FDA panel in 2008. The no vote led to the shutdown and sale of Emphasys, but the rejection ultimately helped convince the FDA and industry to assess their relationship. Ultimately, the two sides improved relations as McCutcheon explains in the podcast. The rejection is somewhat reminiscent of the negative vote issued this week by an advisory panel for Medtronic’s Symplicity Spyral renal denervation (RDN) therapy for hypertension. McCutcheon explains how the negative impact impacted him at the time, but more important how he’s moved on to appreciate the experience. Thanks for listening to the DeviceTalks Podcast Network. Subscribe to the DeviceTalks Podcast Network on any major podcast application.

In the newest episode of AbbottTalks, Vish Charan, divisional VP of product development at Abbott, takes us through the inner workings of the recently FDA-approved AVEIR™ DR Dual Chamber Leadless Pacemaker System, from its inception to its successful clinical trial and FDA approval. Charan also dives deep into the technology, revealing the cutting-edge i2i communication technology that powers AVEIR™ pacemakers, enabling seamless communication between devices for dual chamber pacing and AV synchrony. Finally, Charan discusses the challenges of miniaturization, the remarkable advancements in battery technology that have made the AVEIR™ pacemaker possible, and the potential for further applications in conduction system pacing. As the field of cardiac rhythm management continues to evolve, Charan envisions a future of smaller devices, more features, and enhanced patient care. Make sure to listen in for invaluable insights into the groundbreaking AVEIR™ DR and its potential to transform the landscape of cardiac care. Thank you to Resonant Link for sponsoring this episode of AbbottTalks. For more information about Resonant Link go to www.Resonant-Link.com. Thank you for listening to the AbbottTalks Podcast.

As a thank you for subscribing and listening to the DeviceTalks Weekly Podcast we built a special code to help you register for the Oct. 18-19 DeviceTalks West conference at the Santa Clara Convention Center. Please give a listen! Go to DeviceTalks.com to register now!! Save $300 off the full registration price. Plus, we replay our keynote interview with Intuitive CEO Gary Guthart at last year’s DeviceTalks West event. In this conversation Guthart will provide additional details of Intuitive’s move into endoscopic robotics including the ION robot. He’ll give his assessment of the growing competition in surgical robotics and what it means for Intuitive. Finally, he shares why he thinks the term surgical robotics may have no meaning in the future.

A little over a year after taking over the CEO role at Ambu A/S, Britt Meelby Jensen visits the DeviceTalks Weekly Podcast to draw lessons from her career that led her to lead the single-use endoscope leader last year. At the time, Meelby Jensen says Ambu was missing Wall Street expectations. In this interview, Jensen highlights the benefits of single-use endoscopes, such as improved workflow and reduced waiting times, and emphasizes Ambu's focus on sustainability. She’ll also review the company’s plan to retain its position in the white-hot single-use scope industry. But first Host Tom Salemi take a dive into earnings week with MassDevice Executive Editor Chris Newmarker and Associate Editor Sean Whooley. We won’t dig too deep into the numbers, but instead we’ll ask why Wall Street investors don’t seem too impressed with the performance of some high-flying medical device companies. Join us at DeviceTalks West on Oct. 18-19 for some in-person discussions! Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast application.

This special episode of Boston Scientific Talks brings you DeviceTalks Boston’s keynote conversation with Boston Scientific's executive leaders Meghan Scanlon, President of Urology; Jennifer Saunders, Sr. Manager of Medical Affairs; Ben Cutone, Global Franchise Director of Prostate Health; and Kristin LaRocca, Senior Vice President of Sales. In the conversation, the key figures delve into the innovative strategies and technologies shaping the urology field, highlighting the LithoVue™ Elite Single-Use Digital Flexible Ureteroscope System. They explore how Boston Scientific is addressing care disparities in underrepresented communities, pioneering programs like "close the gap" in cardiology, and advancing accessibility and equality. The conversation also highlights the importance of data-driven decision-making, clinical evidence, and humble dialogue with clinicians to commercialize innovative strategies. The panelists discuss the challenges and rewards of disrupting the market, the role of health economics, and the unique contributions of urologists as innovators. They also touch on commercial modeling and the importance of empathy, self-awareness, and courage in bringing new ideas to life. Tune in to discover how Boston Scientific is not only advancing urological care but also the way the leadership team approaches problems and solutions. Thank you to Clari for sponsoring this episode of Boston Scientific Talks. Go to Clari.com to learn about its unique revenue platform. Thank you for listening to the Boston Scientific Podcast. Subscribe to this podcast on every major podcast platform.

This week's episode features the first of what's sure to be many audio appearances by DeviceTalks Managing Editor Kayleen Brown! We’re also visited by Lisa Carmel and Stephanie Jone, co-chairs of MedtechWomen’s MedtechVISION conference, which is taking place on Sept. 12. They share how the conference's important agenda took shape. Go to MedtechWomen.org to register. Finally, we learn about an exciting new neuromodulation start-up called Motif Neurotech which is developing a tiny, implantable sensor that could advance how TMS therapy is delivered. Steve Goetz, a veteran of Medtronic’s neuromodulation business, explained why he left the giant to join this rising company as chief technology officer. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast application!

In the newest episode of AbbottTalks, Allen Burton, Divisional VP and Chief Medical Officer of Neuromodulation at Abbott, shares insights into the company's innovative neuromodulation therapies. Burton delves into Abbott's FDA-approved treatment for chronic back pain, which uses electrical stimulation to alleviate pain, improve functionality, and reduce reliance on opioids. Burton discusses Abbott’s recent FDA approval to treat people who suffer from back pain with limited surgical options. He also expands on how the company's pioneering treatment for painful diabetic peripheral neuropathy, a condition affecting millions of Americans. This treatment uses electrical stimulation to dampen painful signals in the feet, enabling patients to regain mobility and control over their lives. Burton further introduces the Eterna SCS System, the smallest neurostimulation system in the market, which offers patients a low charging burden and indications for MRI compatibility. Listen to the full episode to hear directly from Abbott's Neuromodulation CMO on how Abbott's patient-centric neuromodulation therapies are impacting the lives of patients suffering from chronic pain and diabetic peripheral neuropathy. Thank you to Resonant Link for sponsoring this episode of AbbottTalks. For more information about Resonant Link go to www.Resonant-Link.com. Thank you for listening to the AbbottTalks Podcast.

In this episode, Host Tom Salemi learns the Elixir Medical story from CEO Motasim Sirhan, who has spent most of his medtech career developing new vascular implants to prop open previously occluded blood vessels. Sirhan led developing of early version of bare metal stents while at Guidant. He’d go on to start and sell a company that developed another vascular device before pairing with Invus Group to start Elixir Medical in 2005. After a false start, the company is collecting promising clinical data for its DynamX vascular scaffolding system. We’ll learn why Sirhan sees this as an leap forward from drug-eluting stents. He also shares stories from his career about taking chances and overcoming fears. This episode is sponsored by DeviceTalks West. Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast application.

In this rare origin-story episode of Boston Scientific Talks, Boston Scientific Founder John Abele unravels the company's unique journey from its inception to becoming a global leader in the medical device industry. Abele delves into the strategic financial planning and diversified product portfolio that shielded the company during challenging times. He underscores the power of partnerships and educational initiatives in making their groundbreaking technology accessible to physicians. Abele also highlights the company's focus on implementing new ideas and the importance of understanding the evolving needs of the medical community. He shares how Boston Scientific's mission to reduce risks, trauma, cost, and time has improved patients' quality of life and empowered physicians with the tools to revolutionize their practices. Tune in now to hear from one of medtech's pioneers and get a rare glimpse into Boston Scientific's hiring strategy, emphasizing the value of curiosity, understanding generational dynamics, and the delicate balance between competition and cooperation. Thank you to Zeus for sponsoring this episode of Boston Scientific Talks. For more information about Zeus go to www.ZeusInc.com. Thank you for listening to the Boston Scientific Podcast.

In this week’s episode, Anthony Fernando, President and CEO of Asensus Surgical, discusses the company's journey in the field of surgical robotics and its focus on digital surgery. He highlights the need for technology to improve outcomes, reduce costs, and increase productivity in the surgical space. Asensus offers the Senhance platform, a robotic system that incorporates machine vision and machine learning to assist surgeons. They are also developing Luna, an integrated digital surgery solution that aims to provide flexibility and collaboration in the operating room. Fernando shares his outlook on the future of surgical robotics. He also gives some advice for medical device executives who are pondering a position outside of the US. Editorial Director Tom Salemi also unpacks the agenda for DeviceTalks West, giving credit to listeners for helping him choose topic and speakers. Register for the conference at DeviceTalks.com.

In this episode of IntuitiveTalks, Glenn Vavoso, a U.S. Navy Veteran and SVP and General Manager APAC at Intuitive, begins by sharing how his time in the Navy led him on a winding road to medtech and, later, valuable insights into the company's strategic expansion in Asia's medical device market, including a $100 million investment. Also, in the episode, Vavoso discusses the factors that led to Intuitive's transition from a distributor model to a direct selling model, highlighting the importance of being close to the customer and directly involved in the market. He also provides an overview of the attitude and adoption limitations towards surgical robotics in various Asian countries, focusing on Japan and Korea, and his strategy to overcome the obstacles. He further delves into the competitive landscape of surgical robotic systems in Asia, revealing that there are 11 active market-released competitive robotic systems in the region. Despite the competition, he emphasizes that there is more opportunity ahead than behind, especially in top-tier institutions. Lastly, Vavoso also touches on the impact of COVID-19 on their operations, explaining how the pandemic has led to a shift in their approach to customer engagement and remote communication with surgeons and hospital executives. Check out the episode to learn how by focusing on opportunities in China and South Korea, building local partnerships, and utilizing virtual tools, Vavoso has charted a course for Intuitive to increase its reach and impact throughout Asia. Join us at DeviceTalk West this October 18-19 at the Santa Clara Convention Center. Visit West.DeviceTalks.com to see our lineup of speakers, panels, and sessions.

In this episode, Boston Scientific Chair, CEO and President Mike Mahoney discusses his journey in the medical device industry, the qualities that make a great leader, and the strategies that have fueled the company's growth. Inspired by his grandfather, a cardiac surgeon, Mahoney initially wanted to become a doctor but ended up pursuing a career in business. Mahoney saw an opportunity at Boston Scientific when the company was struggling. Despite the risks involved, he took on the role of CEO because he believed in his skills and had a long-term vision for the company. Through the efforts of the company's leaders, a strong supply chain team, efficient operations, and a robust innovation pipeline, Boston Scientific has managed to maintain a 14% growth rate in a challenging market environment. Mahoney also highlights the company's focus on interventional medicine, which allows for quick procedures and same-day patient discharges, reducing the burden on hospitals. Mahoney further discusses the company's urology division, which has grown from a $500 million business to a $2 billion business. This growth has been fueled by a combination of organic R&D and acquisitions, creating a wide portfolio of differentiated products. Mahoney further elaborates on the company's diverse portfolio, mentioning the success of their peripheral vascular business and the potential of their diagnostics portfolio. Tune in to this episode for more on Mahoney’s strategies, challenges, and opportunities, offering valuable insights into the company's approach to driving growth and innovation in the medical device industry. Thank you to Resonant Link for sponsoring this episode of Boston Scientific Talks. For more information about Resonant Link go to www.Resonant-Link.com. Thank you for listening to the Boston Scientific Talks Podcast. Subscribe to this podcast on every major podcast platform.

Kevin Hykes, CEO of Augmedics, discusses his journey in the Medtech industry and the development of their augmented reality surgical navigation system, xvision, which allows surgeons to project a image onto a headset display, eliminating the need to look away from the surgical field. The system has been shown to improve accuracy, reduce radiation, and facilitate minimally invasive approaches to spine surgery. Augmedics recently raised $82.8 million in a Series C financing round, which will be used to further develop the technology and expand their commercial footprint. Hykes also shares takeaways and lessons from his past stints as a medtech CEO, including great advice for people looking for their first opportunity. "You need to do it for the right reasons, which I think are the thrill of the chase, the fast pace, the shortened cycle times, the chance to be in the cutting edges of technology in our field." In our newsmaker section, Associate Editor Sean Whooley joins co-hosts Tom Salemi and Chris Newmarker with his report form the American Diabetes Association annual meeting. He shared news from Dexcom, Medtronic, Insulet, Senseonics, Novo Nordisk, Abbott, Fractyl Labs and others. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to this podcast on any major podcast application.

In this episode of DeviceTalks Weekly we’ll talk with Mike Favet, CEO of NeuroPace, about how the company’s RNS technology is helping to transform the lives of patients with drug-resistant epilepsy. NeuroPace, one of the pioneers in neurostimulation, has the only FDA-approved neurostim treatment for epilepsy. Favet took over as CEO four years ago from the founding CEO so we discuss his background, the changes he made at the company, and how NeuroPace is building a market for a medical device to treat a disease that typically can be managed only by pharmaceuticals. Mike Favet will be a panelist on a keynote panel about building a neuromodulation market at DeviceTalks West on Oct. 18-19 at the Santa Clara Convention Center. Co-hosts Tom Salemi and Chris Newmarker introduce a new formula for the Newmarker’s Newsmaker. Companies mentioned including Philips, Biotronik, Medtronic, Johnson & Johnson, GE Healthcare, Depuy Synthes, BD, and many others. Thanks for listening to the DeviceTalks Podcast Network. Subscribe to this network on any major podcast app.

In the opening episode of the DeviceTalks podcast network's newest podcast, AbbottTalks, Dr. Christopher Piorkowski, Divisional VP and Chief Medical Officer of Electrophysiology, and Dr. Philip Adamson, Divisional VP and Chief Medical Officer of Heart Failure, discuss the significant advancements in Abbott's cardiac technology and their forward-looking approach to cardiovascular care. Piorkowski sheds light on the profound impact of technology on patient outcomes in AFib treatment and underscores the importance of enhanced risk stratification tools and personalized therapy approaches. Adamson delves into the progress of Abbott's HeartMate series, specifically the HeartMate 3, highlighting its improved performance and reduced complications compared to its predecessors. Both Abbott leaders stress the essential role of implementation science and foresee an upward trend in enhanced patient identification to administer therapies like the HeartMate 3, aiming to reach patients across the disease spectrum who could significantly benefit from these advanced therapies. Listen now to AbbottTalks' first episode, and make sure to subscribe on all major podcast platforms to get the behind-the-scenes look at Abbott's transformative work across its diverse portfolio. This episode is sponsored by Coatings2Go. For more information go to Coatings2Go.com. Thank you for listening to the AbbottTalks Podcast.

Ariel Sutton, general manager of Imperative Care’s stroke business, joins us to explain why she swapped her medical school dreams for the opportunity to wear steel-toed boots and a hard hat as an engineer. Sutton ultimately would marry her love of medicine with her passion for engineering and built a career helping medical device companies of many sizes to build successful programs. Now she’s leading one of the fastest growing neurovascular businesses in the industry. In her new role she’s going to help guide Imperative Care’s plans to target stroke from many different directions, including surgical robotics. Learn more about Imperative Care here. https://imperativecare.com/zoom-stroke-solution/ This week’s episode is sponsored by DeviceTalks West. Registration opens later next week. Go to DeviceTalks.com. Co-hosts Chris Newmarker and Tom Salemi review this week’s Newmarker’s Newsmakers including iRhythm, Medtronic, Illumina, Hologic, Senseonics, and Know Labs. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast application.

In this episode of Boston Scientific Talks, Peter Pattison, President, Interventional Oncology, and Liza Davis, VP of R&D, Interventional Oncology, share insights into the acquisition of Obsidio and the integration of its unique gel embolic material technology into Boston Scientific's portfolio. The technology, described as a "conformable solid," offers a unique balance between a liquid and solid embolic, providing physicians with precise control and rapid occlusion during interventional oncology procedures. The discussion also covers the successful transition from FDA approval to commercialization, with Obsidio technology already being used in several cases. Looking ahead, Pattison and Davis discuss the potential for further applications of the technology and its integration with Boston Scientific's new coil products. This episode is sponsored by the Medical Business Unit at TE Connectivity. For more information go to TE.com/medical. Thank you for listening to the Boston Scientific Talks Podcast. Subscribe to this podcast on every major podcast platform.

In this episode of IntuitiveTalks, David Robinson, VP of Multiport Design Engineering at Intuitive, delves into the intricacies of the company's multiport system, a flagship product that has been continuously refined since its inception. Robinson discusses the development of the surgical stapler and the surgical table, two key system components, and highlights the unique challenges faced in designing a robotic surgical stapler and ensuring the surgical table could move in sync with the robotic arms for precise operations. The episode also explores the evolution of the multiport system and how additions like the stapler, vessel sealer, and table motion capability have significantly enhanced the system's functionality. Finally, Robinson underscores the importance of critical feedback from surgeons in driving these improvements and shares his excitement about the future of Intuitive Surgical and the impact of their work on improving patient care. Tune into this episode for a fascinating look into the world of robotic-assisted surgery and the ongoing efforts to enhance surgical precision and patient outcomes. Join us and hundreds of other medtech insiders at DeviceTalks West, October 18-19 in Santa Clara, Ca. Find out more at west.devicetalks.com. Thank you for listening to the IntuitiveTalks Podcast. Subscribe to this podcast on every major podcast platform.

The FDA clearance obtained by startup Ezra for its AI technology marks a significant milestone for the company. Ezra wants to reduce MRI times to 15 minutes. Hear more from Fast Five hosts Danielle Kirsh and Chris Newmarker as they outline what the technology does and its potential to streamline MRI scans. B. Braun recently launched its DoseTrac Enterprise infusion management software for hospital systems. The technology can connect up to 40,000 different infusion pumps at once. Get the details from Newmarker about how the technology helps hospitals reach significant results and how the mobility of the system increases efficiency. ABK Biomedical’s FDA investigational device exemption (IDE) approval for tumor-treating microspheres is a significant development in the field of interventional oncology. This milestone enables ABK Biomedical to conduct clinical trials and gather crucial data on the safety and efficacy of their microsphere technology for the treatment of tumors. Kirsh and Newmarker describe the technology and how doctors think it could change oncology treatment. The recent FDA clearance obtained by Philips and Masimo will have a positive impact on their established partnership. The FDA clearance allows the companies to use SedLine brain function monitoring, Regional Oximetry and CO2 measurements in Philips’ patient monitors, IntelliVue MX750 and MX850. Newmarker explains how the technology combination will help care providers act decisively. Bayer’s strategic focus on digital health represents a significant shift in their approach to healthcare. By investing in digital health solutions, Bayer aims to leverage technology to improve patient outcomes, enhance healthcare delivery, and drive innovation across the industry. Kirsh and Newmarker share details about the potential play-in from Bayer, including what the company is currently investing in and what it plans to prioritize in its digital health shift. Check out the show notes at MassDevice.com/podcast.

The global release of Exactech's next-generation GPS Shoulder system marks an important milestone in shoulder arthroplasty. The launch, taking place in EMEA and APAC countries, follows the first surgery in the United Arab Emirates earlier this month. Fast Five Hosts Danielle Kirsh and Chris Newmarker share details about the orthopedic device and what doctors think of the system. With a new CE mark, Establishment Labs has completed a full transition of all currently marketed Motiva implants and tools, as well as the company’s quality management systems, to be in compliance with the new European Medical Device Regulation (MDR). Newmarker explains the devices included in the new indication and what surgeons and executives think about it. The FDA’s breakthrough designation for CardioRenal's Tenor at-home blood potassium measuring device signifies a significant advancement in monitoring and managing blood potassium levels in patients. This innovative device enables individuals to conveniently and accurately measure their potassium levels from the comfort of their own homes. Kirsh and Newmarker explain the benefits of at-home monitoring and how Tenor works. The clash between Masimo management and activist investor Politan has brought attention to the strategic direction and governance of the company. With differing perspectives on key decisions and company performance, this dispute highlights the challenges faced by organizations in managing shareholder expectations. Newmarker details the disagreement between the two parties and who on the board of directors is up for a vote. iRhythm’s receipt of an FDA warning letter regarding its Zio AT quality systems highlights the importance of robust quality control measures in the medical device industry. iRhythm’s response to the FDA warning letter and its actions to address the identified issues will be closely watched by regulators. Hear more about the warning letter from the Fast Five hosts.

The partnership between HeartBeam and Samsung is a significant development in the field of cardiac care, as it combines HeartBeam’s expertise in cardiac services with Samsung’s global reach and technological prowess. Fast Five hosts Danielle Kirsh and Chris Newmarker have all the details of the partnership. Concept Medical’s FDA IDE approval for the sirolimus-coated balloon MagicTouch PTA is a significant development in the treatment of superficial femoral artery disease. This approval allows for the investigation of the device’s safety and efficacy in treating this condition. Kirsh and Newmarker discuss the approval and the other indications the device has received in recent months. Think Surgical’s FDA clearance of its handheld robotic knee surgery device, the TMINI miniature robotic system, represents a major milestone in the field of orthopedic surgery. This innovative technology assists surgeons in performing total knee surgeries with enhanced precision and control. Newmarker explains how the technology works and how it compares to other surgical robots on the market. The transition of Medtronic’s Cardiovascular Diagnostics and Services President Julie Brewer to Baxter highlights the mobility and talent exchange within the medical device industry. Kirsh and Newmarker talk about the shuffle amidst a time of layoffs. Titan Medical’s decision to license out all of its intellectual property to Intuitive Surgical signifies a strategic shift in the company’s focus. In a push to further reduce operating costs in the business, Titan Medical also announced some executive changes, including the resignation of its CEO. Newmarker shares all the details of the licensing deal and who’s moving on in the executive suite.

In this episode, Cheryl R. Blanchard, Ph.D., CEO of Anika Therapeutics, explains how the company is morphing from a biomaterials into a joint preservation business. In an interview with Tom Salemi, editorial director of DeviceTalks, Blanchard points to collaboration she had with biomedical greats over her career, including a formative connection with Ray Elliott, the former CEO of Zimmer. Today, through sizable M&A and internal development, Anika is building a portfolio of ortho biomaterials and new joints that gives is more shots on net. Blanchard explains how Anika’s opportunity has grown its market opportunity from $1 billion to $8 billion. Chris Newmarker, executive editor of life sciences, brings this week’s Newmarker’s Newsmakers bringing news from Neuralink, Abbott, Cala Health, Cue Health, Medtronic, and Zoll Medical. Senior Editor Danielle Kirsh also visits to introduce DeviceTalks Weekly listeners to the new Fast Five Podcast, a daily podcast highlighting the biggest news in medtech. You can subscribe to the MassDevice Fast Five on any major podcast application. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network to receive future episodes of this podcast as well as Boston Scientific Talks, IntuitiveTalks, and StrykerTalks.

This episode of DeviceTalks Weekly brings you DeviceTalks Boston’s opening keynote conversation with Tom Polen, CEO, President and Chairman of Becton Dickinson. In the conversation, Polen recounts his tragic first encounter with the medical device industry, his path into medtech and the CEO’s chair, and the work BD put into helping the world survive the COVID-19 pandemic while also repositioning the company with key M&A and divestitures. The episode was sponsored by Clari. Go to Clari.com to learn about its unique revenue management platform. Chris Newmarker also delivers his Newmarker’s Newsmakers featuring news from Siemens Healthineers, Abbott, Intuitive, Cook Medical, Shockwave Medical, Medtronic and Johnson & Johnson. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast application.

In this compelling episode of Boston Scientific Talks, Kathryn Unger, VP of ESG, and Brad Sorenson, EVP of Global Operations, delve into Boston Scientific's transformative Environmental, Social, and Governance (ESG) initiatives, exploring how these principles are influencing supplier relationships, impacting product design, and exceeding customer expectations. Additionally, they discuss strategies to align business operations with ESG objectives to foster employee engagement, improve patient outcomes, and better support communities. Tune in to this episode for a comprehensive understanding of Boston Scientific's commitment to balancing quality, environmental sustainability, and social responsibility in the medical device industry. Thank you to Canon Virginia for sponsoring this episode. To learn more about how Canon Virginia works with medical device companies, visit www.cvi.canon.com/ Thank you for listening to the Boston Scientific Podcast. Subscribe to this podcast on every major podcast platform.

In our closing session of DeviceTalks Boston, Chris Newmarker, executive editor of life sciences, and Tom Salemi, Editorial Director of DeviceTalks, sit down with two leaders in the field to break down the event and highlight some of the changes coming Medtech’s ways. Joe Mullings, CEO of the Mullings Group, and former J&J Medtech leader Peter Stebbins, now executive chairman of Nurami Medical, cover a broad range of topics on how will Big Pharma, AI, data, private equity and other external forces will impact the medical device industry. Are we going to see more roll ups from PE? Will a new threat emerge to thwart Medtech’s connected care plan. Also, what were the takeaways from the discussions of the conference. Give a listen. Thanks to everyone who made DeviceTalks Boston so special! Thanks for listening to the DeviceTalks Weekly podcast. Subscribe on any podcast application.

Last call for DeviceTalks Boston! In this episode we'll preview our upcoming conference by talking with Paul Grand, CEO of Medtech Innovator, Rebecca Whitney, SVP at ZimView, Holly Scott and Joe Mullings at the Mullings Group. We'll have Fastball Pitches from two Medtech Innovator companies that will be presenting on May 10-11. Register at DeviceTalks.com. Use the code DTWeekly25 to save 25% Chris Newmarker delivers his #newmarkernewsmakers featuring 3M, Zimmer Biomet, Stryker, Medtronic and Casana, maker of a now FDA-approved smart toilet seat. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Player on any major podcast application.

In this episode of Boston Scientific Talks, Boston Scientific's Cat Jennings, President of Peripheral Vascular, and Dave Knapp, VP of R&D, discuss how they are working together to develop new products and technologies that will help patients with peripheral vascular disease, and how they are leveraging data and analytics to drive innovation. They also share their perspectives on the challenges and opportunities in the medical device industry, the importance of diversity and inclusion in the workplace, and how Boston Scientific is positioning itself for future growth. Tune in to this episode to learn more about how the company is adapting to meet the changing needs of the healthcare industry. Thank you to Resonetics for sponsoring this episode. Go to Resonetics.com for more information about the company. Thank you for listening to the Boston Scientific Podcast. Subscribe to this podcast on every major podcast platform.

In this episode, Tom Salemi interviews Mark Dickinson, worldwide president at Cerenovus, the neurovascular business at Johnson & Johnson Medtech. Mark Dickinson shares his unique entry into the medical device industry, how he built his career at the global company, and what the company is doing to develop its devices to treat stroke patients. In addition, we’ll also have interviews with Paul Grand, CEO of Medtech Innovator, and Jeff Alvarez, chief strategy officer at Moon Surgical. Both will be speaking at DeviceTalks Boston on May 10-11. Go to DeviceTalks.com to register. This episode is sponsored by the Medical Business Unit at TE Connectivity. For more information go to TE.Com/medical. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast application.

In this episode of DeviceTalks Weekly, we visit with Claire Biot, vice president, life sciences at Dassault Systèmes to learn about the company’s virtual twin platform. Biot explains how the company is able to establish a digital model of a product requiring testing or patients who would serve as the test subject. The key benefits include faster product development, lower costs, higher sustainability, and stronger ethics. The company’s highest profile project might the Living Heart Project, which serves as a virtual twin of the living heart allowing for faster and safer testing of cardiac devices. Dassault Systèmes is working with the FDA to develop a method for testing. We’ll also connect with Jithesh Veetil, PhD, senior program director, Digital Health & Technology, at the Medical Device Innovation Consortium (MDIC). Veetil will explain how industry can incorporate virtual twin technology into development and testing. Here is a link to the Landscape Report & Industry Survey on the Use of Computational Modeling & Simulation in Medical Device Development. https://mdic.org/wp-content/uploads/2023/01/CMS_Landscape_Report.pdf This episode was sponsored by Dassault Systèmes. Chris Newsmaker, executive editor of life sciences, also delivers his -award-winning-worthy Newmarker’s Newsmakers featuring news from Intuitive, Neuromod Devices, LivaNova, Johnson & Johnson Medtech and Medtronic. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast player.

How concerned should you be about cybersecurity? And as an industry, how do we reduce the risk of using medical devices and potentially exposing our patients' personal data? In this episode, Drew Bomett, chief information security officer for Boston Scientific, discusses the importance of cybersecurity in the medical device industry and the unique challenges that come with securing medical devices, particularly when it comes to legacy products. Additionally, Bomett walks us through the impact of COVID-19 on cybersecurity and how Boston Scientific specifically approaches managing risks and threats, protecting sensitive information, and complying with industry regulations. He also discusses the importance of collaboration between medical device companies, healthcare providers, and regulators to ensure the highest levels of security. Tune in to this episode to learn more about the role of cybersecurity in the medical device industry and the steps that Boston Scientific is taking to protect patients and their data. Thank you to Digi International for sponsoring this episode. And, thank you for listening to the Boston Scientific Talks Podcast. Subscribe to this podcast on every major podcast platform.

In this week’s podcast, FundamentalVR co-founder and CEO Richard Vincent shares the opportunity and need that convinced him to cross the chasm from the tech industry to start a medtech-oriented VR company. Vincent also shares how FundamentalVR has advanced haptic technology to give training surgeons the ability to develop a true feel for surgery even when never touching a human body. FundamentalVR is working with medical device companies now but the company has plans to broaden its business. Vincent and Host Tom Salemi will continue this conversation at DeviceTalks Boston on May 10. Go to DeviceTalks.com to register. Chris Newmarker, executive editor of life sciences at Mass Device, brings back the Newmarker’s Newsmakers highlighting big news from the EPA, Shockwave, Moximed and Medtronic. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to this podcast on any major podcast player.

In this StrykerTalks podcast episode, CEO Kevin Lobo says he's seeing the skies are clearing a bit for the medical device industry and hospitals though challenges remain. Earnings are improving, and new product innovation is producing a super-cycle of new products. Listen now to hear Lobo's perspective on Stryker's position globally and in emerging markets, tailwinds from the COVID-19 pandemic, and innovation factors that fuel continued growth within the organization and beyond. He also shares the company's measured M&A strategy and its position in orthopedic surgical robotics. Thank you to SMC Ltd. for sponsoring this episode. Thank you for listening to the StrykerTalks Podcast. Subscribe to this podcast on every major podcast platform.

In this week’s interview we talk with one of the newer orthopedics players on the block – Enovis, the entity formerly known as Colfax. CEO Matthew L. Trerotola walks us through the decision to move from a diversified industrial player into an orthopedics company and just how the company thinks it can compete against larger, established players in the market. Enovis is weighted heavily in extremities, putting it on a track for fast growth, but sees promising signs it can compete in large joint as well. You’ll also hear our latest Fastball Patch from Cellular Vehicles. This episode was sponsored by DeviceTalks Boston. Thank you for listening to the DeviceTalks Weekly podcast. Subscribe on any major podcast player.

We hand over the reins to all-around great Medtech guy and sales guru Omar M. Khateeb, host of the State of Medtech show on LinkedIn. Chris Newmarker, executive editor of MassDevice, brought along his latest Newmarker’s Newsmakers delivering news about iCad, Better Therapeutics, Philips, GE Healthcare, Masimo and Signifier Health. Chris, Omar and Tom Salemi, Editorial Director of DeviceTalks, share their views on the news before sharing the lessons they’ve learned over their career about how Medtech professionals can position themselves for professional success. The conversation ranges far and wide with discussion about storytelling, knowing your powers, and the threat of “silent non-competes.” We mention a code in there to get 25% off the registration for DeviceTalks Boston (It's OMAR25) on May 10-11. Don’t be shy. Register now at DeviceTalks.com

In the premier episode of the new Boston Scientific Talks podcast series, we learn how Boston Scientific and IBM Research have joined together to address chronic pain - a physical, mental, and physiological condition affecting millions. Boston Scientific's Director R&D, Discovery: Data and Design, Matt McDonald and IBM Research's Global Research Leader, Jeff Rogers shared how the partnership is helping to tailor the needs of the system to the needs of the patients, and the surprises they discovered along the way. The partnership is giving Boston Scientific insights on the power of its stimulation devices but also a better understanding of the broader problem of pain. Thank you to ProMed Molded Products for sponsoring this episode. Thank you for listening to the Boston Scientific Talks Podcast. Subscribe to this podcast on every major podcast platform.

In this episode we’ll speak with two leaders of Ronovo Surgical, a Shanghai-based surgical robotics company that’s looking to challenge Intuitive and all comers to the massive surgical market in China. CEO John Ma and CTO Ying Mao describe the benefits they see in Ronovo Surgical’s unique modular system design. The pair bring experience from Intuitive, Auris, and other medical device companies. Why does Ronovo see its Carina system as a more attractive alternative to legacy MIS systems? And how does it intend to tackle the China market and beyond? Chris Newmarker, executive editor of life sciences, delivers his Newmarker’s Newsmakers after Host Tom Salemi bemoans the uncertain fate of his family’s Kia Rondo. Newsmakers include Silicon Valley Bank, Abbott, CVRx, AdvaMed, Johnson & Johnson and Medtronic. You can find MassDevice Tip Line here. https://www.massdevice.com/massdevice-medtech-layoffs-tips-line/ Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast player. Don’t miss future episodes of DeviceTalks Weekly, IntuitiveTalks, StrykerTalks, and now Boston Scientific Talks.

In the first episode of IntuitiveTalks' newest season, Dave Rosa, who served as executive vice president and chief strategy and growth officer at the time of the interview, shares a look into the past and a glimpse into the future of Intuitive. What did Intuitive look like early on? How does Intuitive define itself today? And what direction is Intuitive heading to further embed itself into the minimally-invasive hall of fame? Rosa was named president of the company in May 2023. Thanks to Maxon Group for sponsoring this episode. Thanks for listening to the IntuitiveTalks Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast application.

A week after the SVB Wall’s fall, we talk with medical device leaders about how they managed the run on Silicon Valley Bank, which filed for Chapter 11 bankruptcy procedure on the morning of the day this episode was published. Pristine Surgical CEO Bryan Lord recounts the steps his management team took after the news broke Thursday night. He also walks us through the 10-point plan that he posted on LinkedIn, including commentary on how members of the industry can support each other. You can read his post here. https://www.linkedin.com/posts/bryanlord_one-ceos-playbook-for-svb-depositors-1-activity-7040425947308650496-FsEc?utm_source=share&utm_medium=member_desktop Joe Mullings, CEO of the Mullings Group, says the venture capital and medtech industry need to take a long look in the mirror given their response to SVB’s cloudy financial picture. Now, the Medtech industry is facing uncertainty over the next 90 days as things sort out. Medtech Innovator CEO Paul Grand walks through this week’s Newmarker’s Newsmakers with us including Perkin Elmer, Fire1, Medtronic, and, of course, Silicon Valley Bank. Paul shares his reaction to the SVB last week, the current economic climate, and what challenges Medtech may be facing in the future. Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast application.

In this podcast episode, Co-Hosts Tom Salemi and Chris Newmarker review how the medtech industry is handing the current shrinking job market. They’ll review this week’s Newmarker’s Newsmakers which includes Medtronic, Biosense Webster, Johnson & Johnson and high profile clinical meetings. Tom then interviews Mike Dineen, CEO of Tioga Cardiovascular, which is pushing the limits for heart valves. Tioga emerged from the prolific Shifamed incubator. Dineen gives history on both Shifamed and Tioga. To learn more about the FTC’s review of non-competes go here. https://www.ftc.gov/news-events/news/press-releases/2023/03/ftc-extends-public-comment-period-its-proposed-rule-ban-noncompete-clauses-until-april-19 Thanks for listening to the DeviceTalks Weekly Podcast.

In this episode, Annie Heath, Stryker’s vice president of diversity, equity and inclusion, explains how an interest in sales brought her to Stryker where she held positions in operations for most of her career. Heath also shares how her personal story inspired her to pursue a role leading Stryker’s DEI effort. In addition to building a more diverse workforce, Stryker is also collaborating with suppliers, clinical societies and other partners to create an environment where everyone feels included. This episode is sponsored by AcuityMD. Thanks for listening to StrykerTalks. Follow the DeviceTalks Podcast Network on any major podcast player to find additional episodes.

Medtech layoffs continue to mount. We’ll use this episode to begin to explore external and internal challenges. Looking externally, longtime industry watcher Henry Soch, now an executive-in-residence at Matter, shares his concerns about the current and future ability of medical device companies – both big and small – getting new technologies into hospitals. You can read Soch’s blog post here. https://healtech.blog/2022/12/28/health-care-disruptors-to-watch-in-2023/ Then, Joe Mullings, CEO of the Mullings Group, brings us inside his conversations with senior leaders of the medical device industry. In this interview, a sober Mullings reviews some of the mistakes large strategics have made. The result may be a few months of layoffs and cost-cutting. Mullings says companies could help themselves and the industry by not requiring their terminated employees to sign non-compete agreements. Mullings ends with some hopeful signs for medtech and useful tips for people looking to protect their careers. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to this podcast on any major podcast application.

In this week’s episode, we’ll hear pitches from the 10 start-ups that have been selected as finalists for Medtech Color’s Pitch Competition. BIOMED – Bobby Ntoya IllumifyDx - Maria Navas-Moreno JuneBrain – Samantha Scott Level 42 AI – Shash Jumbe Movement Interactive – Eric Luster Navigate Maternity – Ariana McGee Oben Health – Peter Njongwe Tanzen Medical – Nilanjan Banerjee, Justin Brooks Thermaband – Debbie Dickinson, Markea Dickinson-Frazier Youme Healthcare – Hafeezah Muhammad Medtech Color Executive Director Kwame Ulmer joins Host Tom Salemi and Mass Device Associate Editor Sean Whooley on this week’s Newmarkers Newsmakers. This week’s list includes Johnson & Johnson, Origami Surgical, Asensus Surgical, Medtronic, AliveCor, and Apple. We also discuss the pitch contest, Medtech Color’s history, and an assessment of how effective the industry has been in increasing diversity of leadership in recent years. Thanks for listening to the DeviceTalks Weekly Podcast. You can listen to episodes of DeviceTalks podcasts on any major podcast player.

Wow, I think we have a cool new format for the podcast! This was a fun one! Holly Scott, vice president and senior partner of the Mullings Group, an executive search firm, shared her industry expertise and insights during Chris Newmarker’s Newsmakers. We covered a lot of ground there while reviewing news from Baxter, Medtronic, Titan Medical, Apple, as well as the many companies that reported layoffs over the coming week. Related topics centered around the waning lure of Working From Home, the move from tech to medtech, and what we have to do to build your own brand. We then examine the current layoff environment. While the situation may not be as bad as it seems on a macrolevel, every layoff brings some disruption to individual workers and families. Expert Coach Holly Scott offers some valuable advice for those who are looking to rebound from receiving a pink slip. She's got Five Steps! Thanks for listening to the DeviceTalks Weekly Podcast. You can listen to this podcast on any major podcast player.

The weekend ended with a bang as Abbott and Globus Medical both announced significant deals. Abbott picked up publicly traded Cardiovascular Solutions for $890 million while Globus Medical acquired – or merged if you prefer – with publicly held spine competitor NuVasive in a deal valued more than $3 billion. In this week’s episode, host Tom Salemi explores each deal with Wall Street Analysts Mike Matson and David Saxon from Needham. The conversation begins with the big question – Is this this start of a robust year for M&A. Executive Editor Chris Newmarker also delivers his Newmarker’s Newsmakers. Abbott, CSI, Globus, and NuVasive top the list along with GE Healthcare’s acquisition of Caption Health. Other medtech companies making the vaunted list include 3M, Dexcom, Ethicon, and Inspire Medical. This episode is sponsored by DeviceTalks Boston. Go to DeviceTalks.com to find out more information about our upcoming in-person conference. Thanks for listening to this episode of DeviceTalks Weekly. You can subscribe this podcast on any major podcast player.

Murthy Simhambhatla launched his medtech career during the epic race to develop groundbreaking drug-eluting stent technologies as a new approach to battling cardiovascular disease. Over two decades later, following a career that took him across the globe and clinical specialities, Simhambhatla finds himself involved in another exciting push to bring new technologies to bear on prevalent medical problems. Simhambhatla leads Setpoint Medical, a trail blazer in the neurostimulation space that’s tapping the vagus nerve as way to battle inflammation. In this discussion, we’ll cover Simhambhatla’s career and how Setpoint is positioned for the future following a significant capital raise. Chris Newmarker, executive editor of life sciences at MassDevice shares his Newmarker’s Newsmakers including Avonics, Invacare, Philips, Johnson & Johnson, 3M, Stryker, Edwards, Hologic, BD, Edwards, and Boston Scientific. Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast player.

Robert Cohen has his eyes on the future of orthopedic surgery, but he brings a wealth of knowledge about its past as well. In this interview, Cohen reviews his long history in orthopedic surgery, dating back to his studies in college. Over his career, Cohen has had a role in materials, 3D-printing, and began working with MAKO Surgical several years before its acquisition by Stryker in 2013. Now Cohen leads the team that will guide Stryker’s digital strategy in the future. Cohen, who chairs the board of the New Jersey Institute of Technology, wraps up the discussion sharing his thoughts about the future of engineering education. This episode is sponsored by Viant. Go to ViantMedical.com to learn more. Thanks for listening to the StrykerTalks Podcast. You can subscribe to the DeviceTalks Podcast Network on any major Podcast Player.

In this week’s episode, CEO Kevin Sayer takes a few minutes to share Dexcom’s vision for the future OUTSIDE of diabetes. What does this mean for people with diabetes and others who could benefit from the powerful Dexcom G7? We also bring in a very popular interview from our MedtronicTalks podcast series – Skip Kiil, president of cranial and spinal technologies, shares some very wise career advice that helped him accelerate his career. He also talks with Tom Salemi about his move to Medtronic and how the company is ramping up to dominate the spinal and cranial spaces. His interview is sponsored by Allied Motion Technologies. Chris Newmarker, executive editor of life sciences at MassDevice shares his Newmarker’s Newsmakers including Dexcom, Medtronic, Masimo, Philips, Abbott and Shockwave. Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast player.

Pristine Surgical CEO Bryan Lord spent his career advising and investing in medical device companies, so he didn’t immediately see how a “conspicuous outsider” like himself would be the right person to serve as CEO of start-up Pristine Surgical. But he immediately recognized the satisfaction in leading the company’s work to create first-of-its-kind 4K single-use surgical arthroscope designed for arthroscopic procedures. After securing 510(k) notification from the FDA, Pristine Surgical is ready to compete in the rigid endoscope market serving orthopedics and general surgery. Lord explains how Pristine can lower costs and improve efficiencies with the new tech and sales model. He also explains how Pristine expects to compete in the much larger flexible endoscope market. Chris Newmarker, executive editor of MassDevice, returns with his Newmarker’s Newsmakers featuring Verily, Medtronic, Sterigenics, CardiacSense, Masimo, and Philips. Our DeviceTalks Weekly Fastball returns with a pitch from FluidIQ. And to hear the entire interview with Steve Oesterle, go here. https://www.devicetalks.com/can-moon-surgical-fill-critical-role-in-the-or-analyst-matsons-take-on-jj-medtronic-and-more/ Thank you for listening to DeviceTalks Weekly. You can subscribe to the podcast on any major podcast application.

Becton Dickinson’s CEO Tom Polen lays out the company’s plan for growth that’s building off a stunning sequence of acquisitions over the past two years that has the company loaded with tech – including digital and robotics tools – to drive its future growth. Polen also shares his tragic introduction to medtech and shares how that experiences influences every decision he makes. Tom Polen will be the opening keynote speaker at DeviceTalks Boston on May 10. In this episode we introduce a new feature – the DeviceTalks Weekly Fastball! This is our own version of a pitch contest where we let medical device start-ups throw their best pitch to potential partners and investors. To contact this week's pitcher - Dialysis-X you can email the founder Oluwagbebemi D. Oyeniyi at ooyeniyi@dialysisx.com. We have our first Newmarker’s Newsmakers of the year delivered by a mysterious guest co-host. Companies making the list include Zimmer Biomet, Baxter, GE Healthcare, Volta Medical, Cardiac Dimensions, Opteev, and ReCor Medical. Thank you for listening to the DeviceTalks Weekly Podcast.

In this episode, your diligent team of DeviceTalkers - Executive Editor Chris Newmarker, Pharma Editor Brian Buntz, Managing Editor Jim Hammerand, Senior Editor Danielle Kirsh, Associate Editor Sean Whooley and DeviceTalks Editorial Director Tom Salemi – assembled to review our Top 10 events, trends and newsmakers. We’ve got some highs – robots, diabetes – and some lows – Supply Chain, CPAP machines – and a whole lot of interesting things right in between. All an all, we’re bullish on what’s to come in 2023! And we only mentioned Covid-19 once. Companies mention include Abbott, Abiomed, Ambu, Becton Dickinson, Boston Scientific, CMR Surgical, Dexcom, Endiatx, embecta, Intuitive, Johnson & Johnson Medtech, Medtronic, Neuralink, Philips, Senseonics, Stryker, Synchron, Vicarious Surgical, Zimmer Biomet, ZimVie, and many more. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to this podcast on any major podcast player.

In this episode, we’ll speak with ReCor Medical’s CEO Andy Weiss and Helen Reeve-Stoffer, PHD, the company’s vice president of clinical affairs. The pair joined the renal denervation company in 2013, before disappointing results of a Medtronic-trial temporarily cratered the entire space. But now through careful clinical testing ReCor Medical is climbing out of that hole and demonstrating the technology could be an effective tool against serious hypertension. To hear the interview we conducted with Andy Weiss in 2021, go here. Executive Editor Chris Newmarker and Tom Salemi, editorial director of DeviceTalks, begin making plans for next week’s end-of-year coverage. If you want to contribute your insights go here and record your own message for the podcast. https://www.massdevice.com/devicetalks-weekly-whats-your-top-story-of-2022/ Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any podcast application.

In this interview, Andy Pierce, group president of MedSurg and Neurotechnology, details how the company strives to create products that nurses and hospital staff find essential to everyday patient care. The kind of attention to detail that can drive a nurse to hug a Neptune waste management system. “This is what we live for at Stryker,” Pierce says. Pierce has spent his entire career at Stryker and offers advice to others who want to do the same. In this interview, Pierce discusses Vocera, ambulatory surgery centers, and other forces changing the healthcare industry. Thank you to Resonetics for sponsoring To listen to our 2021 DeviceTalks Weekly interview with Pierce go here. https://www.devicetalks.com/lobo-and-pierce-talk-wright-cool-tech-robotics-and-the-not-so-secret-plans-to-keep-stryker-growing/

In this episode, Celine Martin, company group chairman, Cardiovascular & Specialty Solutions Group, offers insights from her career at Johnson & Johnson. What are the four variables you need to consider to thrive in a global company. Martin also shares insights on cardiac ablation, neurovascular, and where the company is headed following the acquisition of Abiomed. Paul Grand, CEO of Medtech Innovator, joins as a co-host offering insights on Chris Newmarker’s Newsmakers – Moon Surgical, Butterfly Network, Medtronic, Avail Medsystems, Dexcom, and Fresenius Medical. Grand shares a personal connection to one of the companies. Grand, Newmarker and Tom Salemi also share their thoughts on the retirement of Mike Mussallem, CEO of Edwards Lifesciences. Thank you to Nordson Medical for sponsoring this episode. Go to NordsonMedical.com for more information. Thank you for listening to the DeviceTalks Weekly Podcast You can subscribe to this podcast on any major podcast player.

Unfortunately, we missed Diabetes Awareness Month by a few days, but we get great insights on this dreaded disease from two players in the space. Krista Sugerman, vice president, global marketing & communications at Medtronic’s diabetes business, shares how diabetes has impacted people close to her and why the company is keeping focused on how a diabetes diagnosis can take over someone’s life. We also touch base with newcomer Bigfoot Biomedical. Matt Clemente, Senior Vice President of Product, Development & Delivery at Bigfoot Biomedical, shares his familial connection with diabetes and how he’s dedicated his career to helping people manage the disease. Chris Newmarker also delivers his Newsmakers – Elon Musk, GE Healthcare, Boston Scientific, Apollo Endosurgery, Tital Medical, CMR Surgical, and Johnson & Johnson Medtech. Go here to hear the interview with CMR CEO Per Vegard Nerseth https://www.devicetalks.com/hear-from-the-ceos-of-two-surgical-robotics-companies-that-together-just-raised-over-1-billion/

In this episode of StrykerTalks, Robbie Robinson, president of Stryker’s Spine division, touts the strength of a business build out with sizable acquisitions in recent years, including K2M. Does Robinson see any gaps in Stryker’s offerings? Where can other Stryker businesses help Stryker Spine reach new heights in the coming years? Thanks to Tegra Medical for sponsoring this episode. Thanks for listening to the StrykerTalks Podcast. Subscribe to this podcast on any podcast application.

This episode of IntuitiveTalks is taken from the keynote interview Intuitive CEO Gary Guthart gave at DeviceTalks West. In this conversation Guthart will provide additional details of Intuitive’s move into endoscopic robotics including the ION robot. He'll give his assessment of the growing competition in surgical robotics and what it means for Intuitive. Finally, he shares why he thinks the term surgical robotics may have no meaning in the future. This episode is sponsored by Optikos. Thanks for listening to the IntuitiveTalks Podcast. Subscribe to this podcast on any podcast application.

In this episode, we talk with medtech vet Matt Franklin who left the industry. – sort of – to help lead Akili, developer of EndeavoRx, the first prescription treatment delivered through a video game. The game treats kids with ADHD, but the company has bigger plans. Chris Newmarker, executive editor of life sciences, returns with his newsmakers including CMR Surgical, Affera, Medtronic, Blackrock Neurotech, Cardinal Health, and Stryker. To hear the rest of our interview with CMR CEO Per Vergard Nerseth go here. https://www.devicetalks.com/hear-from-the-ceos-of-two-surgical-robotics-companies-that-together-just-raised-over-1-billion/ 5. https://www.massdevice.com/cmr-surgical-100-mark-versius-systems-installed/ 4. https://www.medicaldesignandoutsourcing.com/medtronic-affera-cardiac-ablation-catheter-mapping-design/ 3. https://www.massdevice.com/blackrock-neurotech-unveils-next-generation-bci-interface/ 2. https://www.massdevice.com/cardinal-health-hospital-level-care-home/ 1. https://www.massdevice.com/stryker-unveils-new-operating-room-model/ Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to this podcast on any major podcast application.

In this episode, Kate Stewart, vice president and general manager of ENT, explains how her first introduction into medical devices came as a patient. Stewart’s Stryker career began in her native Australia but quickly went global. She now leads the ENT business in Minneapolis. Stewart identifies the key leadership quality she’s come to appreciate, pinpoints four critical areas in her specialty, and explains the importance of the Stryker Women’s Network. This episode is sponsored by Boston Micro Fabrication. Thank you for listening to the StrykerTalks Podcast. Subscribe to this podcast on any major podcast application.

In this episode, we’ll talk with Keith Grossman, who brought his long, successful track record as a medtech CEO to what he sees as a truly disruptive neurostimulation company. We’ll talk with Grossman about his decision to join medtech even though unlike some of his counterparts he enjoyed organic chemistry (aka, the Medtech career creator) in college. Over his career, Grossman helped create new medical device marks by leading companies such as Thoratec and Conceptus toward sizable acquisitions. At Nevro, Grossman says he’s overseeing the company’s transformation into a pain company, one that’s managed to grab 20% of a competitive market very quickly. Thanks to Pulse Technologies for sponsoring this episode. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to this podcast on any major podcast application.

In this podcast we’ll talk with Chris Hartman, president, epilepsy, LivaNova, about how the company is developing new tools to use the vagus nerve to limit the impact of epilepsy. We’ll also hear from one of our DeviceTalks West Panels about how workforce shortages are impacting medical device development. The panelists are Nilesh Patel, M.D. Vice President, Medical Affairs, Neuromodulation, Boston Scientific; Farzad Azimpour, M.D. Senior Vice President, Strategic Innovation, Edwards Lifesciences; and Nick West, M.D. Chief Medical Officer, Divisional Vice President, Medical Affairs, Vascular, Abbott. Executive Editor Chris Newmarker deliveres his Newmarker’s Newsmakers – highlighting news from Butterfly Networks, Dentsply Sirona, Stryker, Titan Medical, Johnson & Johnson and Biomed. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to this podcast on all major podcast players.

In this week’s episode, we’ll visit with CL Tian, co-founder and CEO of Phiex Technologies, Medtech Innovator’s 2022 Grand Prize winner chosen by attendees at this week’s AdvaMed conference in Boston. Tian details the pending problems facing the medtech industry due to concerns about current sterilization practices and shares how Phiex could help alleviate the problem. At the start of the episode, co-hosts Tom Salemi and Chris Newmarker are joined by Associated Editor Sean Whooley and Pharma Editor Brian Buntz to revisit the high points of last week’s DeviceTalks West conference in Santa Clara. Thanks to all of our speakers, sponsors and attendees! To read the report mentioned in the podcast go here. https://www.bcg.com/publications/2022/us-ahead-in-medtech-regulation You can find ongoing coverage at MassDevice. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to this podcast on every major podcast player.

Just a short visit today. Paul Grand of the Medtech Innovator introduces us the five finalists of his start-up program. They’ll compete for the top spot at AdvaMed’s meeting next week. in Boston. Remember to join us at DeviceTalks West THIS week. Register at DeviceTalks.com.

In this episode we’ll talk with Kathryn Rieger, PhD, senior director, human factors and user research at Intuitive, about how the surgical robotics leader is working with surgeons to understand how to make its surgical systems easier to use or, for lack of a better word, intuitive. Where should buttons go. What does the blue blinking light mean? And should surgical robotics systems follow a similar template to make it easier for surgeons to master different systems. Thanks to Elsner Engineering Works for sponsoring this episode. Thanks for listening to the IntuitiveTalks Podcast. Subscribe to the DeviceTalks Podcast network to receive future episodes of IntuitiveTalks, StrykerTalks and our flagship DeviceTalks Podcast Weekly.

Editorial Director Tom Salemi provides a sneak peek (listen?) into next week’s DeviceTalks West conference which will be held Oct. 19-20 at the Santa Clara Convention Center. Tom will run through some of the highlights of the agenda which can be viewed at west.devicetalks.com. We also include snippets of past interviews of two keynotes – Gary Guthart, CEO of Intuitive, and Leslie Trigg, CEO of Outset Medical – from past interviews with DeviceTalks. You can find both interviews on DeviceTalks.com. If you’re interested in attending connect with Tom Salemi on LinkedIn. Thanks for listening to the DeviceTalks Weekly Podcast. DeviceTalks Weekly is available on every major podcast player.

In this episode, we’ll first hear from Swarna Alcorn, business unit vice president, Olympus America, about that company’s long held – and growing -position in respiratory tools. We’ll weight the value between reusable and single-use bronchoscopes as well as the dire need for more awareness of lung cancer. Then we’ll connect with Rebecca Whitney, global spine president at ZimVie, the recent spinout of Zimmer Biomet. Whitney recounts why she joined the spinout and where ZimVie is making progress with payers. This episode was sponsored by DeviceTalks West. Thank you for listening to the DeviceTalks Weekly Podcast.

In this week’s episode, we’ll talk with leaders from Zimmer Biomet and Vicarious Surgical about the new partners they’ve entered into with national hospital companies in a bid to further their digital and robotics surgery offerings. Guests include Robert Kraal, Vice President and General Manager, Connected Health at Zimmer Biomet, and Adam Sachs, co-founder and CEO of Vicarious Surgical. You’ll get great background on both companies. One note: Tom Salemi interviewed Sachs during a DeviceTalks Tuesday Webinar. So if you’d rather watch the interview go to DeviceTalks.com where you can find the discussion – complete with video and PowerPoint presentation – available for free. Thanks to Cirtronics for sponsoring! Chris Newmarker, executive editor of life sciences, also returns with his Newmarker’s Newsmakers – Stryker, Smith + Nephew, Medtronic, Johnson & Johnson, and Philips. Thanks for listening to the DeviceTalks Weekly Podcast.

This episode of the DeviceTalks Weekly podcast features a panel discussion I led at Medmarc’s Annual Broker meeting. There are enormous insights on how investors and start-up executives see the opportunities and challenging facing the sector today. Below, you can see time stamps for each of the major topics we covered. We suggest sitting back and listening to the entire podcast – long, but not crazy long – but refer to the time stamps if you’d like to go back and listen again. Thanks to MedMarc for sponsoring! Here is the panel Ali Behbahani, MD, General Partner, NEA Ryan Drant, Founder, Managing Partner, Questa Capital Justin Klein, MD, JD, Vensana Capital Martha Shadan, Medtech CEO, Board Member Here are the topics 3:30 - Intros 8:20 - Concerns about inflation 23:20 – Optimistic or pessimistic about the future 29:20 – Regulatory/Reimbursement 43:00 – Connected Health 51:00 – Opportunities and risks of AI 58:30 – Finding a workforce 1:04:30 – Where have all the VCs gone?! Thanks for listening to the DeviceTalks Weekly Podcast

The medical device industry obviously isn’t immune to the challenges posed by a shaky supply chain. But OEM leaders like Boston Scientific need to work doubly hard to ensure they have the supplies needed to provide devices for patient care. In this episode, we’ll talk with Brad Sorenson, executive vice president, Global Operations, and Paudie O’Connor, senior vice president of supply chain, to learn how Boston Scientific has managed the crisis. Topics we cover include supplier relationships, the value (and risk) of redundancies, how to reducing shipping costs and other critical topics. Supply chain executives at OEMs and smaller vendors will value from the conversation. Thanks to Paxxus for sponsoring this episode. Chris Newmarker also returns to share his Newmarkers Newsmakers – Edwards Lifesciences, Verily, Johnson & Johnson, Smith+ Nephew, and MassDevice’s Big 100! Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe on any major podcast player.

Not sure why but last week's podcasts didn't immediately find their way to some podcast players. They are there now, so enjoy! And thanks for listening.

Nearly 700,000 people die from heart disease, that’s one out of every five deaths, a startling number that could be curtailed with better predictive tools. In this episode, we’ll talk with two medical device companies employing new analytical tools to get a clearer picture of heart health. We’ll first connect with Campbell Rogers, MD, executive vice president and chief medical officer of HeartFlow, who will explain how the company’s HeartFlow FFRCT Analysis tool can bring new data to bear. Then, we’ll connect with James Min, MD, co-founder and CEO of Cleerly, a start-up employing artificial intelligence and other tools that he says will help dispel the mystery of this elusive killer.

In this episode, Eileen Buckley, vice president, corporate responsibility, unpacks how Stryker is following its environmental, social and governance strategies to encourage its employees, suppliers and even customers to meet increased demands for greater healthcare access and a smaller environmental impact. In a time where employees look to work with companies that carry a broader social mission, Buckley says Stryker sees real business benefits by answering the call issued by societal stakeholders as well as its shareholders. This episode is sponsored by Dassault Systemes. Thank you for listening to the StrykerTalks Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast application including Amazon, Apple, Spotify and Google.

In this episode, two senior leaders from Medtronic’s Cardiovascular Diagnostics & Services group share the group’s vision of “turning data into the right therapy.” Sanjiv Arora, vice president of business development and strategy, and Leo Rapallini, vice president of research & development, explain how trail-blazing technologies like the LINQ family of ICMs are a great tool in measuring infrequent – but important - cardiac events. But the company sees an opportunity to employ these tiny implantable data-collection devices to provide data that might enable doctors to predict problems before they come, both in cardiac care and other areas as part of a broader disease management strategy. This episode was sponsored by Isometric. To listen to the earlier episode featuring Julie Brewer, president, Cardiovascular Diagnostics and Services go here. https://news.medtronic.com/medtronictalks-podcast-julie-brewer

In this episode, two newer players to the surgical robotics space explain how they’re planning to grab their appropriate slice of the growing market. First, we’ll talk with Kurt Azarbarzin, CEO of EndoQuest Robotics, which is developing the world’s first endoluminal robotic surgical system that can access the body through the mouth or anus. In our second interview, Dvir Cohen, CEO of Momentis Surgical, shares the benefit of the Anovo System, which is indicated for use in robotic-assisted transvaginal benign surgical procedures. Chris Newmarker brings his Newmarkers Newsmakers including news from Abbott, Teleflex, Medtronic as well as special reports on neural implants and surgical robotics. You can find them both on MassDevice.com. But here’s the link to the surgical robotics article. https://www.massdevice.com/16-surgical-robotics-companies-you-need-to-know/ Thanks for listening to DeviceTalks Weekly.

In this episode, Mike Panos, president of the trauma and extremities division, explains how Stryker built a powerhouse in their shoulder and foot and ankle businesses through internal development and the acquisition of Wright Medical. The purchase brought Stryker a new line of products and a virtual planning tool called Blueprint. We also explore the trauma business, including where Stryker sees opportunities for innovation and growth. This episode is sponsored by Tecomet. Please subscribe to this podcast on every major podcast player Thank you for listening to the StrykerTalks Podcast.

In this episode of the DeviceTalks Weekly Podcast, we collect three very different perspectives on what it takes to find jobs/employees in this current labor market. First, we connect with Joe McClung, president of Floodgate Medical, an executive search firm focused on the medical device industry, for an overview of the current market and some tips for job seekers. (Floodgate also sponsored this episode.) Next, Emma Plouffe, vice president of people and culture at Vicarious Surgical, tells us some of the tools she’s using to find talent for the fast-growing surgical robotics company. Then, we end the episode connecting with Elizabeth Steele, vice president of Microspec Corp., a contract manufacturing business that’s making a bold move to find and retain new employees. Of course, Chris Newmarker, executive editor of MassDevice, brings his Newmarkers Newsmakers – BD, GE Healthcare, AliveCor and Philips Respironics. Please subscribe on all major podcast players. Thanks for listening to DeviceTalks Weekly.

In this replay of our most recent MedtronicTalks episode, Dr. Laura Mauri shares the career path that started with an early interest in medicine brought, at least partly, by her mother’s cancer diagnosis. Mauri directed that interest in caring for patients – and an innate ability to keep cool under pressure – to become an interventional cardiologist, a career that led her to appreciate the benefits of new technologies. This interest in new devices drew her to join Medtronic in 2018. This year, she was named senior vice president and chief scientific, medical and regulatory officer. We’ll talk with her about the “good surprises’ she encountered at Medtronic as well as the impact that the pandemic’s fallout will have on clinical trials and clinical workflow going forward. This episode is sponsored by Medmarc insurance Group.

In this replay of the popular MedtronicTalks podcast episode, Greg Smith brought decades of supply chain experience with him when he joined Medtronic last year during the throes of pandemic-induced pressures on supply chain. Over that time, Smith has been working with company leaders and outside suppliers to mitigate the challenges being wrought by the string of global crises. In this episode, we’ll learn how Medtronic is working to build a stronger supply chain that will allow it to build an inventory capable of keeping critical medical devices flowing to customers. This podcast is sponsored by Donatelle.

In this episode, Tom O’Brien, Ethicon’s worldwide president of endomechanical, gives a detailed lesson on the design of its Echelon 3000 surgical stapler, from recognizing the huge problem of surgical complications and identifying how to build a stapler that’s more suited to ALL surgeons. The Echelon 3000 is designed with 39% greater jaw aperture and a 27% greater articulation span, as well as software that provides real-time haptic and audible device feedback to help enable surgeons to make critical adjustments during procedures. Executive Editor Life Sciences Chris Newmarker conducts that interview and brings his Newmarker’s Newsmakers hitting upon news from Stryker, Pear Therapeutics, Dexcom and 3M. We also talk about the world’s largest orthopedics companies (find the list here https://www.massdevice.com/10-largest-orthopedic-device-companies-in-the-world-2022/) and the current spate of disappointing earnings reports from medical device companies If you’re interested in learning more about our upcoming DeviceTalks West event, join Editorial Director Tom Salemi on this short webinar. https://event.on24.com/wcc/r/3878353/5BD2F587B74A5106D4FFC61E92BC6354 Subscribe on all major podcast players.

In this episode, Camille Chang Gilmore, vice president, human resources and global chief diversity officer, explains why she accepted Boston Scientific CEO Mike Mahoney’s offer to help lead the company’s diversity and inclusion efforts. This company’s work led to the creation of multiple programs promoting equity and combatting racism, earning Boston Scientific multiple awards and recognition from outside the company. She also shares as personal memory that speaks to the success she’s seen. This episode is brought to you by KNF. In this week’s Newmarker’s Newsmakers, Executive Editor Chris Newmarker brings a bounty of big news items from Synchron, Amazon, Intuitive, J&J and iRhythm.

In this episode of IntuitiveTalks, Jonathan Conta, vice president of product management, shares Intuitive’s vision for its da Vinci SP system, a single-port system. Rather than using four arms outside the body that require multiple ports, da Vinci SP can create triangulation inside the body. Intuitive has secured broad approval for the system in Korea, but broader US approval has been coming slowly. The company is working with surgeon customers and internal engineering teams to find the right fit for da Vinci SP. The episode is sponsored by Biomerics.

In this episode, Boston Scientific CEO Michael Mahoney makes his DeviceTalks Weekly Podcast debut. In this jam-packed interview, Mahoney walks us through the cultural changes Boston Scientific has made since he joined the company a decade ago. He explains how restructuring has helped to identify leaders rather than managers. How Boston Scientific encourages people to take risks. Where does Boston Scientific see growth in markets and technologies. (We ask if Boston needs a surgical robotics platform.) Mahoney also explains how Boston Scientific knows when to let an opportunity go. We talk about experiences from his own career that others can take us lessons. Mahoney also explains what co-founder Pete Nicholas, who passed away recently, meant to the company, and what Boston Scientific will look like in five years. How will Boston Scientific move forward if the economy weakens. This episode is sponsored by PSN Labs. Executive editor Chris Newmarker brings his #NewmarkersNewsmakers – Cardinal Health, Acutus Medical, Medtronic and Boston Scientific. We also walk through a list of Medical Device companies are responding to the SCOTUS’s overturning Roe v. Wade and what this might mean for healthcare care data collection.

In this week’s episode, Cala Health CEO Renee Ryan joins us in the Newmarker’s Newsmaker’s booth to share her insights on the news of the week including an interesting meeting with Mike Mahoney before he become CEO of Boston Scientific. Ryan also shares details on the growing success of the Cala Trio, a device worn on the wrist to help control essential tremors. We dive deep into Cala’s story, talking with Deanna Harshbarger, vice president, product, and Doug Biehn, chief commercial officer. This episode is sponsored by AcuityMD. Executive Editor Chris Newmarker returns with his Newmarker’s Newsmakers – GE Healthcare, Boston Scientific, Ekso Bionic, Medtronic and Abbott.

In this episode, Michael Matson, analyst at Needham, explains his thoughts behind a possible J&J acquisition of Boston Scientific. He also explains why he downgraded Medtronic and his take on supply chain issues. The rest of the episode will focus on Moon Surgical, which recently closed on a $31 million Series A to build a new robot that could lend critical assistance to surgeons. We speak with CEO Ann Osdoit about the company’s plans as well as investor and advisor Steve Oesterle, formerly of Medtronic. Oesterle also gives his assessment of the broader medical device-technology convergence including some fascinating forecasts for Verily. This episode is sponsored by KNF. Also hear more information about our upcoming DeviceTalks Tuesdays session and DeviceTalks West in-person meeting.

This week listeners will get to hear how Stryker is incorporating Vocera, Gauss and other tech into its DRE strategy. We’ll get a visit from fellow podcaster Keith Figlioli of LRV Health to talk about Oracle’s acquisition of Cerner. And Chris “WorkLord” Newmarker brings a star-studded Newmarker’s Newsmakers feature Smith & Nephew, GE Healthcare, Ethicon, Medtronic, and Moon Surgical. Thank you to Flexan for sponsoring this episode! Go to Flexan.com. Newmarker’s Newsmakers 5. Smith & Nephew makes historic move? https://www.massdevice.com/smithnephew-moving-out-of-hull-uk/ 4.GE Healthcare keeps making news! https://www.massdevice.com/ge-healthcare-workload-management-software-radiologists/ 3. Have you seen Ethicon's stapler? https://www.massdevice.com/ethicon-launches-next-gen-surgical-stapler/ 2. Medtronic adds more Neuromed Knowhow https://www.massdevice.com/medtronic-announces-new-chief-medical-officer-for-neuromodulation-unit/ 1. Moon launches robotic surgery bid https://www.massdevice.com/moon-surgical-raises-31m-robotic-surgery-system/

In this episode, we’ll take a deeper look into our Newmarker’s Newsmakers with Andrew Jay, general partner at the Borna Health Fund, a hedge fund that invests in medical technology companies. We’ll take about Stryker’s recent regulatory success; Quidel’s game-changing acquisition; Medtronic’s dialysis deal with DaVita and shareholder votes against executive pay at Masimo. We’ll also take a deeper look into the swirling speculation that Johnson & Johnson could look to buy Boston Scientific. In the second half of the show, we’ll run our latest MedtronicTalks podcast episode that highlighted the work the company and industry is doing to identify and combat healthcare inequity. Finally, we’ll also hear some helpful advice on cybersecurity. #5. https://www.massdevice.com/strykers-spine-guidance-software-fda-clearance/ #4 https://www.massdevice.com/quidel-ortho-clinical-diagnostics-combine/ #3 https://www.massdevice.com/medtronic-davita-kidney-device-company/ #2 https://www.massdevice.com/masimo-no-vote-executive-pay/ #1 https://www.drugdeliverybusiness.com/dexcom-quashes-insulet-merger/ https://www.massdevice.com/will-johnson-johnson-buy-boston-scientific/ Subscribe on any major podcast channel.

Parenthood changes everyone, but Mark Paul’s life took a drastically different turn the moment his oldest child was born. Paul discovered he had a passion for the OR and patient treatment, a realization that convinced him to switch careers to the medical device industry. Today, Paul leads Stryker’s neurovascular business which, he says, contains the origins of the stroke treatment industry. In this interview, Paul reviews the strength and strategies of the “micro plumbers” who are helping people who are at risk of suffering a stroke or are trying to find their way back. This episode is sponsored by Resonetics.

Message from co-host Tom Salemi, editorial director of DeviceTalks. Check out MedtronicTalks and StrykerTalks at DeviceTalks.com. You can also subscribe to MedtronicTalks on any podcast player.

In this episode the MassDevice editorial team will break down all the action at DeviceTalks Boston. You’ll also hear from keynote speaker Eric Benjamin, executive vice president of innovation, strategy and digital products, at the company. To read MassDevice’s coverage of DeviceTalks Boston go here. https://www.massdevice.com/tag/devicetalks-boston/ Thank you to our sponsor DeepDyve. To try out DeepDyve go to https://get.deepdyve.com/devicetalks/

First, a quick recap of DeviceTalks Boston. Then, a MedtronicTalks Podcast Replay, in which Austin L. Chiang, MD, explains why he brought his sizable social media following to Medtronic, where he serves as chief medical officer of the Gastrointestinal business. Chiang says his decision is directly tied to his excitement about Medtronic’s growing suite of GI products including the AI-powered GI Genius and the swallowable PillCam. Chiang explains why he chose to couple the company’s broad platform with his own social media presence to reach more patients who may need treatment of gastrointestinal care. He also gives advice to other physicians who may want to amplify their own voices through social media.

DeviceTalks Boston is here! Win a free registration. In this week’s episode, we’ll give you a little taste of what you’ll see at the Boston Convention & Exhibition Center on May 10-11. Friend and colleague Steve Crowe, editorial director of the Healthcare Robotics Engineering Forum, will share what attendees will see at that meeting, which is co-located with DeviceTalks Boston. Then, we’ll talk with Peter Stebbins about his Opening Keynote Interview with medtech veteran Peter Doyle, who is now dean of Harvard John A. Paulson School of Engineering and Applied Sciences. We’ll also get a final update from Paul Grand, CEO of Medtech Innovator, about the 22 mid-stage medical device companies that will be presenting at DeviceTalks Boston. A selected few will then compete at Medtech Innovator’s Pitch Contest on May 11. And to demonstrate we’re not just selling you on an event, we talk with Dave Evans, co-founder and CEO of Fictiv, a technology company that has raised nearly $200 million to fix – or disrupt – the supply chain. Finally, a contest for loyal and attentive DeviceTalks Weekly Podcast listeners. Win free registration to DeviceTalks Boston!

In this episode, Nick Spadea-Anello, Boston Scientific’s global president of electrophysiology, will explain how the $1.7 billion paid for Baylis Medical will help expand the Boston's extensive EP portfolio. We also talk about the message he likes to impart upon employees of recently acquired companies, sharing some lessons he learned when Boston Scientific acquired his then-employer, Guidant. We also welcome Brian Johnson, president of MassMedic, the top medical device association in New England, into the booth as our co-host. Johnson, of course, brings his insider perspective to Newmarker’s Newsmakers, but he also shares how everyone needs to do a better job of sharing medtech’s stories. He should know. Johnson is the co-founder of MassDevice and DeviceTalks! So we got an origin story as well. Executive editor Chris Newmarker brought a powerful newsmaker list including an interesting take on a recent collaboration between Medtronic and GE Healthcare. Other newsmakers include Alcon, Philips, Abbott, and the deal between Medtronic and Acutus medical that might be an answer to Boston’s acquisition of Bayliss. 5 - https://www.massdevice.com/alcon-smartcataract-study-shows-enhanced-time-savings-during-cataract-surgery/ 4- https://www.medicaldesignandoutsourcing.com/doj-subpoenas-philips-over-respironics-recall-ceo-addresses-investigation/ 3 - https://www.massdevice.com/abbott-launches-upgraded-digital-health-app-for-neurostimulation/ More Abbott news today... https://www.massdevice.com/abbott-announces-u-s-launch-of-amplatzer-steerable-delivery-sheath-for-amulet-device/ 2 - https://www.massdevice.com/ge-healthcare-medtronic-to-collaborate-on-improving-outpatient-care/ 1 - https://www.massdevice.com/acutus-medical-sells-left-heart-access-portfolio-to-medtronic-in-50m-deal/

In this episode, we’ll talk to two of the more innovative companies in the peripheral vascular space – Shockwave Medical and LimFlow – about how they’re helping to treat people who previously had few or zero options. This episode is brought to you by Confluent Medical. LimFlow CEO Dan Rose walked us through his decision to build his Medtech career in Europe. He also talked about LimFlow’s unique approach to using veins as a route to deliver blood to limbs rather than return blood to the heart. Our second interview is with Doug Godshall, CEO and President of Shockwave Medical. Godshall admittedly came to medtech later in his career, but he’s taken on some of its most serious and intractable problems, first as CEO of HeartWare and now Shockwave Medical. You can learn more about Shockwave here https://shockwavemedical.com/about/our-story/ and LimFlow here. https://limflow.com/ We’ll also have Chris Newmarker delivering his Newmarker’s Newsmakers including news from Philips, Johnson & Johnson MedTech, Natus Medical, Amazon Web Services, and Dentsplay Sirona. Subscribe to this podcast on all major podcast apps. #5 https://www.massdevice.com/philips-has-another-round-of-serious-ventilator-recalls/ #4 https://www.massdevice.com/johnson-johnson-medtech-is-shopping-for-ma-deals/ #3 https://www.massdevice.com/archimed-group-to-acquire-natus-medical-for-1-2b/ #2 https://www.medicaldesignandoutsourcing.com/amazon-web-services-aws-cloud-chief-medical-officer-taha-kass-hout-machine-learning-ai/ #1 https://www.massdevice.com/dentsply-sirona-sacks-ceo/

In this week’s episode, we interview Joe Army, CEO of Vapotherm, and Alton Shader, CEO of Viant. First. We’ll follow Army’s heartful move into Medtech, which includes his current role as CEO of Vapotherm, maker of the high flow nasal cannula that proved to be a highly effective tool to treat patients hospitalized with COVID-19. We’ll later learn that Vapotherm’s ability to supply hospitals with this life-saving technology was in doubt due to labor shortages. But Shader details how the contract manufacturer stepped in to immediately help with Vapotherm’s dilemma. The interview is a taste of the discussion Vapotherm and Viant will lead at DeviceTalks Boston on May 10. Go to devicetalks.com to register. We also bring in former Johnson & Johnson executive Peter Stebbins to tell us about his upcoming interview with Frank Doyle III, dean of Harvard’s John A. Paulson School of Engineering and Applied Sciences. Doyle will be our keynote interview subject on the morning of May 10 at DeviceTalks Boston. Stebbins also provides his experience and insights to this week’s Newmarker’s Newsmakers including news from Medtronic, Masimo, Boston Scientific, GE Healthcare and FitBit. #5 https://www.medicaldesignandoutsourcing.com/medtronics-ceo-would-like-to-put-the-tech-in-medtech/ #4 https://www.massdevice.com/masimo-completes-acquisition-of-sound-united/ #3 https://www.massdevice.com/boston-scientific-wins-fda-approval-for-imaged-guided-software-for-dbs-therapy/ #2 https://www.massdevice.com/ge-healthcare-elekta-collaborate-to-expand-precision-radiation-therapy-access/ #1 https://www.massdevice.com/fda-clears-fitbit-ppg-algorithm-to-detect-afib/

In this episode of StrykerTalks, Jessica Mathieson, vice president and general manager of the Acute Care, recounts her unusual path into the medical device industry, giving advice to others interested in making the transition. The conversation then delves into an unassuming – but critical – piece of medical equipment – the hospital bed where most patient-healthcare interaction takes place. Later in the interview, Mathieson will talk about Stryker’s work to provide new technologies that help healthcare workers handle their increasing stress loads; technologies that incorporate technology from the recently acquired Vocera. Also, how is Stryker sharing risk with hospitals to increase patient safety?

In this episode, Penumbra CEO Adam Elsesser shares why he left a successful law career to become CEO of a medical device startup. After selling that company to Boston Scientific, Elsesser and his co-founders started Penumbra, which has steadily built businesses in stroke and vascular businesses. But Penumbra’s biggest business may be an immersive VR technology system that’s able to improve mental health. This episode is sponsored by TE Connectivity. Executive Editor Chris Newmarker brings his top stories of the week. This episode’s Newmarker’s Newsmakers including Ascensia, Senseonics, GE Healthcare, Olympus, DJO, Abbott. We also highlight the biggest news of the quarter coming, including an acquisition by Medtronic. Subscribe to this podcast on any major podcast player.

In this episode, we’ll assemble the news team to bring you stories big, small and in the middle. Associate Editor Sean Whooley delivers HUGE results. He interviews CEO Dev Kurdikar and CFO Jake Elguicze, leaders of the newly spun out Embecta, the one-time business of Becton Dickinson that’s now an immediate player in the diabetes space. Later on, Jim Hammerand, managing editor of Medical Design & Outsourcing magazine, interviews Torrey Smith, the CEO and Co-founder of Endiatx, a small company developing microrobots that could someday replace the work of an endoscope. In between we’ll hear the Newmarker’s Newsmakers from Chris Newmarker, executive editor of life sciences. This week’s top stories including new from Philips, Biobeat, Staar Surgical, BD, Embecta and Owens Minor. Find the articles here: https://www.massdevice.com/government-warns-on-cybersecurity-issues-with-philips-e-alert-mri-monitoring-system/ https://www.massdevice.com/fda-clears-biobeats-remote-vital-sign-monitoring-system/ https://www.massdevice.com/staar-surgical-wins-fda-approval-for-evo-visian-implantable-collamer-lens/ https://www.massdevice.com/bd-completes-spinoff-of-embecta-diabetes-company/ https://www.massdevice.com/owens-minor-completes-1-6b-acquisition-of-apria/ To read Jim Hammerand's Medical Design and Outsourcing cover story on Endiatx go here. https://www.medicaldesignandoutsourcing.com/endiatx-pillbot-stomach-cam-swims-torrey-smith/ Subscribe on all major podcast apps.

In this episode of IntuitiveTalks, we take our first look at Intuitive’s Future Forward program, a three-piece initiative to better understand how the company fits best into an evolving healthcare landscale. Our guests are Julian Nikolchev, an experienced medical device entrepreneur and investor who now serves as SVP, Development and Strategy at the Intuitive. Nikolchev led the creation of Intuitive Ventures, a $100 million corporate venture capital program led by our second guest, Oliver Keown, MD, a physician turned investor who is leading the creation of an intriguing portfolio of digital and medical device companies that will help inform Intuitive’s future. You can see Intuitive’s full team and portfolio here. https://ventures.intuitive.com/

In this episode of the DeviceTalks Weekly Podcast, we speak with Yuriy Lebed, the CEO of Pharmaxi LLC, a CRO based in Kyiv, Urkaine, that works with pharmaceutical and medical device companies across the globe. In an interview from Lviv, Lebed says he was as shocked as many that Russia would invade its neighbor. The attack forced him to relocate with his family to Lviv, in the western part of the country. From there, he’s been able to lead the CRO as it keeps many clinical trials running. He calls the country’s regulators are “heroes” for vowing to process approvals while the capital city is bombed. He also says Pharmaxi is already planning for the future, which includes expanding operations into Poland and working within EU countries. You can find a way to donate to relief efforts for Ukraine here. https://www.forbes.com/advisor/personal-finance/donate-relief-to-ukraine

In this episode, we talk to two principals of Johnson & Johnson MedTech’s push to bring higher powered tech into its digital surgery strategy. In separate interviews, Johnson & Johnson Group CIO and Global VP of Medical Devices Larry Jones and Office of Digital Innovation Leader Peter Schulam (who also serves as global head of medical affairs, clinical affairs and pre-clinical research for Johnson & Johnson Medical Devices Cos.) explain how the company is moving toward the future. In our Newmarker’s Newsmakers segment, Jim Hammerand, managing editor of Medical Design and Outsourcing, tells us about his ongoing Cloud series. We first heard from Jones and Schulam in an MDO article. Link below. Jim also joins Chris Newmarker, executive editor of life sciences, and Tom Salemi, Editorial Director of DeviceTalks, in discussing medtech’s news of the week including news from robotic pill maker EndiaTx, Johnson & Johnson, Medtronic, DexCom and GE Healthcare and AliveCor. Also, listen for the code to save 25% off registration to DeviceTalks Boston and DeviceTalks Minnesota. TODAYS LINKS MDO Article - https://www.medicaldesignandoutsourcing.com/johnson-jnj-microsoft-cloud-larry-jones-peter-schulam/ Newsmaker #5 - https://www.medicaldesignandoutsourcing.com/endiatx-pillbot-stomach-cam-swims-torrey-smith/ Newsmaker #4 - https://www.massdevice.com/johnson-johnson-medical-devices-rebrand-medtech-jnj-name-change/ Newsmaker #3 - https://www.massdevice.com/medtronic-names-new-presidents-for-diabetes-surgical-robotics-cardiac-rhythm-units/ Newsmaker #2 - https://www.drugdeliverybusiness.com/dexcom-wins-ce-mark-for-next-gen-g7-cgm-will-begin-european-launch-within-weeks/ Newsmaker #1 - https://www.massdevice.com/ge-healthcare-alivecor-partner-to-reduce-cardiac-related-hospitalizations/ Donate to World Central Kitchen - https://wck.org/ Subscribe on all major podcast channels.

In this debut episode of the StrykerTalks Podcast series, Spencer Stiles, group president of orthopaedics and spine business at the medical device giant, reveals the mixture of art and science that went into successfully integrating Wright Medical into Stryker’s industry leading orthopedic business. What does Wright’s portfolio and personnel bring to the table? We’ll also talk about MAKO’s future. How will robotic surgery fit into healthcare delivery more broadly, and what does new complementary tech make possible.

In this week’s podcast, we’ll speak with Sally Saba, MD, Medtronic’s chief inclusion and diversity officer, about the company’s work to create a more welcoming – and better performing – workplace. Paul Grand, CEO of MedTech Innovator, returns to take part in Executive Editor’s Chris Newmarker’s Newsmaker session. We talk about hour industry’s response to Russia’s invasion of Ukraine, Ryan Egeland, MD, joining Big Sky Innovator, the top-performing companies of 2021, the collapse of another SPAC deal, and an eye-opening approval. https://www.medicaldesignandoutsourcing.com/how-medtech-and-pharma-are-responding-to-russias-invasion-of-ukraine/ https://www.massdevice.com/former-cardiovascular-systems-chief-medical-officer-joins-big-sky-biomedical-incubator/ https://www.massdevice.com/these-10-medtech-companies-stocks-performed-best-in-2021/ https://www.massdevice.com/memic-innovative-surgerys-spac-deal-is-off/ https://www.massdevice.com/alcon-launches-clareon-intraocular-lens-in-u-s/ BUY A MAMMOTH TOOTH FOR A GOOD CAUSE - https://www.newburyportnews.com/news/mammoth-find-for-gigantic-ukrainian-cause/article_bed30a28-a093-11ec-a3a2-370b99bd241b.html LEARN ABOUT DEVICETALKS BOSTON https://gateway.on24.com/wcc/eh/2927718/lp/3691568/were-back-an-insiders-look-into-bringing-back-a-better-devicetalks-boston SIGN UP to try to present at DeviceTalks Boston though the MedTech Innovator Program https://medtechinnovator.org/apply/

In this week’s episode of the DeviceTalks Weekly Podcast, Vafa Jamali, CEO of the newest medical device company ZimVie, speaks with Chris Newmarker, executive editor at MassDevice, about the companys’ plans post-spinout from Zimmer Biomet. Jamali explains where the company sees opportunities to compete in the spinal space. In addition to the interview, we talk about the medical device industry’s support of Ukraine, as it’s being invaded by Russia. If you want to support Ukrainians during this attack you can find some charities here. https://www.forbes.com/advisor/personal-finance/donate-relief-to-ukraine/ In our Newmarker’s Newsmaker’s segment we hit about news from Siemens Healthineers, Roche, Philips, Varian, Heartflow, and Butterfly Networks. If you want to see the agenda for DeviceTalks Boston go here. https://boston.devicetalks.com/ If you want to register for my webinar discussing our plans for our in-person DeviceTalks Boston meeting go here. https://gateway.on24.com/wcc/eh/2927718/lp/3691568/were-back-an-insiders-look-into-bringing-back-a-better-devicetalks-boston

In this episode, we’ll speak with Heather Hudnut Page, vice president and general manager of peripheral vascular at Philips about the company’s ongoing efforts to build an image-guided therapy program. Hudnut Page will walk us through the four sizable acquisitions Philips has made to build out its pipeline. We first visited Philips two years ago when we spoke with Chris Landon, Senior Vice President and Business Leader for Image-guided therapy devices. Chris Landon returns to the podcast to share his thoughts on this week’s Newsmarker’s Newsmakers. This week, Executive Editor Chris Newmarker highlighted the news from Baxter, Shockwave, Smith & Nephew, Medtronic, and Abbott. Subscribe to this podcast on any major podcast channel. You can listen to Chris Landon's interview here. https://www.devicetalks.com/philips-imaged-guided-leader-landon-shares-global-giants-plans-for-minimally-invasive-devices/

Welcome to the first ever DeviceTalks Weekly Pitchcast! This week Kwame Ulmer, executive director of Medtech Color, sits in on the Newsmaker segment and delivers details on the upcoming Medtech Color Pitch Contest. Then, you can hear from the contests finalists themselves - AllergenIQ, bTECH LLC, Candlelit Therapy, Dialysis-X, Diatech Diabetes, Free From Marketplace, SealCath, Sunny and TAB Diagnostics. You can watch the pitch competition on March 8 by registering at MedtechColor.org. Chris Newmarker's Newsmakers includes Philips, Boston Scientific, Bayliss, Johnson & Johnson, DePuy Synthes and Masimo. Subscribe to this podcast on every major podcast channel.

This week we’ll focus on a few of the exciting companies in the diabetes space. Associate Editor Sean Whooley first tracks down Dexcom CEO Kevin Sayer, who discusses the company’s next-generation G7 continuous glucose monitor, which is awaiting FDA approval. Then, Sean speaks with Bigfoot Biomedical CEO Jeffrey Brewer to learn more about what he calls “a transformational attempt” to simplify CGMs with an all-in-one platform with a smart insulin pen cap. Finally, Sean interviews Senseonics CMO Dr. Francine Kaufman about the company’s Eversense 180-day CGM, which just received FDA approval. Chris Newmarker brings his Newsmakers of the week including Amazon, Thermo Fisher, HeartFlow, Abbott, Cooper Company and Cook Medical. This episode was sponsored by Accumold. Subscribe to this podcast on major podcast channels.

In this episode we’ll interview Michael Friedrich, CEO of Distalmotion, creator of Dexter, a robotic system used for laparoscopic procedures. Friedrich details how Dexter is positioned to build a market in an area untapped by other surgical robotic systems. The company recently closed on a $90 million Series E led by Revival Healthcare and 415 Capital. (For a related podcast listen to our most recent episode of Intuitive Talks on your DeviceTalks Weekly Library.) Executive editor Chris Newsmaker delivers his Newsmaker’s Newsmakers – Boston Scientific, Medtronic, BD, Hologic and Senseonics. Find out how these companies are tied to the upcoming DeviceTalks Boston meeting and listen for the discount code. Subscribe to this podcast!

We drill down on diagnostics – including COVID-19 testing – with Dave Hickey, newly promoted executive vice president and president of the life sciences segment of BD and Brooke Story, who took over his post as worldwide president of integrated diagnostic solutions. How did BD handle the crushing demand for at-home tests and where is diagnostics headed in the future. Paul Grand, CEO of Medtech Innovator, sits in with Chris Newmarker and Tom Salemi on this week’s Newmarker’s Newsmakers. He also delivers some important deadlines for medical device startups. This week's Newsmakers include Medtronic, Edwards Lifesciences, Distal Motion, Respironics and ZimVie. Find out more about Medtech Innovator at MedtechInnovator.org. Register for DeviceTalks at devicetalks.com. Use the discount code mentioned in this episode! Subscribe to this podcast on any major podcast channel.

In this episode, we learn about Intuitive’s OTHER ground-breaking robot, the ION endoluminal system. This episode is sponsored by Maxon Group. ION allows for robot-assisted bronchoscopic procedures such as biopsies in the hardest to reach areas of the lung. The FDA cleared the ION system in 2019. We speak with Charlie Dean, vice president and general manager of the endoluminal business unit at Intuitive, an engineer who has spent his career working to make smaller, more effective minimally invasive tools. We also talk with Oliver Wagner, MD, vice president and medical officer of the endoluminal division. Wagner explains how his long-time pursuit of NOTES led him to join Intuitive. He also sees a future where ION can serve as a platform for many other devices. Subscribe to this podcast on every major podcast platform.

In this week’s DeviceTalks Weekly podcast, Outset Medical’s Leslie Trigg recounts the career detour that led her to a successful career in medical devices. Drawing on past experiences, the CEO explains why she chose to lead Outset’s mission to create a dialysis system that restore the freedom lost to the demand of traditional in-clinic dialysis. Outset’s “enterprise system” for dialysis now allows patients to treat themselves at home when and where they want. Can Outset serve as a model for other “hospital at home” approaches. Chris Newmarker delivers another stellar Newmarker’s Newsmakers featuring news from the Big 100, Edwards Life Sciences, Inspire Medical, Dexcom, Medtronic, Neurometrix, Augmedics and Acutus Medical. Subscribe on all major podcast channels.

In this episode, two senior orthopedics executives at DePuy Synthes walk us through the company’s growing portfolio. First, Rajit Kamal, worldwide president, sports medicine and shoulder reconstruction, lays out the opportunity for the growing shoulder market and explains what the INHANCE Shoulder System offers to surgeons. He also details what it will take for ortho companies to grow the shoulder market. Later, Andrew Ekdahl, Worldwide President, Joint Reconstruction, updates us on the company’s VELYS surgical robotic system. He explains how new digital and robotic tech will change the orthopedics industry. Instead of Newmarker’s Newsmakers, this week host Tom Salemi will review the most listened to DeviceTalks Weekly Episodes of 2021. We’ll also announce upcoming news in in-person conferences, digital meetings and podcasts – including a NEW podcast powered by DeviceTalks. Subscribe to all these podcasts at most major podcast platforms.

Happy New Year! In this first episode of 2022, we’ll learn a lot about Olympus Corp.’s plans to expand into the medtech industry. The global behemoth has been doubling down on the industry in recent years. COO Nacho Abia and Gabriela Kaynor, global division head of therapeutic solutions in the Americas, will lay out the plans to build into other parts of the medtech industry. Chris Newmarker is back with his Newmarker’s Newsmakers! Chris will bring news from Boston Scientific, GE Healthcare, Titan Medical, Relievant Medsystems, Medtronic, Memic Innovative Surgery, and Stryker. Subscribe to catch future episodes on any major podcast player.

In this episode, we’ll dive deep into the Heart Failure business at Abbott. First we’ll connect with Philip Adamson, MD, chief medical officer of the group. Dr. Adamson uses an explanation of CardioMEMS to give a vivid portrait of how patients live with heart failure. Technology, he says, makes turns those patients into their own health care workers. This podcast is sponsored by KNF. Then, we’ll talk with Kevin Bourque, vice president of research and development, and Robert Kormos, division VP, global affairs of heart failure, about the advances of Heartmate 3. Both also detail how Abbott is working to help children suffering from the condition. Dr. Kormos also shares the most gratifying part of his job. The entire editorial staff joins the podcast to share their personal top stories of 2021. News includes mentions from Vicarious Surgical, ResMed, Philips, Pfizer, BioNTech, Abbott, Dexcom and Insulet. Happy New Year!!! We'll see you in 2022. LIKE! FOLLOW! SUBSCRIBE!

In this episode we’ll explore potentially life-saving treatments for hypertension and stroke. First, we’ll talk with Sandra Saldana, CEO of the start-up Alva Health, which is developing a wearable system that can detect strokes. Alva Health won the 2021 Global Competition of the Medtech Innovator program. Then we’ll explore renal denervation, the exciting but vexing method of lowering hypertension by ablating nerves in the kidney. We’ll talk to the leaders in this space including Andy Weiss, CEO of Recor Medical, a division of Otsuka Holdings, that’s developing the Paradise Renal Denervation system. Weiss, a medtech veteran, shares his long-term views, one why he still sees Renal Denervation as a game-changer. Then, we’ll run an excerpt of the MedtronicTalks podcast interview with Jason Weidman, senior vice president and president of the coronary and renal denervation business at Medtronic. Weidman details Medtronic’s latest regulatory hiccups but, like Weiss, explains why he sees renal denervation as an important new therapy that can save the lives of people struggling to control their hypertension. You can listen to the entire interview with Weidman here. https://www.devicetalks.com/weidman-talks-us-through-the-long-road-to-get-symplicity-ready-to-help-patients-with-hypertension/.

In this episode, we learn about the data collecting during surgical robotic systems. Chief Digital Officer Brian Miller and Tony Jarc, Director, Research and Data Science , detail the importance of data being collected by Intuitive’s surgical robotic systems and how the company uses the data to help guide surgeons in the future.

In this episode, we’ll do a deep dive with Stryker Corp., which recently hosted an in-person analyst day. In our first interview Andy Pierce, group president of MedSurg and Neurotechnology, will update us on his group’s wide-ranging portfolio, including an artificial intelligence-enabled tool to save the lives of patients at risk of dying of post-partem hemorrhaging. Kevin Lobo, chair and CEO, visits next to update on the company’s plans to keep building on its market leader status. We’ll talk about the Wright Medical integration, what makes a good acquisition, and how the rise of surgical robotics is helping Stryker build out its MAKO product. In between all this, co-costs Tom Salemi and Chris Newmarker review this week’s Newmarker’s Newsmakers including items from GE Healthcare, Best Buy, the FDA, DePuy Synthes and Boston Scientific. We also talk about pie.

Just a short message from Tom and Chris, two grateful guys who don't like pumpkin sausage.

This week’s discussion begins on the stage in Las Vegas where Tom Salemi interviewed Kwame Ulmer of Ulmer Ventures and Medtech Color at Medmarc’s annual broker meeting. This episode is sponsored by Medmarc. The conversation hit upon five areas that have changed over the past two years due to the pandemic or critical concerns over equity and fairness. In this podcast, Ulmer speaks to the slow progress being made in medtech in diversifying the workforce. But he also offers signs of hope and introduced Medtech Color. Ulmer will also speak to improvements made at the FDA, where he started his medtech career. He also provides an update on a comprehensive survey of the FDA being conducted by the biomed program at UCLA. We’ll also hear post-conference interviews with Jennifer Fried, CEO of Explorer Surgical, who will share how that company successfully pivoted during the pandemic. Mark Leahey, CEO of MDMA, will update on the MCIT ruling that would deliver surer reimbursement for medical device companies with breakthrough products. Finally, Jonathan Norris of Silicon Valley Bank shares surprising changes to early and late-stage financings as well as medical device exits. Subscribe to this podcast on all major podcast applications.

In this week’s episode, we follow up on our first episode focused on Transcatheter Aortic Valve Replacement (TAVR). This time we speak with one of the market leaders, Medtronic, about their broad structural heart portfolio. Nina Goodheart, president of Structural Heart, walks us through each valve and explains why Medtronic is sponsoring a clinical trial pitting its aortic valve against a rival’s. We also hear from the new competitor on the block, Abbott, which recently earned FDA approval for its valve. Santosh Prabhu, PhD, introduces the new entry and explains why this work is so important to him personally.

In the second episode of IntuitiveTalks, two senior executives explain how the company gets surgeons and hospitals to understand the benefits of the Da Vinci system. EVP Dr. Myriam Curet, who describes herself as a late adopter of technology, shares why she opted to join Intuitive as CMO early on after trying the Da Vinci robot. Similarly, SVP Gillian Duncan, who heads physician training and development, says her early experience with the robotic system convince her to leave her academic career to join the robotics pioneer. Subscribe to this podcast on all major podcast applications.

This week we’ll hear from Chris Barry, CEO of NuVasive. Barry joined NuVasive at a critical period in 2018. Now, the company is building out its portfolio of surgical tools, adding a digital surgery platform, planning its own move into robotics and finally making training much easier for its surgeons through new facilities, both real and virtual. Danielle Kirsh, senior editor, and Jim Hammerand, deliver the highlights from this month’s Medical Design and Outsourcing Magazine, our Women in Medtech issue. Danielle reveals some disheartening news about jobs and research dollars going to women while Jim shares hopeful details from some of the profiles. Chris Newmarker, executive editor, identifies this week’s Newmarker’s Newsmakers – Avail Medsystems, Integra Lifesciences, GE, Medtronic and NuVasive. Subscribe to this podcast on all major podcast applications.

The surgical robots are back in this episode of the DeviceTalks Weekly Podcast. First we’ll speak with Megan Rosengarten, president of robotics at Medtronic, about what the CE Mark for the Hugo surgical robot system means for current and future applications. Then, we speak with Ivan Tornos, COO of Zimmer Biomet, about that company’s broad technology offerings include ZBEdge, PersonaIQ Knee Implant, and other digital data collectors. Tornos says Zimmer Biomet intends to be the boldest company in the medtech industry. Chris Newmarker is back to deliver this week’s Newmarker’s Newsmakers – Intuitive Surgical, Xenter, Moderna, Medtronic, and Johnson & Johnson. Associate Editor Sean Whooley joins in on the fun. Subscribe to this podcast on all major podcast applications.

The urology specialty faces a critical moment, with 10 urologists ready to retire for every new urologist entering the field. That puts the onus on medical device companies to develop faster, safer and more efficacious ways to break down kidney stones, shrink enlarged prostates and handle other critical treatments. In this week’s episode, we’ll speak with Meghan Scanlon, SVP and president, Urology and Pelvic Health at Boston Scientific about that company’s growing pipeline bolstered by the acquisition of Lumenis. This episode was sponsored by KNF Neuberger. We’ll also connect with the leaders of Zenflow – CEO Nick Damiano and President Susan Stimson – about the start-up’s minimally invasive treatment for urinary obstruction caused by enlarged prostate, or benign prostatic hyperplasia (BPH). Finally, we have all-hands (or most hands) on deck for this episodes Newmarker's Newsmakers. Jim Hammerand, managing editor of Medical Design and Outsourcing, talks about Koya Medical and Hologic. Associate Editor Sean Whooley shares his insights on Varian and Explorer Surgical. Pharma Editor Brian Buntz gives us the latest on the never ending saga of Covid-19 booster approval. Subscribe on all major podcast applications.

In this first episode of the new IntuitiveTalks Podcast, we’ll start right at the beginning. CEO Gary S. Guthart recalls how a court side basketball conversation led to his introduction to the early form of a surgical robot and convinced him to join. He also shares his expectations for the surging surgical robotics field, including how the company will view emerging competition. This episode is sponsored by Tegra Medical.

Co-hosts Tom Salemi and Chris Newmarker announce the newest member of the DeviceTalks Podcast family - IntuitiveTalks!

Get it? Attractive? Magnets. Yeh, we’ll, we’re tired from putting this monster podcast episode together but it’s so, so good. You’ll hear from David Fischel, CEO of Stereotaxis, a 30-plus year old medtech that’s going through a quiet but deliberate reboot. Fischel says he took the company over because Stereotaxis’ magnetic robotic surgery system makes interventional surgery safer, an assertion supported by Daniel Cooper, MD, associate professor at Washington University School of Medicine. Stereotaxis appears to be on the cusp of something big. Then, Alberto Rodriguez-Navarro, MD, tells us why he sold everything to move from his native Chile to move to Silicon Valley and start Levitra Magnetics. The company is anticipating FDA approval for its own robotic system that could help hospitals overcome staffing shortages during laparoscopic procedures. We’ll also hear our sponsor Futek explain how its miniaturized sensors are advancing robotic surgery. Chris Newmarker, executive editor of life sciences, delivers the week’s big news featuring Siemen Healthineers, LumiraDx, Boston Scientific, Abbott and Medtronic. Senior editor Danielle Kirsh updates us on the Theranos trial. Subscribe to this podcast on all major channels.

This episode of the DeviceTalks Weekly Podcast draws from two realities First, Russell Powers, worldwide president, shoulder reconstruction, sports medicine, and spine at DePuy Synthes details how the company’s new Inhance Shoulder system will help the company grab market share in the increasingly competitive space. Later, we meet Dr. Justin Barad, CEO of OssoVR, on his own turf, conducting an interview in OssoVR’s virtual reality training platform. In the interview, Dr. Barad demonstrates why virtual reality training help alleviate the growing demands on surgeons while also improving performance. Chris Newmarker, executive editor of life sciences, identifies this week’s Newmarker’s Newsmakers including Abbott, Medtronic, and Vicarious Surgical. Senior editor Danielle Kirsh also shares her insights on the ongoing Theranos trial, including damaging testimony from General James Mattis. Subscribe to this podcast on all major channels!

Zoll Medical’s acquisition of Itamar Medical is just latest sign of the opportunity diagnosing and treating sleep apnea presents to medical device companies, especially following the CPAP machine recall issued by Philips Respironics earlier this summer. This week, we’ll talk with two of the leaders in this increasingly competitive market. First, we’ll reconnect with Tim Herbert, CEO of Inspire Medical Systems, to learn how that neurostimulation company is working to serve patients seeking an alternative to CPAP machines. This is our second visit with Tim Herbert. You can find his earlier interview on DeviceTalks.com. Then we welcome Michael “Mick” Farrell, CEO of ResMed, the leading provider of CPAP machines. Farrell explains why the apnea market is growing and what this means for the future of ResMed, which has grown into other respiratory businesses. Chris Newmarker returns! The executive editor of life sciences at MassDevice presents his Newmarker’s Newsmakers including Zoll, Itamar, Medtronic, Medicrea, iRhythm, Zimmer and its new spinout, ZimVie. We also discuss CMS’s disappointing backtrack on reimbursing innovative technologies. Danielle Kirsh, senior editor of life sciences, also presents a short report on the trial of Theranos founder Elizabeth Holmes.

Edward Lifesciences’ acquisition of Percutaneous Valve Technologies helped mark the birth of one of medtech’s great game-changers – the development of the transcatheter aortic valve replacement. In this week’s episode, Stanton Rowe, the former CEO of PVT, will walk us through the early days of TAVR, including the enormous doubt the start-up faced as it developed the technology. He also explained how Edwards came to acquire the start-up, which had strong interest from Medtronic, Boston Scientific, and others. Rowe, who is now CEO of the NXT Biomedical incubator, also offers some provocative thoughts on the origins of medtech innovation (and explains why he misses medical device conferences.) Larry Wood, corporate vice president at Edwards Lifesciences, will explain why Edwards opted to pursue PVT rather than continue to develop its own TAVR technology. He also explains why the clinical trial testing of the valve now known as Sapien was so difficult and how he rewrote the compensation packages for his TAVR sales team to help build confidence in the new technology. Scan the QR code for more information about our upcoming DeviceTalks Tuesday discussion with Sagentia! You can subscribe to this podcast on most major podcast players including Amazon, Apple, Google, and Spotify.

This week, DeviceTalks Weekly Podcast examines the single-use endoscope market. We’ll hear from market leaders Ambu and Boston Scientific in a replay of interviews we conducted in September 2020. Guests include Ambu’s CEO Juan Jose Gonzalez and Stephen Block as well Boston Scientific’s Endoscopy executives Dr. Brian Dunkin, chief medical officer, and Unit President David Pierce. You’re also invited to participate in a discussion led by TE Connectivity on Tuesday’s DeviceTalks Tuesday. Chris Newmarker, executive editor of life sciences at MassDevice, presents this week’s top Newmarker’s Newsmakers – Abbott, Boston Scientific, Medtronic, Johnston & Johnson, Auris and Amazon. Subscribe to this podcast on Amazon, Google, Apple, Spotify and other major apps.

New therapeutic approaches require fresh perspectives, and few perspectives were as fresh as Dr. Steven Mickelsen, the developer of a potentially paradigm shifting cardiac ablation treatment – pulse field ablation. Dr. Mickelsen, a high school dropout turned musician, fell deep enough in love with electrophysiology to go back to school, obtain a medical degree, and put his inclination to tinker to work in developing a new type of ablation. In this podcast we’ll walk down the path that led Dr. Mickelsen to create Farapulse, the early pioneer in this form of energy that now belongs to Boston Scientific. Dr. Mickelsen left the company a few years ago but he’s resumed his work helping Acutus Medical bring their technology to the market. He serves as that company’s chief translational science officer. In our second talk, we connect with Dr. Kenneth Stein, senior vice president and CMO of Boston Scientific’s cardiac rhythm management business. Dr. Stein allows us to pick up where Farapulse is leaving off, explaining why Boston Scientific bought the company now and what the plans are for the ablation systems, which has CE Mark but still requires FDA approval. Dr. Stein also shares advice for those physicians who may want to join a corporation. We also bring in Medtronic’s Rebecca Seidel, president of cardiac Ablation Solutions, and Dr. Robert Kowal, vice president of medical affairs and CMO at the cardiac rhythm and heart failure business. In this excerpt from our recent MedtronicTalks Podcast, Seidel and Dr. Kowal give a quick update on that company’s pulse field ablation technology. This week’s Newmarker’s Newsmakers is delivered by Senior Editor Danielle Kirsh and Associate Editor Sean Whooley including news from Ultrahuman, Johnson & Johnson, ResMed, Abiomed, and Abbott. Subscribe to this podcast on Amazon, Apple, Google and Spotify and other leading podcast apps.

Let's get interventional. This week, we talk with leaders from Abbott and Cordis about their plans to advance of medtech's stablest business. Duke Rohlen, executive chair, will explain to co-host Tom Salemi why he led the purchase of Cordis from Cardinal. Meanwhile, Dr. Nick West, CMO and DVP of vascular at Abbott, updates Associated Editor Sean Whooley on the Xience pipeline. This week's Newmarker's Newsmakers brings the big news from Abbott, Heartflow, Intersect ENT, Intuitive, Medtronic, Philips, and Resmed. Subscribe to this podcast on all major podcast applications!

This week’s episode focuses on the entrepreneurs. We open up with an interview with Andy Doraiswamy, founder and CEO of Koya Medical, a company he founded to help find a therapy for his ailing father. Then we revisit with Dr. Todd Brinton, chief scientific officer and corporate vice president at Edwards. This interview initially ran in May 2020 but we’re playing it again to amplify the unusual path that entrepreneurs take to find success.

This week's episode focuses on new hope for people with diabetes. Brad Paddock, CEO of CeQur, explains how its "wearable pen" can deliver insulin in a better way while Sean Salmon, head of Medtronic's diabetes business, reviews that company's growing portfolio. He also gives insights on its intriguing partnership with the private equity group, Blackstone. Chris Newmarker, executive editor of life sciences, drops a weighty Newmarker's Newmakers featuring stories from Hillrom, Baxter, NeuroMetrix, Philips, Medtronic and BD. Subscribe to this podcast on all major podcast apps.

The bioelectronics industry is poised to take off so we visited with Carolina Aguilar, CEO/Co-founder, INBRAIN Neuroelectronics about the field's potential. Chris Newmarker, executive editor of life sciences at MassDevice, delivers his Newmarker's Newsmakers highlighting news from Dexcom, NeuroMetrix, Nevro, Ancora and the Galien foundation. Subscribe to this podcast on Google, Amazon, Apple, Spotify and other major podcast channels.

Vicarious Surgical and CMR Surgical recently combined to raise over $1 billion from public and private investors. Big money clearly as found surgical robotics. Now what? We connect with Per Vegard Nerseth, the new CEO of CMR. Nerseth comes to CMR from the robotics industry, so he brings deep industry understanding of what it will take to get CMR to the next level. The company closed on $600 million for a Series D, which is likely the largest private medtech investment in history. Later, we reconnect with Adam Sachs, co-founder and CEO of Vicarious Surgical. Sachs walks us through the process of merging with a SPAC (not for the faint-hearted.) With over $400 million in hand, Vicarious is bringing in senior talent and moving to a legacy filled new HQ to prepare for its next stage. Chris Newmarker, executive editor of life sciences at MassDevice, brings his Newmarker's Newsmakers highlighting news from Stryker, Heartflow, Hillrom, BardyDx, TransMedics and Imperative Care. Subscribe to this podcast on every major podcast channel!

This week we’ll focus on investor insights. First, we’ll talk with Danielle Antalffy, managing director at SVB Leerink. Antalffy covers most of the major medtechs but we’ll focus on a new report she issues on sugaring home-based dialysis business. What does this mean for Outset specifically? More broadly, do other medtechs need to build out their at-home/connectivity function? Also, what does NeuroPace’s success mean for other medtech companies. In a follow up to our interview with Dr. James Min, CEO of Cleerly Health, we talk with two venture investors in the early heart attack risk detection company. Justin Klein, MD, of Vensana Capital walks us through the steps he took before leading the company’s recent $43 million Series B round. Tripp Peake of LRV Health explains why the company interests his venture firm’s limited partner base. This is an opportunity for entrepreneurs to better understand the venture capital due diligence process. Chris Newmarker, executive editor of life sciences, delivers his Newmarker’s Newsmakers brings top news from Conformis, Stryker, Siemens Healthineers, Abbott, Medtronic and Levita Magnetics. LIKE! FOLLOW! SUBSCRIBE! We’re on most major podcast channels.

In this week's DeviceTalks Weekly Podcast, Minnetronix CEO Jeremy Maniak explains how the CMO is using internal know how to develop medical devices that can be sold by outside partners. We also hear from Dr. James Min of Cleerly Health about that company's start and the process that went into raising $43 million. Chris Newmarker, executive editor of life sciences at MassDevice, is back to deliver his NewmarkersNewsmakers including news from Costa Rica, Vicarious Surgical, Ethicon, Medtronic and ResMed. Subscribe to this podcast today on all major podcast channels.

Nicole J. Walker, managing partner, Arboretum Ventures, tells a unique medtech story that begins with her sick grandfather and follows up with her refusal to remove her foot from the door at Advanced Cardiovascular Systems. She says she learned early on that she may not always have all the answers when making a decision but she would have the instincts and mettle to push through. This combination moved through jobs at Guidant, Abbott, Baird and now Arboretum Ventures where she sees an enormous opportunity finding medical device companies.

A year ago, Geoff Martha took over as CEO of medtech's large single company. With the sector in lockdown, the company still undertook a massive reorganization and moved to adopt a new "Medtronic Mindset" that would favor the bold. In this interview, Martha reviews Year 1, sharing some positive outcomes and disappointments. Chris Newmarker, executive editor of life sciences, delivers his Newmarkers Newsmakers featuring items from Abbott, Amazon, CVRx, Medtronic, and migraines. Subscribe on all major podcast platforms - Apple, Google, Amazon, Spotify.

In this week’s podcast, Chris Newmarker, executive editor of life sciences, speaks with Laura Rector, Smith + Nephew’s vice president of ambulatory surgery centers and digital health, about the company’s ARIA care management platform. The system uses 3D imaging, artificial intelligence and other tools to help patients recover more quickly from large joint replacement surgery. What’s next for the ortho leader? Meanwhile, Kaila Krum, managing director of Truist Securities, delivers insights on two major stories of the week – the decision by Mike Coyle to leave the CEO post at iRhythm and Medtronic’s decision to pull its Heartware HVAD off the shelves. Those two stories topped this week’s Newmarker’s Newsmakers, which also include items featuring Abbott, Abiomed and the FDA. Subscribe on Google, Amazon, Apple, Spotify, and other leading podcast channels.

This week we’ll explore innovation and social equity. First, we’ll hear a portion of an interview with Martha Ha, chief privacy officer and chief counsel of corporate governance, and Jon de Csepel, CMO, vice president, medical affairs of the Americas. The pair will explain how the company is reaching out to employees of Asia and Pacific Island and helping them to understand how to better work within the corporate culture. The entire interview can be heard in the latest MedtronicTalks Podcast Josh Makower, MD, is our closing keynote guest. Makower quite possibly invented modern day medtech innovation. In this interview, Makower shares his earliest inventions – kind of mind-blowing – and how his early work at Pfizer helped him create the innovation process used today by biodesign programs across the world, including Stanford Biodesign where Dr. Makower will take over as director this fall. This interview is essential for any individual or organization that wants to innovate. Chris Newmarker, executive editor of life sciences at MassDevice, returns to the podcast with a Newmarker’s Newsmakers that highlights COVID-19, Rapid Medical, iRhythm, Elizabeth Holmes and Medtronic. Tom Salemi also has big news! Subscribe to this podcast on Apple Podcasts, Google, Spotify, Amazon and other major platforms.

This week, the DeviceTalks Weekly Podcasts delivers some learning. First, Dr. Nick West, CMO & divisional VP of global medical affairs at Abbott’s vascular business, discusses the European launch of the company's new coronary imaging platform. Dr. West explains how the AI-powered platform works and the benefits it offers for decision-making during coronary stenting procedures. He also delves into the AI-based technology behind the platform and the direction both imaging and medtech as a whole are heading with AI. Then, Mike Carrel, CEO and president of AtriCure, explains how the company became a force focusing on the atrial fibrillation (Afib) and left atrial appendage (LAA) markets. Carrel walks listeners through the company’s efforts to expand its reach into the connected pain management market. But then he makes a strong case building out its Afib pipeline which includes the EPi-Sense System, which in April received FDA approval to treat patients diagnosed with long-standing persistent atrial fibrillation. Sean Whooley, associate editor at MassDevice, delivers this week’s Newmarkers Newsmakers with updates from Google, Memic (SPAC ATTACK!), Medtronic, Teleflex, and Abbott.

Jeff Mirviss, executive vice president of Boston Scientific’s peripheral business, explains why the specialty’s name doesn’t really reflect the importance of arteries, veins and other “highways” that his business group is addressing. Mirviss explains where the peripheral business is headed, and why Boston Scientific is uniquely positioned to address the business. He also shares lessons learned over his 20-plus years at Boston Scientific including the challenges presented by the Guidant acquisition and the new spirit infused by CEO Michael Mahoney. We also speak with Eric Kolodziej, corporate vice president and global head quality and regulatory affairs at Hologic, about how clinical trial management is changing. What role will real world evidence play going forward, and how will Hologic and others follow up on the record number of EUA’s issued over the past year by the FDA. Chris Newmarker, executive editor of life sciences at Mass Device, delivers his Newmarker’s Newsmakers bringing news from Medtronic, Abbott, Zimmer Biomet and Shockwave. Pharma Editor Brian Buntz also sits in the virtual booth to talk about the new Pharma 50 report compiled by our editorial team. Subscribe today on most major podcast applications

In this episode, two of the executives leading Medtronic’s push into robotics surgery update listeners on the progress and potential of Medtronic's MAZOR X Stealth and Hugo RAS system platforms. Megan Rosengarten, president of surgical robotics, says HUGO is poised to deliver surgeons newfound capabilities and options. The company hopes to begin selling the system later this year after filing for a CE Mark in Europe and an IDE with the US Food and Drug Administration. Chris Newmarker, executive editor of life sciences at MassDevice, delivers this week’s Newmarker’s Newsmakers including reports from Neuroelectrics, Medtronic, and Apple. Danielle Kirsh, senior editor, also updates listeners on her recent report on four catheter-based devices to watch for this year. Also, an update from our underground medtech analyst – Barry the Groundhog. Please subscribe on all major podcast channels - Amazon, Apple, Google, Spotify

Can Proximie bring safer surgery to the wider world? How is Getinge answering call for ventilators? In this week’s podcast senior executives from Getinge and Proximie – two very different sized companies – explain how the COVID-19 pandemic accelerated their business. In the opening keynote conversation, Eric Honroth, president, Getinge North America, explained how the company more than doubled its production of ventilators in 2020. He also discusses recent FDA clearances for two lines of critical devices. In our closing keynote, Dr. Nadine Hachach-Haram, CEO and founder of Proximie, says the start-up reached its 2023-24 projected size in just a few months as hospitals and medical device companies sought the ability to collect surgeons to the outside world. Dr. Hachach-Haram, a reconstructive surgeon, gives a detailed account of how a growing shortage of surgeons convinced her to start a technology company. She also shares how the technology ultimately restored the life of someone very close to her. Chris Newmarker, executive editor of MassDevice, offers up his Top 5 Newmarker’s Newsmakers including news about human-monkey embryos, Abbott, Stryker, Medtronic and DJO. Don't forget to subscribe to this podcast! And our new MedtronicTalks podcast.

In this podcast, iRhythm CEO Mike Coyle discusses his decision to join the digital health leader in January. Coyle’s had to hit the ground running as iRhythm manages some challenging decisions from regional Medicare payors but he also sees great opportunity for the company’s ZIO platform across the healthcare spectrum. In this conversation, Coyle discusses • How he came to join the Medtech industry. • The potential for its ZIO cardiac monitoring technology • How the company is dealing with a disappointing reimbursement • How the company will pursue the large asymptomatic market • What’s expected to come from the company’s partnership with Verily We also introduce the newest member of our DeviceTalks Podcast family. Catch an excerpt of the first episode in this week’s podcast. Subscribe to hear future episodes. Caffeine-fueled Chris Newmarker, executive editor of life sciences at Mass Device, takes a break from earnings week to roll out a powerful #newmarkersjnewmakers bringing news from Zimmer Biomet, Stryker, Emergent Biosolutions, Intuitive Surgical, Medtronic and NeuroPace. Subscribe on all major podcast players.

This week, Liane Teplitsky, vice president and general manager of worldwide robotics at Zimmer Biomet, shares her excitement for the burgeoning data business emerging in orthopedics. Teplitsky, an engineer who built her medtech career in the cardiac R&D and sales at St. Jude and Abbott, walks us through the interconnected offerings of Zimmer’s ZBEdge suite of digital and robotics technologies. We also speak with Achuta Kadambi, assistant professor to the UCLA Samueli School of Engineering, about a column he contributed to Science suggesting physics may be causing medical devices to perform at varying levels in people of different races. Kadambi explains his own work in the field and suggests how medical device developers may want to move forward in the future. Go here to read the MDO article on this topic and find the link to the Science column. https://www.medicaldesignandoutsourcing.com/ucla-prof-racial-bias-in-medical-devices-based-in-physics/ Chris Newmarker of MassDevice reports on another SPAC ATTACK in this week’s Newsmarker’s Newsmakers – Siemens Healthineers, Varian, Zoll, Respicardia, Endologix, PQ Bypass, Vicarious Surgical, Medline Industries. And find out what happened to that chicken.... Subscribe today on all major podcast channels.

In this week’s podcast, Derek Herrera explains how a serious battle injury he received while leading Marines in Afghanistan led him to build a career in medtech. Herrera has founded two companies – Spinal Singularity and Habit Camera – to create devices that can improve and save the lives of people who need help the most. Herrera also explains how his military training is serving him so well in medtech and how the medical device industry would benefit from including more veterans in its workforce. We’ll also hear from Kwame Ulmer, principal at Ulmer Ventures and a lecturer at UCLA Anderson’s School of Management, about an effort his helping to lead to update the landmark study compiled by Josh Makower in 2010. The study blasted a regulatory process that it called “unpredictable, inefficient and expensive.” Its finding led to introspection and changes, according to Ulmer who served at the FDA at the time. Now Ulmer is working with UCLA leaders to update the study. He’s hoping to connect with 200 medical device and digital health executives to understand how they’re working with the agency. For more information go to MedtechStudy.com. For more information on the original study go here - https://www.massdevice.com/study-fda-related-activities-cost-24-million-510k/ Meanwhile, Medtech Media Mogul Chris Newmarker, executive editor of life sciences, will unveil his Newmarker’s Newsmakers including reports from Google, Varian, Boston Scientific, Hologic, LumiraDx, and a report detailing racial inequity in how LVADs are implanted. Subscribe to this podcast on all major podcast applications.

This week, we’ll talk with Lisa Earnhardt, executive vice president, medical devices at Abbott about how the life sciences giant pivoted during the pandemic. Earnhardt shares what programs were given greater priority when the impact of the lockdown became clear and why the company performed so well in one of its key businesses. We also explore this week’s news that the FTC will oppose Illumina’s acquisition of Grail. First, we talk with Dr. Christopher Keir, vice president of medical affairs at Grail, about the great potential of the company’s diagnostic technologies. The interview was recorded last month prior to the FTC’s decision. Then we talk to Vijay Kumar, senior managing director at Evercore ISI, about why the FTC is making a strong case to block the deal. And, of course, Chris Newmarker, executive editor of Mass Device, delivers this week’s Newmarker’s Newsmakers including news from Illumina, Grail, Corindus, Zimmer Biomet, BD, Medtronic and Abbott. Finally, don’t forget to join us on Clubhouse for DeviceTalks Weekly Live at 1 pm ET on Wed.

Hologic CEO Steve MacMillan says last March he didn’t appreciate how COVID-19 would change the world forever. But the diagnostics company quickly rose to the challenge, creating one of the surer supplies of diagnostic tools to chart the pandemic's severity. In this DeviceTalks Weekly Podcast, MacMillan shares how Hologic pivoted to meet the calls for help from political leaders in the US and around the world. He also shares what’s next for the company which has shed its aesthetics business in favor of a tighter new course, a course that includes the creation of an innovative information index that will yield new data on women’s health. While Hologic rose to the challenge during the pandemic, GuardianLane is ready to help children who are coping with grief, including the loss of loved ones to COVID-19 and other diseases. CEO Kristina Jones shares the story that won the first pitch contest held by Medtech Color, an organization founded to help people of color thrive in the medical device industry. We’ll also hear from our sponsor, PackWorld USA, a leader in heat sealing technology. Chris Newmarker, executive editor of MassDevice, delivers this week’s Newmarker's Newsmakers including news from ThermoFisher Scientific, Second Sight, Boston Scientific and Medtronic. Senior Editor Danielle Kirsh also joins us to review her overview on how top medical device are faring a year after the start of the pandemic. https://www.medicaldesignandoutsourcing.com/how-big-medtech-fared-during-a-year-of-covid-19/ Subscribe now on all major podcast channels.

HAPPY BIG 5-0!! This week’s is our 50th DeviceTalks Weekly Podcast, and we’re going to celebrate! Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices, Johnson & Johnson, makes her DeviceTalks Weekly debut. In this update, McEvoy delivers great insights on several areas of interest including: • COVID-19’s impact on J&J in the past, and what changes may remain in the future. • J&J’s far-ranging digital surgery portfolio could bolster many of its specialties. • How the company uses its innovation network to accelerate development • Why she’s bullish on the future of eye care. • How the company will prepare for future challenges. We also talk with Naomi Murray, Director of Advanced Operations-Additive Technology at Stryker about her almost predestined path to join the orthopedics leader. She’ll be leading the March 23 discussion on Additive Manufacturing at DeviceTalks Tuesday. Register at DeviceTalks.com. Colleague Lisa Eitel, executive editor of Design World, crashes the party to tell us about her upcoming Women in Engineering webcast. Register for that discussion at https://www.designworldonline.com/design-world-online-events-and-webinars/ Finally, Chris Newmarker delivers some good news and bad Newmarker's Newsmakers from the digital pages of MassDevice, Medical Design & Outsourcing, and other sites. Companies highlighted include Frequency, Medtronic, Theranos, GE Healthcare, DJO and Stryker Subscribe now on any major podcast channel. Google. Apple. Spotify. Amazon, etc.

Shacey Petrovic, CEO and president of Insulet, explains how the company is giving people with diabetes new tools to manage their disease, a never-ending task that can require HUNDREDS of decisions per day. In this interview, Petrovic explains why research wasn't for her; why she decided to leave her first CEO job to join Insulet; and how the company is building the a glucose-delivery device that could convince people with diabetes to give up the certainty of the shot. In this episode, we also hear from Dr. Niki Panich, a practicing physician who is now CEO of a company that can help hospitals and health care facilities process their N95 masks on site. Dr. Panich will be a speaker on this Monday's DeviceTalks Clubhouse series. Finally, Chris Newmarker delivers the big news of the week involving Baxter, Adaptive Biotechnologies, Boston Scientific, Abbott, and AdvaMed.

In the longest DeviceTalks Weekly Podcast ever created, the leaders of three digital surgery companies – two with robotic components – explain where their systems will fit into Medtech future. Anthony Fernando, the CEO of newly names Asensus (formerly Transenterix) maps out the company’s future in delivering a better solution for laproscopic procedure. Todd Usen – a veteran of big Medtech companies – explains why he swapped P&Ls for just the L’s of a start-up Active Surgical, which is building a surgical mapping tool that could help surgeons avoid deadly errors. Finally, Maurice Ferre,’ founder of orthopedic pioneer MAKO Surgical, says Memix is positioned to grab the opportunity being missed by larger medtech companies building their own robotic systems. He also walks us through the dinner where Stryker CEO Kevin Lobo made an offer that MAKO did not refuse. MassDevice Honcho Chris Newmarker delivers his Newmarker’s Newsmakers featuring stories from Medtronic, Hillrom, BardyDx, Boston Scientific, Lumenis, and Memic Innovative Surgery. Associate editor Sean Whooley joins the show take on Chris in Robot Surgery Name Jeopardy!! You’ll also hear from our great sponsors Packworld USA, PSN Labs and Finnegan.

Less than a year into his role as CEO, Geoff Martha and the Medtronic leadership has overseen a significant overhaul of medtech’s largest player. In our closing keynote conversation, Martha says the company is clearing minor COVID-19 bump and sees open road for the company to continue to grab share from competitors. Martha details what products are gaining the most traction while also identifying those that still have some ground to gain. We also discuss: - When it may bring its renal denervation project to the FDA - Why the surgical robotic Hugo system will be worth the wait (and why development has taken more than a decade) - Whether or not Medtronic will collaborate more with private equity firms, early-stage incubators and maybe even SPACs? - What will the company’s acquisition strategy look like in 2021. And why. - Why the price-cutting for drug-eluting stents may represent an opportunity for Medtronic’s more innovative products. Opening our episode is an important interview with Duke Rohlen, CEO of Ajax Health. Rohlen, a company builder who has generated more than a $1 billion in selling his companies to larger strategics, explains how his work with KKR creates more fertile opportunity for innovative medtech start-ups. Rohlen introduces us to Zeus Health, a new KKR-partnership that will be used to give medtech start-up CEOs the capital – and options – they need to build the next generation of innovative medtech products. Rohlen also breaks down the three critical stages of start-up development. Chris Newmarker, executive editor of Life Sciences, delivers his #NewmarkersNewsmakers. Topping the list is Asensus, the recently renamed Transenterix followed by Becton Dickinson announcing a new deal with Scanwell, former Verb CEO Scott Huennekens leading a new SPAC, Abiomed CEO Michael Minogue leading AdvaMed and PavidMed spinning of a subsidiary, Lucid Medical. Paul Heney of Design World, a sister publication to MassDevice, also invites medtech engineers to submit their best work to the R&D 100 contest for most innovative creations. Find out more at https://www.rd100conference.com/

Inspire Medical CEO Tim Herbert never set out to be a CEO. Yet, he spun a promising #sleepapnea technology out of Medtronic. He then assembled a team that helps hard-to-treat apnea patients live healthier lives through better sleep. Oh, and the electrical engineer turned startup-CEO took the medtech public in 2018. Listen to this episode to hear how Inspire management worked with the FDA, payers and public investor to build a burgeoning neuromed giant. We also talk to Rob Bodor, the incoming CEO at Protolabs. Bodor succeeds the highly successful Vicki Holt who built the manufacturing company into an acquisitive powerhouse. Bodor shares what's next for the company. Co-costs Chris Newmarker, executive editor of life sciences at MassDevice, unveils this week's Newmarker's Newsmakers featuring news from Thermo Fisher Scientific, Mainstay Medical, Theranos, Butterfly Networks and Zimmer Biomet's Newco. Subscribe today on your major podcast apps - Apple, Amazon, Spotify.

Please lift this jam-packed episode with your legs, not your back. *We'll hear inspirational words from the legendary Dean Kamen who is shifting his life’s focus into medtech. *Todd Pope takes the CEO seat at a new company built to tackle hospital-acquired-infections and COVID *Joe Mullings of the Mullings Group explains why now is the best time to be in the Medtech industry. Chris Newmarker, executive editor of life sciences, delivers a murderers row of #newmarkersnewsmakers with Philips, Medtronic, iRyhthm, Canary Medical and Apollo Endosurgery. To hear Dean Kamen's entire interview with my Design World colleague Paul Heney go here. It's free and outstanding! https://gateway.on24.com/wcc/eh/2927718/lp/2870030/engineering-robots-for-the-future Thanks for subscribing!

In this week’s episode learn how Greg Lucier, executive chairman of Corza Medical, intends to use his experience and GTCR's capital to build a surgical supply company that he says will challenge medtech's (almost) monopolies. Corza's strategy rests upon customization, a high level of digitalization and customer service. Lucier also explains how working on the railroads led to his joining the medtech industry. Chris Newmarker, executive editor of life science, interviews Rich Newitter, Managing Director, Medical Supplies and Devices, about Zimmer Biomet’s decision to spin off its dental and spinal business into a new company. Newitter also explains how Zimmer Biomet is grabbing share in the orthopedic space and building an enviable portfolio of digital sensors and systems. Zimmer Biomet and Corza Medical led this week’s Newmarkers Newsmakers, but we also hear news about Philips, CooperSurgical, Aegea, 3M, Abbott as well of mentions of Medtronic, Boston Scientific and others. Subscribe now on your favorite podcast player!

In this episode of the DeviceTalks Weekly Podcast, Angelique Johnson, CEO of MEMstim, shares her “accidental entrepreneur” story and how it has enabled her the help others pursuing the same dream. Johnson, co-founder of MedtechColor, an organization seeking to further the advancement of people of color in the medical device industry, details the groups goals and invites entrepreneurs of color to apply for the group’s Pitch Contest. The deadline is Feb. 5. Go to medtechcolor.org for more information. Truist Security Managing Director Kaila Krum answers questions about medtech’s Q4 performance, diving deeper on Stryker and other companies. Krum also shares details on a survey conducted by the research team that sought to answer the question – when will hospitals start seeing elective patients again. Pharma Editor Brian Buntz returns to the podcast to tell his story of his 10 days wearing a continuous glucose monitor from Dexcom. Buntz wrote about the experience here, but he shares more details on the podcast. https://www.drugdeliverybusiness.com/how-cgms-can-inspire-lifestyle-changes/ Finally, Chris Newmarker, executive editor of life sciences, delivers his #newmarkersnewsmakers featuring Titan, Mylan, Zimmer Biomet, and Butterfly.

The pandemic has accelerated innovation in many ways but the physical pressures on entrepreneurs, innovators and engineers is very real. In this episode of the DeviceTalks Weekly Podcast, a panel representing early-stage and tech transfer efforts explain how they're helping individuals and young companies work through the unique challenges of the time, including: *Finding capital *Working with corporates *Understanding opportunities in a changing healthcare market *Are there silver linings Guests include Jennifer McCaney, PhD,,co-executive director, UCLA Biodesign Jackie Mejia, PhD, director, gBeta Medtech Scott Morley, director, office of economic partnerships, University of Pittsburgh This conversation is a condensed version of our Jan. 19 DeviceTalks Tuesday. Go to DeviceTalks.com to watch the entire presentation. Co-host Chris Newmarker, executive editor of MassDevice, also shares his top 5 stories of the week, aka, NewmarkersNewsmakers. The big news belongs to DePuy, Philips, Boston Scientific, Transenterix and President Biden.

This week we’ll dig deep into digital surgery, robotics and the power of THE CLOUD. In our opening keynote conversation, Mark Toland, CEO of Medical Micro Instruments, explains why the company’s microsurgical robot has a chance to be in most hospitals. The company has CE Mark, a controlled commercial roll out and plans to knock in the FDA’s door sometime in 2022 where it will face huge competition (or, we think, potential acquirers if history holds out.) Watch the cool CNBC video here. https://www.cnbc.com/2020/10/28/italy-symani-surgical-robotic-system-improves-microsurgery-procedures.html Next, we talk with Scott “Go Go Go” Huennekens, employee number 1 at the former Verb Surgical, about the state of digital medtech. Huennekens, who previously led and sold Volcano Corp., explains why you can no longer have the latter without the former. Kal Patel, CEO of BrightInsight, explains why medtech must follow a different path – with equally unique challenges – to fully enjoy the power of digital connection. Danielle Kirsh, senior editor of Mass Device, drops by to bring us up to date at two cool devices presented at CES 2001. You can read about Omron and Binah.ai here. https://www.medicaldesignandoutsourcing.com/ces-2021-medical-technologies-you-need-to-know/ Finally, Co-hosts Tom Salemi and Chris Newmarker walk through this week’s #NewmarkersNewsmakers featuring news from Abbott, Steris, Cantel and Theranos.

Dr. Robert Kowal, CMO of Medtronic’s cardiac rhythm and heart failure business and vice president of medical affairs, explains how new tech, savvy patients, eager physicians and, yes, COVID-19, has fueled a renaissance for remote technology, once seen as a mature, staid business. Dr. Kowal also shares an amazing story of a patient who may owe his life to a timely conversation between his pacemaker and cellphone. Jon Norris, managing director of healthcare at Silicon Valley Bank, delivers three big takeaways from his report on 2020 fundraising. Medtech venture capitalists and start-ups didn’t let the lockdown slow their fund-raising efforts, and their efforts were buoyed by surprising strong exiting opportunities through IPOs and M&A. Co-hosts Chris Newmarker and Tom Salemi review the medtech industry’s response to the riot and occupation of the Capitol building. This week’s #NewmarkersNewsmakers includes news from Smith & Nephew, Stryker, and the disappearing Haven.

Happy Vaccine Week! This week, we’ll visit with the medtech professionals who are working to get the vaccines into the right hands – and arms – of the people who need it most. This week’s guests include • Elizabeth Woody, Senior Vice President, Public Affairs at BD • Claudia Roa, Vice President Life Science & Healthcare Sector, Americas Global Customer Solutions at DHL • Eric Eskioğlu, MD, EVP & Chief Medical Officer, Novant Health Co-hosts Tom Salemi and Chris Newmarker welcome Brian Buntz, medtech pro and now pharma editor at WTWH Media, for a recap of the top 10 #newmarkersnewsmakers of 2020. We also look ahead to 2021 offering our Big, Bold Predictions for the New Year. (And someone offers to pick up the first round of drinks at DeviceTalks Boston in October…well, sort of.) This is the final episode of the DeviceTalks Weekly Podcast for 2020! Thanks to the tens of thousands (yep, really) people who have joined us on this audio journey. We’ll be back in January with a new DeviceTalks Weekly Podcast. Subscribe now so you don’t miss it!

The past year of pandemic, social unrest and a divisive election - provided a crash course in crisis management for CEOs. In this week’s DeviceTalks Weekly Podcast, Kevin Lobo, the CEO of Stryker, explains how he led his company through this difficult year. His recipe for success is long, but it includes priorities, communication and listening. Lobo also is serving his final year as chairman of AdvaMed. He shares how that experience gave him an even better appreciation of the medtech industry, which he says got treated unfairly at times but still came through with high grades. Joining us for the first time as a co-host is Nancy Crotti, managing editor of Medical Design and Outsourcing. She’ll talk about the upcoming leadership issue. Meanwhile, Sean Whooley, assistant editor of MassDevice, will share the five big news items of the week aka #NewmarkersNewsmakers. This week’s news comes from Quest, Pfizer, Boston Scientific and Medtronic. And we'll learn which co-host had a steak cooked for them by a future president of the United States. Subscribe today on all your podcast players!

In this episode of the DeviceTalks Weekly Podcast, Medtronic CEO Geoff Martha brings us on the inside of Medtronic’s ongoing reorganization. Martha explains how the new company will be structured to work with outside vendors. (Hint: more autonomy, not total autonomy.) He also explains why the company’s push to instill more competitive juice is aligned with its overarching mission of innovation. Martha also discussed his long path to medtech and Medtronic. How he first met Omar Ishrak and why institutions like Medtronic and other medtech companies need to step up on a social scale. This week, Dave Franchino, president of Delve, explains how the company is adapting innovation to fit the pandemic. (And suggests if you’re not finding opportunities to innovate, you’re simply not looking hard enough.) But there is no DeviceTalks party without Chris Newmarker, executive editor of MassDevice, who shares this episode’s Newmarker Newsmakers. Companies covered include Medtronic, Vectorious Medical Technologies, GE Healthcare, Stryker and Butterfly Network. Subscribe today you major podcast platforms!

DeviceTalks Weekly listeners will need some gravy to digest this Thanksgiving feast-sized podcast featuring news and insights from three stellar guests in addition to two new installments of #2minutedetalks chapters from Delve Inc. and Explorer Surgical. This week we visit with… Mark Leahey, president of the Medical Device Manufacturers Association, who explains where medtech might fits in this evolving political climate. Spencer Stiles, group president of orthopaedic and spine at Stryker, who shares details on the Wright acquisition and the secret to the success of placing MAKO surgical robots in hospitals Art Collins, senior advisor to Explorer Surgical. The former Chairman and CEO discusses leadership, Medtronic and the future for startups like Explorer. Also co-host Chris Newmarker, executive editor of MassDevice, shares his selections for this week’s #newmarkersnewsmakers which includes news from BD, Boston Scientific and Johnson & Johnson.

This week’s DeviceTalks Weekly Podcast examines medtech’s readiness for the next COVID-19 surge. Hospitals are ready, but their appetite for expensive medical devices has changed, forcing medtech companies to change how they sell or lose out entirely. Justin Cassidy and Henry Soch of Vizient reveal why hospital executives are forced to divert funds away from new devices. They also explain how the power structure in capital purchases is shifting away from technology committees, creating a new challenge for medtech sales teams. Kaila Krum, managing director of Truist Securities, explains how companies like Stryker, Zimmer Biomet and Globus are successfully putting units in hospitals. She confirms medtech companies are being forced to evolve the way they work with hospitals. In the 2-minute-DeTalks, product development leader, podcast and president of Delve Dave Franchino joins us in a 2minute-detalks to explain how the company helps clients find the best solution to vexing problem. (Delve.com.) Explorer Surgical CEO Jennifer Fried makes the case for how her innovative start-ups tech company’s will not only connect surgeons with remote sales reps but also giving a broader view of how successful teams function. Chris Newmarker, executive editor of MassDevice, reveals his #NewmarkersNewsmakers highlighting contributions by Abbott, Stryker, Joe Biden, and EU-MDR.

In this episode of the DeviceTalks Weekly Podcast, we’ll talk with Intuitive Surgical's Julian Nikolchev, senior vice president, corporate development and strategy and Oliver Keown, MD, director of Intuitive Ventures, about the new $100 million venture fund. How will the capital be invested? Where does Intuitive see the opportunity, and how does the program fit into the robotic surgical company’s broader mandate to expand the profile of its product offerings? In our opening keynote, Neal Moat, MD, chief medical officer of Abbott’s structural heart business, talks about the success of the MitraClip and the impact COVID-19 is having on patients and Abbott personnel. Chris Newmarker, executive editor of MassDevice, will roll out his Newmarker’s Newsmakers including news about Abbott, Masimo and Stryker. Sean Whooley, assistant editor, will also give an earning wrap on the show highlighting interesting reports from Inspire Medical, Hologic, Stryker and Coloplast. DeviceTalks listeners are also invited to nominate their own Newmarker's Newsmakers of 2020. Use this online ballot to make your suggestions. We'll send out a ballot of the finalists later this month. Go to https://www.surveymonkey.com/r/MWDPVKD to vote! Subscribe today to receive future podcasts!

In this week’s episode of DeviceTalks Weekly the editorial team from MassDevice reviews the Medical Design & Outsourcing’s Women in Medtech issue bringing you insights through interviews with Katie Syzman, corporate VP and the GM of critical care at Edwards Lifesciences, Naomi Murray, Stryker’s director of advanced operations, and Patty Post, CEO of Startup Checkable Medical. Szyman will share Edwards’ view of artificial intelligence. Murray will share her future vision on additive manufacturing while Post will reveal the lessons learned in her first post as startup CEO of a diagnostic company. In our closing keynote conversation, Vijay Kumar, managing director at Evercore ISI, will explain why Exact Science’s acquisition of liquid biopsy company wasn’t exactly a surprise (though the $2 billion pricetag might have been.) He also assesses Boston Scientific’s COVID-19 comeback. What does the rise in cases mean for the company and the rest of medtech? Chris Newmarker, executive editor of life sciences, delivers this week’s Newmarker’s Newsmakers which highlights reports on Abbott, Baxter, Intuitive Surgical and Siemens. Senior Editor Danielle Kirsh also is on hand to talk through MassDevice Big 100 report. Assistant editor Sean Whooley also joins the conversation.

In this week’s DeviceTalks Weekly podcast, we visit with Chris Landon, senior vice president and business leader of image guided therapy devices at Philips about that company’s plans to build a medtech powerhouse. In this conversation we’ll learn -Why Landon left Medtronic -Where Philips fits into medtech’s future -How Philips hopes to expand -Will Philips invest directly in start-ups? -How did Covid-19 impact Philips? We’ll also get Landon’s stance on pumpkin sausages. Disgusting or delicious? We also welcome back Chris Newmarker, executive editor of Mass Device, who delivers his Newmarker's Newsmakers including news from GE Healthcare, Merit Medical, Pharma, Eurofins (Paris:ERF.PA) and DxTerity Diagnostics and the FDA Subscribe today on your podcast apps!

In this week’s DeviceTalks Weekly podcast, we’ll first delve into Medtech’s own brewing Supreme Court battle. In our opening keynote address sponsored by Medical Design and Outsourcing, J. Michael Jakes, a partner at Finnegan, will tell us why the industry should be watching when the Supremes review the latest patent battle between Arthrex and Smith & Nephew. We’ll also talk about Medtronic’s Analyst Meeting where CEO Geoff Martha and the team rolled out its decentralization plan that calls for the creation of 20 semi-independent business units. Kaila Krum, managing director at Truist Securities, returns to break down the highlight of the meetings including pipelines and partnership with The Foundry, Amazon and others. Sean Whooley, assistant editor at Mass Device, pinch hosts for the vacationing Chris Newmarker and delivered with a rock solid #newmarkersnewsmakers that includes news from Abbott, Arthrex, Smith & Nephew, GE, and, of course, Medtronic.

In this week’s DeviceTalks Weekly Podcast, our opening and closing keynote interviews focus on executives at companies from very different stages. MANUFACTURING AND SOURCING: Skip Kiil took the helm of Smith + Nephew’s global orthopedics business to transform the business. The company’s recent acquisition of Integra’s extremities will further that mission. In our closing keynote conversation, the president of orthopedics updates us on the new technologies and tools that Smith + Nephew is rolling out to help orthopedic patients. Kiil will hit upon Smith + Nephew’s: • CORI Robotics surgical tools • Real Intelligence platform • Interest in Ambulatory Surgery Centers •  Balance of OUS vs. US •  Future plans for extremities INNOVATION AND FINANCE: Start-up Rhaeos took home this year’s Grand Prize from the Medtech Innovator Global Competition at the Virtual Medtech Conference. In our 0pening keynote, CEO Anna Lisa Somera tells us why she went “all in” on developing a hydrocephalus wearable device that can help this suffering patient population. Somera will discuss • Winning the Global Competition • The power of Rhaeous’ wearable technology • Medtech’s ability to help long suffering patients • The start-up’s fundraising plans. Co-hosts Tom Salemi and Chris Newmarker will also review this week’s biggest stories on MassDevice including former Medtronic CEO Omar Ishrak’s legacy, current Medtronic CEO Geoff Martha’s optimism, and Avail Medsystem’s $100 million plans to grow procedural telemedicine.

In a double dose of New Tools and Technology interviews, co-host Tom Salemi talks with two companies using connective technology to build out innovative service businesses.  Medtech veteran Daniel Hawkins, CEO of Avail Medsystems, creator of a procedural telemedicine system that can open up the operating room for sales reps and surgical experts. Hawkins explains how Avail will provide the equipment to hospitals for free while creating new channels for medical device companies to advise surgeons in the operating room. You can learn more about Avail’s approach on our upcoming DeviceTalks Tuesday episode on Oct. 6. https://www.devicetalks.com/devicetalks-tuesdays-agenda/  In our opening interview, Ira Bahr, COO of AliveCor, explains how the company’s AI-enabled, consumer EKG device, KardiaMobile 6L, is connecting heart patient with their physicians. The company is selling the device for patient monitoring both in home and clinical trial settings. How will tech like this open the the clinical trial market. Also, learn how AliveCor is shifting into more of a service company. Meanwhile, co-cost Chris Newmarker, executive editor of life sciences at MassDevice, is off the the races with his #NewmarkersNewsmakers which includes BD, Boston Scientific, Coloplast, Medtronic and Smith+Nephew.

Medtech People: In this week’s DeviceTalks Weekly Podcast, we’ll talk about overcoming unfairness and inequity. In our keynote interview, Boston Scientific’s Camille Chang Gilmore, vice president, human resources, global chief diversity officer, and Michael Jaff, MD, CMO of its peripheral vascular group, reintroduce us to the company’s Close the Gap program. Launched in 2006, Close the Gap seeks to address the lack of care being delivered to underserved populations, including people of color and people earning lower incomes. The two Boston Science executives will explain why Close the Gap is more essential than ever, and what we as an industry need to do to bring equality to care. Go to knowyourhealth.com for more information. In our first interview, Jeff Karp, MD, a prolific inventor and entrepreneur, shares his early challenges as a child when a learning difference limited his performance in school. After hearing some stern advice from teachers, Karp identified the problem and explained how overcoming his challenges gave him the ability to see innovative ways to solve problems. Go to devicetalks.com to see the rest of the Device Talks Tuesday interview from Sept. 22. https://www.devicetalks.com/devicetalks-tuesdays-on-demand-sessions/ And, of course, Chris Newmarker, executive editor of MassDevice, runs us through Newmarker’s Newsmakers, the top 5 performing articles on MassDevice. Subjects include Boston Scientific, Farapulse, the FDA, and NanoVibronix. https://www.massdevice.com/the-top-5-massdevice-stories-of-the-week-september-25-2020/ GUESTS:  Camille Chang Gilmore, vice president, human resources and global chief diversity officer, Boston Scientific  Michael Jaff, MD, vice president, CMO, Boston Scientific, peripheral vascular group  Jeff Karp, MD, professor of medicine, Brigham and Women’s Hospital, Harvard Medical School HOSTS  Chris Newmarker, executive editor, life sciences, WTWH Media  Tom Salemi, editorial director, DeviceTalks

INNOVATION & FINANCE: Is the traditional road show dead? Leslie Trigg, CEO of Outset Medical, fresh off taking the renal care company public, says despite initially grieving her inability to meet investors in person, she agrees that Zoom meetings gave her all the insights she needed to stage a successful IPO. In fact, she says the video calls might have even engendered a deeper understanding between executives and investors. Trigg also explains how Outset came to broaden its overall mission to create an enterprise system for dialysis. NEW TOOLS & TECHNOLOGY: The doctor will see you now … from 3,000 miles away. Doug Teany, COO of Corindus Vascular Robotics, says the company’s Corpath interventional robotic system will save lives and money by shortening the distance between critical patients and capable care. Using the emerging 5G network, Corindus is moving toward a future where interventionalists can treat patients in different area codes, time zones and countries. The company is profiled in a 5G documentary called “Speed of Thought.” Check it out on Amazon Prime and other channels. Finally, the week wouldn't be complete with Chris Newmarker, executive editor of MassDevice, revealing this week’s #Newmarkersnewsmakers featuring news from Hologic, Varian, Smith & Nephew, and Outset Medical.

MANUFACTURING & SOURCING: This week, the DeviceTalks Weekly Podcast explores the potential of single-use endoscopes. Co-host Tom Salemi interviews leaders from the leaders – Ambu and Boston Scientific. First, Ambu CEO Juan Jose Gonzalez and Stephen Block, president of Ambu US, introduce us to one of medtech’s fastest growing companies. Ambu is moving into the single-use market with a less expensive alternative to those offered by larger rival Boston Scientific. We’ll find how Gonzalez and Block view the opportunity. In our second interview, we dig into the EXALT offering with Boston Scientific’s CMO Brian Dunkin, MD and Dave Pierce, EVP and President MedSurg. After a slow start due to COVID-19 shutdowns, Boston Scientific is putting the pedal to the metal by leveraging its extensive reach and might. Executives from both companies share why they can't see the ceiling to the potential of this technology. MassDevice's Executive Editor Chris Newmarker will reveal this week’s #NewmarkersNewsmakers including Bardy Diagnostics, Kevin Hykes, COVID-19 Vaccine makers, Theranica, Joe Biden, Donald Trump and Theranos founder Elizabeth Holmes.

Our line up in Episode 25 of the DeviceTalks Weekly Podcast INNOVATION & FINANCE – Managing Partner Karen Long says COVID-19 isn’t slowing down KCK Group, which closed on two major investments this summer. Long will be speaking on our first DeviceTalks Tuesday’s “Raising Capital in the Zoom Age.” Go to devicetalks.com. REGULATORY & REIMBURSEMENT – Gail Daubert, founding partner at 4Front Strategies walks us through the proposed CMS rule to pay for innovative breakthrough technologies. Daubert suggests industry leaders offer their feedback on the proposed rule. For information on submitting feed back go to https://www.federalregister.gov/documents/2020/09/01/2020-19289/medicare-program-medicare-coverage-of-innovative-technology-mcit-and-definition-of-reasonable-and NEWMARKER’S NEWSMAKERS – Chris Newmarker, executive editor of life sciences at MassDevice, reports on the five biggest Medtech newsmakers. Items involve Medtronic, IBM, Elon Musk, and CMS.

In this week’s DeviceTalks Weekly Podcast, Kaila Krum, managing director at Truist Securities, explains why Medtronic is talking tough about finding new growth. Can the medtech giant pull off CEO Geoff Martha’s pledge to `Go Big or Go Home.” Juan-Pablo Mas, partner at Action Potential Venture Capital, lends insights on his group’s commitment to EXO (pronounced echo), a maker of a portable ultrasound imaging device that might have somewhat unforeseen therapeutic applications. He also shares his hopes for LatinxVC, a non-profit creating opportunities in venture capital. Senior Editor Danielle Kirsh and Assistant Editor Sean Whooley pinch hit for Chris Newmarker. Kirsh lays out her plans for this year’s Women in Medtech issue and Whooley walks us through this week’s Top 5 stories (aka Newmarker’s Newsmakers.) Medtronic, Abbott, Boston Scientific, Pelvital, and iRhythm all make the list. But who is number 1?

In this week’s episode of the DeviceTalks Weekly podcast, co-hosts Tom Salemi, editorial director of DeviceTalks, and Chris Newmarker, executive editor of life sciences, review this week's Top 5 medtech stories, aka “Newmarker’s Newsmakers,” with news coming from CureVac, Avail Medsystems, ClearMask, Thermo Fisher and Bayer. We also hear from two executives from Fractyl Laboratories — CEO Dr. Harith Rajagopalan and CFO Lisa Davidson — about its recent $55 million Series E round of financing and the strides they're making in developing a device to treat diabetes. In a second interview, Cala Health CEO Renee Ryan gives us an update on the Cala Trio’s clinical success and how the start-up is working through COVID-19. Finally, Chris and Tom hint at an upcoming event for the DTW community.

DeviceTalks Weekly: Ep. 22 – This week’s episode of DeviceTalks Weekly is brought to you by the later V, as in Vizient and Vicarious Surgical. Bharat Sundaram, COO and president of Vizient, will share how the healthcare supplier is strengthening the supply of PPE for hospitals. He'll also reveal when the company expects to see US hospitals running at pre-Covid levels. Hint, it'll be a while. Adam Sachs, CEO of Vicarious Surgical, tells us how the company will put a new round of capital from high-powered investors to work in developing to develop a surgical system employing robotic and virtual reality technologies. How does the start-up expect to compete with the established leaders in the robotics space? Co-host Chris Newmarker, executive editor, life sciences, will walk us through the five biggest newsmakers on the MassDevice site. Number one may surprise you, but given the time, perhaps it shouldn’t.

Ten ways medtech is finding its footing during the pandemic When COVID19 set upon the US in March, medtech executives had a month at most to tell Wall Street analysts how the pandemic had hit the industry’s largest companies. We heard about short-term hits in revenues, procedures and employee headcounts, but uncertainty clearly ruled the day. Over the past weeks, medtech executives from several leading companies reported back to analysts with a full quarter under their belt. To be sure, no one can claim to hold a full grasp on this crisis, but a survey of the calls reveals several observations worth pointing out . In this podcast, we’ll list our Top 10. Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players. It’s available on Apple Podcasts, Spotify and other podcast channels.

In this week’s podcast, two executives from Thrive Earlier Detection explain how the “turbo-charged” diagnostics company intends to upend how, when and where cancer is diagnosed. Isaac Kinde, MD, PhD, co-founder and head of research and innovation, walks us through the company’s CancerSEEK test and how the company is marrying new technology with an innovative clinical approach. Meanwhile, Isaac Ro, tells host Tom Salemi how the company closed on $257 million (hint: lots of Zoom) and why he left a career on Wall Street to join this innovative start-up. Chris Newmarker, executive editor of life sciences at MassDevice, also counts down on the biggest newsmakers in this week’s MassDevice. Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players. It’s available on Apple Podcasts, Spotify and other podcast channels.

In this week’s podcast, we talk with Holly Logue, general counsel at Drawbridge Health, about the OneDraw, an innovative new tool that might upend the collecting, storage and testing of blood. Logue, a panelist in the upcoming DeviceTalks Tuesdays sponsored by Finnegan, will explain how her past work on Capitol Hill is helping this Silicon Valley company’s plans. Meanwhile, we speak with Daveen Chopra, corporate vice president of surgical structural heart at Edwards Lifesciences, about that company’s commitment to treating the most serious cardiac patients. The company recently won FDA approval for its Konect Resilia aortic valve conduit, a vital new tool in helping heart patients, including many requiring emergency story. Co-costs Tom Salemi, editorial director of DeviceTalks, and Chris Newmarker, executive editor of life sciences at MassDevice, review the five biggest news stories of the week. We'll talk about Abbott, Becton Dickinson, Boston Scientific, Edwards Lifesciences, and Theranos. Number one may surprise you.

For years, medtech companies have known connectivity was good for them, but the promise of data streaming through devices didn't match the reality. COVID-19 changed that, creating an opportunity for device companies with connectivity plans in place. In this episode, we speak with Dr. David Hayes, CMO of Biotronik, about that companies success in connecting cardiology patients. Meanwhile, Bill Betten of S3 Connected Health explains what device companies must do to prepare for medtech's next age. We also review the week's top news involving Medtronic, Johnson & Johnson, Abbott, Edwards, and Smith+Nephew

DeviceTalks Weekly: Ep. 17 – In this week’s episode of DeviceTalks Weekly, we follow up with Nadim Yared, CEO of CVRx, the guest of last week’s episode, to catch up on how the medtech executives is managing during the pandemic. Yared also shares some far-reaching views on what the medtech industry needs to work toward to improve diversity in its workforce and provide equality for society. We also visit with Mira Sahney, CEO of Hyalex Orthopaedics, one of medtech’s most interesting startups; Hyalex was identified as a notable startup in the recent report in Medical Design and Outsourcing. In this interview, Sahney reveals Hyalex’ origins, the state of its potential cartilage replacement product, and why start-ups have a natural advantage operating in a pandemic. Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

Nadim Yared, CEO of CVRx This week, CVRX reported positive six-month trial results for its Barostim Neo, an FDA-approved treatment for heart failure. The results follow years of close work between the agency and CVRx, one of the more ambitious startups in medtech. CVRx is targeting a huge clinical need with novel neuromodulation technology. In this week’s DeviceTalks Weekly podcast, CEO Nadim Yared walks us through the negotiations the company went through with the FDA to get to this point. Yared, the prior chairman of the industry group AdvaMed, also shares the story of his career, which started early on when he secured a job at GE even before graduating college. In this talk, Yared speaks to several issues including: The power of confidence and the dangers of overconfidence when building a career. -How he decided to take the job at CVRx (and why he didn’t initially want to talk about the job with a recruiter.) -What CVRx learned from other successes and failures in renal denervation. -Why the company is betting big on heart failure, but doesn't have a Chief Medical Officer. -Whether or not his role as chairman at AdvaMed impacted his work at CVRx. -Can medtechs generate good returns after raising hundreds of millions in capital? This conversation took place prior to the emergence of COVID-19, so DTW host Tom Salemi visited again with Yared more recently. We’ll play that interview in next week’s episode of DeviceTalks Weekly. If you’re looking for more medtech discussions, register now for DeviceTalks Weekly at devicetalks.com. Subscribe to he podcast. Don’t miss an episode!

DeviceTalks Weekly: Ep. 15 – Why FDA put the pedal to the metal for radar and hummingbirds. And why medtech needs Google. In this week’s episode of DeviceTalks Weekly, co-hosts Chris Newmarker and Tom Salemi dig into the recent successes by start-ups Circadia Health and Perceptis Medical, which both saw expedited approval from the FDA due to the pandemic. We also unveil the 20 medical device companies you need to know. https://www.medicaldesignandoutsourcing.com/20-medical-device-startups-you-need-to-know-2020/ Circadia CEO Fares Siddiqui discusses the quick approval that came for his company’s C100 system that uses radar to monitor respiratory function. Preceptis Medical CEO Steve Anderson, meanwhile, explains why the agency – and he hopes payers – want to see his company’s ear-tube implanting system on the market. We also visit with Heidi Dohse, Sr. Program Manager at Google’s Cloud Healthcare & Life Sciences organization, who will be leading the upcoming DeviceTalks Tuesday’s discussion about how medtech devices can use data to better serve its sickest patients. https://www.devicetalks.com/devicetalks-tuesdays-agenda/ Dohse partners with physicians and researchers around the world to provide insights regarding the patient experience and ideas for engagement. She travels globally educating audiences on digital health, data and healthcare. On Tuesday, she’ll discuss. • How do we weigh “patient lifestyles” vs. “therapy/product” lifecycles”? • What impact will connected devices and apps have on patient outcomes? • How can data help improve and even transform the patient experience? • Speaker: Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

This week’s DeviceTalks Weekly podcast episode talks with industry leaders about improving worker diversity and developing new ways to treat COVID-19 patients. Kevin Lobo, chairman and CEO of Stryker, explains how his company – and the industry group AdvaMed – has been working  to increase diversity of its workforce, particularly in senior and sales positions. Lobo is serving a two-year term as chairman of AdvaMed. In this interview, Lobo speaks specifically to how Stryker is tracking progress, where it has come up short, and how it’s working to help workers identify their own biases. Lobo also says Stryker is poised to regain momentum after the pandemic. Next, Kevin Sayer, executive chairman, CEO and president of Dexcom, says the company’s continuous glucose monitors are finding a home in hospitals as they help monitor the health of COVID-19 patients. Sayer says the company’s monitors have helped keep patients, especially diabetics, off ventilators and allowed them to get discharged more quickly. What’s next for Dexcom? “We think this is an important market for us, not just COVID-wise,” Sayer says. Finally, Raj Denhoy, equity research analyst at Jefferies, breaks down private equity group Blackstone’s investment in Medtronic’s diabetes line. Why would the medtech giant take outside money? Is this something we’ll see more of in medtech? Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

DeviceTalks Weekly: Ep. 13 –  Cala Health CEO Renee Ryan Brings Business Building Insights to Bioelectronic Medicine Startup In this week’s episode of DeviceTalks Weekly, Tom Salemi, editorial director of DeviceTalks events and content, visits with Renee Ryan, the CEO of neuromodulation startup Cala Health. Ryan came to Cala from the venerable medtech investor Johnson & Johnson Development Corp., where she made over 15 investments helping to create companies including Auris Surgical, Cala and digital surgery play Verb Surgical, J&J’s joint venture with Verily. “I really set my mind to [asking] was there a way we could create our own opportunities,” she said of her eight years as the corporate investor. We ask Ryan about her move into medtech investing from investment banking as well as the  “secret power” that helped her succeed as an investor and an executive. We’ll also discuss the unique commercial strategy Cala is employing as it begins rolling out its Cala Trio, a bioelectronic device developed to treat essential tremor. The interview was conducted in February. What role will tech companies play in medtech’s future? Did Verb Surgical meet her expectations? As CEO how do you manage investor syndicates with multiple corporate investors? Can Cala secure reimbursement and create a new market for tremors? What grade did she skip as a child? Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

In this week’s DeviceTalks Weekly podcast, we attempt to deliver heartfelt and hard won advice in a sort of commencement address by Todd Brinton, MD, Corporate Vice President, Advanced Technology and Chief Scientific Officer of Edwards Lifesciences. Dr. Brinton sits down with host Tom Salemi to share his path into Medtech. Brinton shares great advice for anyone looking for a new career or opportunity in medtech. NOTE: This conversation was recorded in March, prior to the full impact of the COVID-19 pandemic.

DeviceTalks Weekly: Ep. 11 – Medtronic is buckling up and ready to buy In this week’s episode of DeviceTalks Weekly, we dip into Medtronic’s quarterly call to hear why company executives feel the medtech sector is already rebounding. The global giant also intends to start using its vast cash reserves to bolster its bottomline through M&A. We’ll also talk with Jeff Champagne of MPR about medtech’s need for speed. He’ll be leading a discussion on this subject and more on the upcoming DeviceTalks Tuesdays. Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

DeviceTalks Weekly: Ep. 10 – How do medtech investors, CEOS manage portfolio companies going forward? In this week’s episode of DeviceTalks Weekly, we talk with two successful starters of medtech companies about how they’re building and maintaining their medtech portfolios during this pandemic landscape. Our guests this week are… • Justin Klein, MD, managing partner, Vensana Capital • Duke Rohlen, chairman, Ajax Health Together, Klein and Rohlen have created, backed and sold medtech companies that have generated billions. Klein, formerly of New Enterprise Associates, now co-manages his own venture firm, Vensana Capital. He previously served on the board of directors of Cartiva (acquired), ChromaCode, CV Ingenuity (acquired), EPIX Therapeutics (acquired), FIRE1, GPB Scientific, Intact Vascular, Metavention, Personal Genome Diagnostics, PhaseBio Pharmaceuticals (IPO), Relievant Medsystems, Senseonics (IPO), Topera (acquired), Ulthera (acquired), Vertiflex (acquired), Vesper Medical, and VytronUS (acquired). Rohlen, who leads a holdings company backed by private equity giant KKR, previously served as chairman and CEO of EPIX, Co-founder, Chairman and CEO of Spirox, Inc (sold to Entellus Medical) and co-founder and CEO of CV Ingenuity. He was also president of Fox Hollow before it was acquired by EV3. In this podcast we’ll learn how VCs are looking at investment opportunities in this market • Are they making new investments? • What impact is this having on valuation? • Do VCs give stronger consideration to new concerns like supply chain? • When will they get clinical trials up and running? Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

In this week’s episode of DeviceTalks Weekly, Tom Salemi speaks with two executive recruiters about what they see in the medtech market. Over the past month, we’ve seen several medtech companies – big and small – cutting jobs and reducing hours but what does this mean long-term. In this podcast we’ll identify a few companies that are hiring, but we’ll talk in-depth with the recruiters about… • How bad is the current market? • What’s the likelihood for recovery? • What skills are in greater demand? • What can people do to strengthen their hand? Guests are: • David L. Vied, global sector leader, Global Sector Leader, Medical Devices and Diagnostics, Korn Ferry • Giovanni Lauricella, vice president, medtech practice-lead, The Mullings Group Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

DeviceTalks Weekly: Ep. 8 – AdvaMed‘s Scott Whitaker on pandemic readiness, Jon Norris of SVB shares Q1 venture capital investment data In this week’s episode of DeviceTalks Weekly, Scott Whitaker, CEO of AdvaMed, shares concerns he had over how the federal government would work with the medtech industry during the pandemic crisis. Does he feel the medtech industry was treated fairly? How does he see the federal government and medtech industry working together in the future? He answers those questions and more. In our second interview, Jonathan Norris, managing director of Silicon Valley Bank, shares first-quarter data for medtech venture investments. The results might surprise you. Guests are: • Scott Whitaker, CEO, AdvaMed • Jonathan Norris, managing director, Silicon Valley bank Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

In this week’s episode of DeviceTalks Weekly, Tom Salemi and Chris Newmarker stare at each other through the Zoom lens while talking about the positive news from Baxter and Conformis, the hopeful projections from Edwards, and the cautionary tone from Medtronic. We also interview Mark McIlduff, general manager, US, at the newly named CRO, Avania on the state of clinical trials. What changes might we expect in the future? Mark brings great insights. Guests are: • Mark McIlduff, general manager, US, Avania Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

DeviceTalks Weekly: Ep.6 – Hear about the Coventor Ventilator, COVID-19 and Q1 Earnings and MassDevice’s Medtech 100 Index In this week’s episode of DeviceTalks Weekly, Aaron Tucker of the Earl Bakken Medical Center shares the origin of the recently approved Coventor ventilator, which will be manufactured at-cost by Boston Scientific. We’ll also hear Abbott CEO Robert Ford comments from the company’s Q1 analyst call as we begin to dissect how the COVID-19 pandemic will impact medtech earnings. Finally, Danielle Kirsh, senior editor at WTWH Media, will share the origins of our new Medtech 100 Index, a powerful new tool for measuring how large medtech companies are managing in this new economy. Guests are: • Aaron Tucker, Lab Supervisor, University of Minnesota Earl E. Bakken Medical Device Center • Danielle Kirsh, Senior Editor, WTWH Media Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

DeviceTalks Weekly: Ep.5 –What impact is COVID-19 having on start-ups? Raising capital for start-up is never easy. Try doing it during a pandemic. In this week’s DeviceTalks Weekly, we’ll try to help entrepreneurs by talking with two guests who are committed to helping start-ups find the funding they need. Paul Grand, founder and CEO of MedTech Innovator, explains how he’s working to keep start-ups connected to capital. His popular MedTech Innovator program is adapting to the times and creating new ways for start-ups to get in front of investors. We’ll also talk with Shai Policker, CEO at MEDX Xcelerator, an incubator backed by Boston Scientific, Intellectual Ventures and others. Based in Israel, MEDX is moving forward and interested in investing capital in start-ups worldwide. Co-host Chris Newmarker, executive editor, life sciences, for WTWH Media, also updates us on what articles are drawing the most interest on MassDevice and Medical Design and Outsourcing. Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

DeviceTalks Weekly: Ep.4 –What does Medtronic's Puritan reveal mean for medtech? Medtronic’s earned plaudits and praise for sharing the design specifications for its Puritan Bennett 560 (PB560) ventilators. But will the gesture actually lead to more ventilators being manufactured? In this episode of DeviceTalks Weekly, we’ll talk with experts who will tell us what the plans do and do not say. We’ll also get some legal insights on what strings are attached to the open source effort. Guests are: • D. Brian Kacedon, Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP • Lee Teschler, Executive Editor, WTWH Media • Scott Thielman, CTO, Product Creation Studio Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

In this week’s DeviceTalks Weekly, we’ll examine how governmental effort, both foreign and domestic, are hitting the medtech industry. Our guests include Tracy Eberly, CEO of Fang Consulting, a regulatory advisory group. Eberly will update listeners on what pushing back the MDR deadline could mean for medtech companies and why some companies may be less than thrilled with the decision. In our second conversation, Joy Sturm, procurement expert and partner at the DC office of Law Firm Hogan Lovells, walks us through the powers contained within the Defense Production Act invoked last week by the Trump administration. Sturm, who brings 20-years of governmental purchasing experience to the conversation, answer several key questions including: What CAN and CAN’T the government do under the act? Which federal agencies are responsible for executing the DPA? Can companies secure capital to pay for DPA-supported efforts? What player is missing on the field in the battle against COVID-19? Also, AdvaMed is also looking  for direction from the Federal government. You may be surprised by the potential source of leadership. Finally, MassDevice Honcho Chris Newmarker talks DYI ventilators. Check out Mass Device's Sean Whooley's feature here.  And what does the FDA say about these projects?

In this week’s DeviceTalks Weekly Podcast, hosts Tom Salemi and Chris Newmarker will detail medtech’s essential role in the escalating war against COVID-19. This week’s guests are Fluidda CEO Jan De Backer and Kevin Thornal, division president of diagnostic solutions at Hologic. The executive will explain how their new FDA tools will aid against the diagnosis and treatment of COVID-19. We also ask them how the recently invoked Defense Production Act will impact medtech’s fight against the pandemic.

Welcome to the DeviceTalks Weekly Podcast, a regular – and sometimes irregular – opportunity to visit with the editorial team at MassDevice and Medical Design and Outsourcing. This week, Chris Newmarker, Executive Editor, Life Sciences, at WTWH Media, reviews our COVID-19 coverage with Tom Salemi, Editorial Director, DeviceTalks. Tom also chats with Raj Denhoy, Managing Director, Equity Research Analyst at Jefferies, who details how the Medtech sector is fairing in this unprecedented uncertainty. While most Medtechs stand on strong financial footing, Denhoy issues a warning to investors that another correction may be coming once analysts start assessing the impact on earnings. Still, he says there are safe havens out there and identifies one in the podcast. Finally, Tom and Chris explore what impact social distancing may have on medtech in the short-term – sales and deals - and long-term – innovation.

Gary Guthart, the longtime CEO of Intuitive Surgical, tells MassDevice.com Executive Editor Brad Perriello why he's so confident about staying on top of the robot-assisted surgery heap, the company's five buckets for in-house R&D; and what he looks for in potential business partners.

DeviceTalks goes inside the union of two of the most innovative companies in the world, Google and Johnson and Johnson as they look to change the face of surgery. In this episode, we chat with Scott Huennekens, President and CEO, Verb Surgical, the robotic surgery platform spinout from Google and JNJ. Huennekens shares with us the mission of Verb, insights from his career in medical startups and why he thinks robots will be performing surgery in 50 years.

There's an old saying that Ginger Rogers did everything Fred Astaire did but she did it backwards and in high heels. For Nancy Briefs, Deborah DiSanzo and Martha Shadan, it's also a challenge they know well. These CEOs and medtech veterans have made the journey from the ranks of the medtech industry to the corner office, making them, sadly, a rarity in this industry where just 1 out of 7 women in medicine hold senior executive positions. In this panel, recorded live at our DeviceTalks Boston event features remarks from DiSanzo, IBM Watson General Manager, Ms. Briefs, CEO, InfoBionic and Ms. Shadan, CEO, Rotation Medical.

Bill Carpou took over at OCTANe 18 months ago with the mission to increase Orange County, California's image as a technology super hub. Through programs like the Medical Device Investor Forum and a new emphasis on helping local companies stay in the area, OCTANe is one of the most innovative industry council's in the medical device space. We talked to Bill about OCTANe's upcoming event, as well as its recent merger with the Orange County Technology Alliance.

Jeff Burbank started NxStage Medical in 1999 on the premise that patients with chronic kidney disease would benefit from bringing hemodialysis out of the clinic and into their homes. Now, 17 years later Burbank's hypothesis has been proven out and his Lawrence, Mass.-based company is topping more than $300 million in annual sales, while making a real difference in the lives of patients. In this interview, recorded at DeviceTalks Boston on September 28, 2016, we sit down with Jeff to discuss his business journey.

When Jeffery McCaulley took the reigns at Smiths Medical, the company was in a slump. Several years of flat growth and a potential merger that didn’t go through, had sapped the winning spirit of the Twin Cities, Minn.- based company. However, with McCaulley’s arrival, came a renewed sense of what was possible for Smiths Medical. The medtech veteran employed several new initiatives, honed at companies like GE to rebuild the company’s culture and move it back on a path to growth. In this podcast, we discuss McCaulley’s playbook when it comes to fostering a winning culture in the medical device industry.

This interview, recorded live on June 6, 2016 in St. Paul, Minn. at DeviceTalks Minnesota, is one of the funniest, most enlightening and interesting discussions we've ever had at DeviceTalks. Teleflex CEO Benson Smith takes us through his career from door-to-door salesman to CEO of 1 of the top performing medical device companies in the past five years. Listen all the way to the end to hear an unforgettable tale of going all out to get the job.

Dr. Paul Walker speaks to MassDevice about his efforts to take on endotoxins and sepsis at the head of Spectral Medical, his history with the deadly condition and what’s next for the burgeoning Canadian medical device firm.

Innovative Trauma Care, a San Antonio, TX-based startup, has found a new way to stop the bleeding. The company's flagship product, the iTClamp is a hemorrhage control device for use in the extremities, scalp and neck. The device, which looks like a hair clip, seals the edges of a wound closed to stop further blood loss until the wound can be surgically repaired. We spoke to CEO Joe Brennan about the device and how it can help improve survival rates in trauma incidents.

Novocure, the St. Helier, Jersey-based medical device company, which raised more than $158M in an IPO last year, is trying to change the way we fight cancer. Company officials say its proprietary tumor treating fields technology, marketed under the product name Optune, are a new tool in the war against some of the deadliest forms of cancer. MassDevice publisher Brian Johnson recently caught up with Doyle to discuss the technology, the company's origins and how its current concentration on glioblastoma is just the beginning.

Patrick Daly, CEO, Cohera Medical talks to MassDevice Executive Editor, Brad Perriello about starting up the absorbable surgical adhesives and sealants company, how he raised one of the largest seed rounds in history and why he's moving the company to Raleigh, NC. This episode was recorded on February 29, 2016 at DeviceTalks Raleigh.

On this episode of DeviceTalks we dive into life in the corner office with Bill Hawkins, former CEO of Medtronic and chairman of Immucor. Hawkins shares his experiences on the front lines of medicine where he has spent 25 years leading companies as diverse as start ups to the world's largest medical device company.

Martin Fitchet is responsible for R&D at JNJ's medical device unit, a tall task for anyone but appropriate for this former surgeon. In this episode of DeviceTalks, we talk about what innovation means to a behemoth like JNJ and what areas he sees in medicine that are ripe for disruption.

Clostridium difficile or C. diff. is a growing crisis in the U.S. with over 29,000 deaths and 500,000 cases annually, according to the CDC. The disease, which CDC officials warned can kill people in less than 30 days, is characterized by severe diarrhea, fever, and loss of appetite. Sadly, many elderly and infirmed patients are among the most vulnerable. Roseville, Minn.-based Rebiotix is one of a handful of companies looking to harness the human microbiome into a treatment for recurrent C. diff, which impacts about 20-30% of patients, where there are currently no approved drugs to treat patients with two or more recurrences. Rebiotix is currently in Phase 2 clinical trials for the treatment, which harnesses gut microbiota and turns them into therapies. The company hopes recurrent C. diff is just the 1st in a pipeline of treatments than can be derived from the microbiome. On this episode of DeviceTalks we discuss C.diff with Reviotix CEO Lee Jones. What personal stories led her to this mission; How powerful the human microbiome will be in the future of combating disease and the differences between running a medtech company and a biotech company.

For a man who took a private company from $17 million in sales to a $4.5 billion publicly traded juggernaut, John Brown is a remarkably humble man. However, he is, by all intents and purposes, the man who put Stryker on the map. Today, the Kalamazoo, Mich.-based medical device company nets nearly $10 billion in annual sales. In this episode of DeviceTalks, recorded at the recent AdvaMed 2015 conference, Brown spoke to us about how he built such impressive results during his tenure at Stryker, including the lessons he learned along the way.

Big things sometimes come in small packages. For Sirtex Medical, the big thing comes in a really small package. The Australian medical device company’s flagship product - the SIR-sphere - is made up of 30 to 60 million microspheres about the size of a grain of sand, which are injected into the hepatic artery and flow into the liver where they kill tumors from the inside. In this episode of DeviceTalks, MassDevice.com publisher Brian Johnson talks with Mangano about the company, the learning curve he had of moving from a traditional medical device company to an oncology company and why the cancer market may be ripe for other medtech companies to enter.

Colon cancer is one of the most preventable cancers, yet it is also one of the deadliest forms of the disease. In this episode, we speak with Graham Lidgard, the Chief Science Officer, Senior Vice President of Research and Development at Exact Sciences, a Wisc. -based company that has developed a non invasive test to detect colorectal cancer without having to undergo a colonoscopy. We talk to Graham about the Cologuard test and his 40 year career developing breakthrough medical technology.

Before Stephen Ubl departed for a job as the chief lobbyist for the pharmaceutical industry, medtech's main man in Washington D.C. sat down with us to reflect on his time as CEO of AdvaMed. In this episode of DeviceTalks, we go deep into Ubl's background, the fights over the medical device tax, forging a new partnership with the FDA and more.

Marie Johnson turned tragedy into a mission. In 2002, the CEO of Aum Cardiovascular lost her husband to a sudden heart attack, despite the fact that he was, by all accounts, a perfectly healthy man. Fast forward 13 years and her company has commercialized a non-invasive test designed to quickly detect significant coronary stenosis called the CADence. Johnson hopes the pre FDA-approved device, which is on the market in Germany, will eliminate needless death due to coronary artery disease. In this interview, recorded live at our DeviceTalks Minnesota event, touches on Johnson's incredible story.

Dr. Manny Villafana is one of the most successful men in the history of medical innovation, having founded four companies, including CPI/Guidant Corp. and St. Jude Medical, Inc. His most recent venture, Kips Bay Medical was supposed to be his best work yet. However, problems with the FDA and shortfalls on funding doomed the company, which shut down in September 2015. Recorded live on September 23rd at DeviceTalks Minnesota, just one day after he resigned as CEO of Kips Bay Medical, we discuss failure with Dr. Villafana. How does someone who has had so much success deal with the opposite? What comes next for this serial entrepreneur?

Stephen Marsh has more than 70 patents to his name but his most recent endeavor, the Airing device, may make him a household name. The Airing is a hoseless, maskless, disposable micro CPAP machine, which could one day change the game in sleep apnea. However, Marsh and company have already made quite the mark on medtech by running one of the most successful crowdfunding campaigns ever. The company has raised more than $1 million on Indiegogo, more than 10 times its initial goal. In this episode of DeviceTalks, we talk to Marsh about the Airing device, inventing technology that sticks and how the company pulled off such a successful crowd funding campaign.

Ten years after it was spun out of MIT, Invivo Thereapeutics and its neuro scaffold treatment for traumatic spinal cord injuries is moving closer to a reality. The company has completed enrollment of its 5 patient pilot study, which has made headlines around the world and is looking to push forward on adding more patients. In this episode of DeviceTalks, we talk to new CEO Mark Perrin about the company and why there has been so little movement in the fight against paralysis.

In this episode of DeviceTalks, recorded live at our DeviceTalks Boston event at Boston Scientific's corporate headquarters, we sit down with CEO Mike Mahoney to discuss the company's recent turnaround. Mahoney, who joined the company as its CEO in 2012, sat down with MassDevice's Brian Johnson to take us inside how the company has improved its performance.

Reshape Medical recently received FDA approval for its Duo balloon system for obesity. The company bills the device as an alternative to bariatric surgery for the majority of patients suffering from this global epidemic. In this episode we dig into the obesity epidemic and how ReShape Medical is looking to change the paradigm of care for patients needing to lose a significant amount of weight.

In this episode we catch up with LifeScience Alley CEO Shaye Mandle about doing business in Minnesota's world class medical device cluster. We delve into why the medical device and life sciences community clustered in the Twin Cities, what trends are developing in funding, m&a and technology in the area and, of course, where to go for a power breakfast in the area.

In this episode of DeviceTalks, we delve deeply into emotion and how teaching computers to recognize emotions led to a potentially major breakthrough in medical technology with MIT scientist and entrepreneur Rosalind Picard. Listen to hear the backstory behind her book Affective Computing, her work with artificial intelligence and pioneering wearable technology.

Rotation Medical is changing the game when it comes to treating rotator cuff disease, one of the most prevalent orthopedic conditions that people suffer from. We talk to CEO Martha Shadan about Rotation Medical's revolutionary biologic treatment and how the orthopedic world is changing.

Tal Medical's roots go back to a serendipitous discovery at McLean Hospital where patients suffering from bi-polar disorder reported feeling better after MRI. In this episode of DeviceTalks, Jan Skvarka, CEO, Tal Medical tells us about how that discovery could one day lead to a new clinical pathway for care for patients suffering from acute depression.

In this DeviceTalks podcast, we talk with Merit Medical founder and CEO Fred Lampropoulos about starting the Utah-based medical device company, his thoughts on leadership and his experience as a musician opening for The Doors and The Beach Boys.

Medtech entrepreneur, patient safety advocate Joe Kiani, CEO, Masimo Corp. talks about building the company from scratch. In addition, he discusses his mission as the founder of the Patient Safety Movement Foundation, recorded at DeviceTalks West on November 19, 2014. Also featured, B. Braun CEO Carroll Neubauer.

MassDevice publisher Brian Johnson interviews Caroll Neubauer, CEO, B. Braun Medical about the medical device tax, Obamacare, patient safety and the current state of the medical device industry.

One day, Second Sight Medical CEO Robert Greenberg, may be considered one of the most important figures in the fight against blindness. On this episode of DeviceTalks, he discusses the journey to bring sight to the blind with the Argus II "Bionic Eye. "

Manny Villafanna, founder, St. Jude Medical, Guidant and Kip's Bay Medical, joins medtech CEOs Brian Concannon, Duane DeSisto, Charles Carignan and Carmichael Roberts for a discussion on leadership.

This CEO panel was recorded on July 15, 2014 at DeviceTalks Boston, hosted by MassDevice.com. It features CEOs from BIOM, Insulet and Carmichael Roberts, founder MC10, Arsenal Medical and 480 Biomedical.

MassDevice publisher Brian Johnson interviews Haemonetics CEO Brian Concannon about the company's history, its present and the future of blood management and blood donation. The interview was recorded at DeviceTalks Boston on July 15, 2014.

Panel discussion recorded at June 24th DeviceTalks Minnesota event featuring Nadim Yared, Deb Rectenwald, Philip Ebeling.

This MassDevice podcast featuring Covidien's Stacy Enxing Seng was recorded live on June 24th at DeviceTalks Minnesota.

Glooko CEO Rick Altinger and MassDevice's Brian Johnson discuss Glooko's mobile diabetes management app. Altinger describes the economics behind the Glooko platform, as well as the app's ability to foster easy communication between diabetes patients and healthcare providers.

MassDevice’s Brian Johnson and CeQur's CEO Jim Peterson discuss Peterson’s personal connection to diabetes, and how that personal connection has impacted the company’s direction.

MassDevice reporter Brad Periello speaks with CEO and founder of NxStage Medical Jeff Burbank, Zoll CEO Richard Packer, ConforMIS CEO Philipp Lang, and Ocular Therapeutix CEO Amar Sawhney about what it takes to keep companies on the cutting edge, as well as their ups and downs as heads of major medtech companies.

Johnson & Johnson's Global Medical Solutions Group Worldwide Chairman Karen Licitra talks about her role within Johnson & Johnson and how she thinks the economics of healthcare and the medical device industry need to change in order to accommodate the future.

Former Kinetic Concepts CEO Catherine Burzik takes you inside the $6.1 billion merger of Kinetic Concepts with Apax Partners in 2011, the largest leveraged buyout since the fall of Lehman Brothers.

Medtronic CEO Omar Ishrak sat down with MassDevice's Brian Johnson to talk about his two years on the job at the Minneapolis-based medtech company. Ishrak shared his experiences, as well as the insights he has gained as Medtronic's CEO.

Semprus BioSciences Corp. hopes to reduce the 60,000 deaths and $11 billion in costs related to "surface failures" of vascular catheters with its Sustain technology for coating medical devices.

William Hawkins, former chairman and CEO of Medtronic Inc., dishes on mergers and acquisitions, the Food & Drug Administration and healthcare reform.

Dr. Thomas Fogarty, the founder of the Fogarty Institute for Innovation, discusses the investment climate for medical innovation, venture capital and explains why his passion for winemaking is actually an extension of his medical career.

Capsule Tech's newly appointed North America president Stuart Long tells MassDevice about the company's surging growth and what it means to be a "middleware" service provider.

Soteira CEO Larry Jasinski talks to MassDevice about overcoming the odds with spinal fusion devices and managing a 510(k) win even after the FDA switched things up mid-stream.

Covidien CEO Joe Almeida speaks at the MassDevice Big 100 Roundtable, July 11, 2011 about innovation, emerging markets and the worst mistake he's made in his professional career.

Two decades after pioneering the technology that became Lasik, Avedro Inc. CEO David Muller is working to make the procedure safer and more effective.

Neuronetics president & CEO Bruce Shook on treating an incurable psychiatric disorder, chasing reimbursement and turning psychiatrists into medical device proceduralists.

Alfred Mann Foundation CEO David Hankin tells MassDevice how to make an artificial nervous system using microstimulators that communicate wirelessly through the body.

After a stellar 2010, Michael Mussallem, CEO of Edwards Lifesciences Corp., is feeling bullish on transcatheter heart valves and the future of the Irvine, Calif.-based cardiac device maker.

Medical device company Abiomed's CEO Mike Minogue and Stu Randle, CEO of GI Dynamics, sit down with MassDevice.com editor Brad Perriello at the MassDevice Big 100 Roundtable East.

Johns Hopkins patient safety expert Peter Pronovost on medical errors, medical device data and the role medtech must accept in preventing needless deaths.

Allergan CEO David Pyott speaks at the 2012 MassDevice Big 100 West about why the Irvine, Calif.-based medical aesthetics company is selling its Lap-Band business, why Botox is so popular and what the medical device industry can learn from the world of aesthetics.

Three months before he took the reins at Boston Scientific, Mike Mahoney told MassDevice his thoughts on how he looked to turnaround the medical device giant in this podcast from the MassDevice Big 100 East